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Permanently living at high altitude (HA) directly affects the cardiovascular system because 
of lower arterial blood oxygen content compared to sea-level and other associated 
physiological changes. It is uncertain if there are clear-cut benefits or risks to 
cardiovascular health from living at HA and whether these benefits or risks, if they exist, 
vary in different populations. In Nepal, a comprehensive cardiovascular risk assessment of 
a sample of individuals representing a HA population has not previously been performed. 
The main aims of this project were to estimate, in residents at HA, the prevalence of 
coronary heart disease (CHD) and cerebrovascular disease; to estimate the distribution of 
key cardiovascular risk factors; and to estimate any possible relationships between CHD or 
blood pressure with altitude.  
Methods 
The study design was a cross-sectional survey. The sampling technique was cluster 
sampling of study areas on the basis of altitude level, population density and logistical 
support to undertake the study, but the participants within the study areas were randomly 
selected. The sample consisted of 521 residents aged 30 years or over from the Nepal 
districts of Mustang and Humla, permanently living at altitudes of 2800 metre (m), 2890 
m, 3270 m, or 3620 m. Data was collected by administering the WHO STEPS interview 
questionnaire for non-communicable disease risk factors, a questionnaire for verifying 
stroke-free status (QVSFS), bio-physical measurements (blood pressure, height, weight, 
waist, hip), biochemical measurements (lipid profile and glycated haemoglobin), and a 
resting 12 lead electrocardiogram (ECG). The prevalence of CHD was defined as the 
presence of pathological Q waves in the ECG or self-report of personal history of CHD 
(previous event of myocardial infarction (MI) or chest pain from heart disease (angina)). 
ECG recordings were categorized as definitely abnormal (e.g. showing evidence of 
previous MI, borderline (e.g. non-specific T-wave inversion) or normal after review by a 
cardiologist using standard widely accepted criteria. Blood pressure (systolic/diastolic) was 
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classified as normal (<120/80 mmHg), pre-hypertension (HT) (120–39/80–89 mmHg), HT 
(≥140/90 mmHg), Stage I HT (140–159/90–99 mmHg), and Stage II HT (≥160/100 
mmHg). Analysis of variance (ANOVA) and analysis of covariance (ANCOVA) models 
were used for the relationship between systolic blood pressure (SBP), diastolic blood 
pressure (DBP) and altitude. Logistic regression was used to estimate the association 
between an abnormal (or borderline abnormal) ECG and altitude in univariate and 
multivariate models. 
Results 
None of the participants showed definite electrocardiographic evidence of CHD. Overall, 
5.6% of the participants gave a self-reported history of CHD. Altogether 19.6% of the 
participants had an abnormal (or borderline abnormal) ECG. The main categories of 
abnormality were right axis deviation (5.4%) and left ventricular hypertrophy by voltage 
criteria (3.5%). Observed ECG abnormalities differed between ethnic populations: 
suggestive of left sided cardiac abnormalities in the Mustang district with a majority 
population of Tibetans; and right sided abnormalities in the Humla district with a majority 
population of Khas-Arya. There was a moderate association between the probability of 
abnormal (or borderline abnormal) ECG and altitude, adjusted for  potential confounding 
variables, with an odds ratio for a greater probability of an abnormal ECG (95% CI) of 
2.83 (1.07 to 7.45), P=0.03 per 1000 m elevation of altitude.  
A history of stroke or of symptoms of stroke (by positive self-report of at least one 
criterion of the QVSFS) was identified in 6.7% of the participants. 
A multivariate model adjusting for potential confounding variables showed that there was 
moderate evidence of an association between SBP and altitude; mean SBP (95% CI) 
increase by 11.3 mmHg (-0.1 to 22.7), P=0.05 for every 1000 m elevation.  
The distribution and prevalence of key cardiovascular disease-related risk factors did not 
differ by altitude level. Rather, they differed by ethnicity, residential settings (urban or 
rural) and cultural practices. The prevalence of HT or being on treatment for HT was 
higher in the Mustang district with dominant Tibetan-related populations (between 41% 
and 54.5%) than in the Humla district, with dominant Khas-Arya (29.1%). Only 3.3% to 
iv 
 
10.3% participants in Mustang self-reported being current smokers, whereas this rate was 
38.6% in Humla. The prevalence of current drinker was high at all altitude levels ranging 
from 45.4% (3620 m) to 63.9% (3270 m). The prevalence of abnormal lipid components, 
diabetes or being on treatment for diabetes, and overweight or obesity, were all higher in 
urban (2800 m and 3620 m) compared to rural (3270 m and 2890 m) residential settings.  
Conclusion 
The HA populations sampled in this study had a lower prevalence of CHD and a higher 
prevalence of stroke than that of relevant comparator low altitude populations. None of the 
participants had ECG evidence of past CHD. Cardiovascular risk profiles of HA 
populations may depend on altitude, ethnicity, cultural lifestyle practices, and residential 
setting (urban or rural). Altitude per se could be an important additional risk factor because 
of its association with SBP and abnormal (or borderline abnormal) ECG. Different 
ancestry-related physiological responses to the low oxygen environment at HA may affect 
cardiovascular health consistent with the evidence of different patterns of ECG 
abnormality. The findings of the present study suggest that ethnicity and associated 
lifestyle or cultural practices (such as salt and alcohol intake, smoking habit) and 
residential settings (mainly differences in physical activity and fruit and vegetable 
consumption in urban and rural participants), are also likely to be important determinants 
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1 Introduction 
This chapter is divided into eight sections:  
1.1 Background on populations of the world living at high altitude (HA) and their environmental 
challenges.  
1.2 Human physiological responses to low atmospheric pressure.  
1.3 Health and diseases prevalent at HA.  
1.4 A brief overview of cardiovascular disease (CVD) trends, mortality and morbidity at HA. 
1.5 Life expectancy, CVD and risk factors for CVD in HA areas of Nepal.  
1.6 A statement of the problem.  
1.7 The significance of the study. 
1.8 The aims and objectives of the study. 
1.1 Background  
The term 'high altitude' (HA) is not uniformly defined in the scientific literature. However, an 
altitude of 2500 metre (m) or above is the conventional demarcation for HA (Pawson & Jest, 
1978) because people generally start to experience adverse symptoms such as shortness of breath 
and increased heart rate, nausea, dizziness, satiety and fatigue above this altitude (Lossio, 2006).  
Using this definition of HA, more than 140 million people in the world permanently live at HA, 
comprising 2% of the global population (Moore, Niermeyer, & Zamudio, 1998). Established 
human populations living in the Ethiopian summits of Africa, the Himalayan mountains of Asia, 
and the Andean mountains of South America have a long history of HA residency: 70,000 years, 
25,000 years, and 11,000 years respectively (Beall, 2007). The largest populations at HA are 80 
million in the Himalayan mountains of Asia and 35 million in the Andean mountains of South 
America (Moore et al., 1998). The capitals of three of the four main Andean countries are 
located at HA: La Paz (Bolivia), Bogota (Columbia), and Quito (Ecuador). Between 2% and 
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45% of the populations of Asian Countries – China, India, Nepal, Kyrgyzstan, Afghanistan and 
Bhutan – live at HA. An estimated 80 million people live in four high plateaus of China alone: 
Qinghai (Tibet), Inner Mongolia, Yun-Gui and the Yellow land plateau (Niermeyer, Zamudio, & 
Moore, 2001). 
La Rinconada, a mining village in Peru, at an altitude of 5100 m is the highest permanent 
settlement in the world, and has a population of around 7000. The Ma Gu area (altitude 5067 m) 
of Tibet, with a population around 800, and Dingboche area (4400 m) of Nepal, with a 
population of 200, are also other permanent human settlements at the extreme end of the range of 
HA residency (West, 2002). 
Living at HA is associated with consequences of the geography, such as access problems due to 
mountainous and rugged terrain. However, it is also associated with other challenges to human 
life such as decreased partial pressure of oxygen, cold temperatures, and increased exposure to 
ultraviolet radiation. The most important physiological factor affecting the health and well-being 
of HA residents is likely the reduced partial pressure of oxygen.  
Figure 1.1 shows the inverse relationship between atmospheric and inspired oxygen levels at 
increasing altitude. 
 
Figure 1.1: Ambient oxygen levels, measured by the partial pressure of oxygen (solid line) 
or as a percent of sea-level values (dashed line) decrease with increasing altitude 
(Adapted from: Beall C. M. Two routes to functional adaptation: Tibetan and Andean high-altitude 
natives. Proc Natl Acad Sci 2007;104(Suppl 1):8655-60). 
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Those born and habitually living at HA tend to adopt particular lifestyle characteristics. Most HA 
populations are involved in agricultural work and their living conditions are poor. They have 
very few options for nutrition because only a limited range of crops and vegetables can be 
produced in such extreme climatic conditions. Potatoes and highland barleys are perhaps the 
most commonly cultivated crops at HA. Fruits and green vegetables are difficult to grow at HA, 
particularly in the Himalayan regions of Asia. Most HA natives herd sheep, goats and yaks for 
meat, butter and cheese; use animal products such as wool and manure; and also use the animals 
as a means of transportation. Interestingly, in Tibet butter production was so universal that it was 
used to pay taxes and as an acceptable form of wages for daily labour (Stevens, 1996). 
HA residents are usually physically active because of the physical demands of both arable and 
pastoral farming, although during the extremely cold winters people mostly stay inside their 
houses and outdoor activities virtually cease. Butter-laden salty tea and alcohol intake are central 
facets of lifestyle in HA residents of Tibetan cultural regions. The traditional diet of Tibetans 
consequently includes high levels of salt, at a minimum of 20 to 30 grams (g) per day (Sehgal, 
Krishan, Malhotra, & Gupta, 1968; Sun, 1986). This is five times more than the World Health 
Organization (WHO) recommendation for regular dietary intake. Traditional food consumption 
also comprises large quantities of meat and a high level of consumption of alcohol (Luobu, 2012; 
X. Zhao et al., 2012). In Andean HA areas, chewing coca (the raw material from which cocaine 
is produced) is popular among natives as they believe it is beneficial in combating the harsh 
climatic conditions (Hanna, 1974). These practices are strongly culturally embedded in social 
rituals, such as weddings, funerals and feasts. 
Despite hostile environmental conditions and a reduced capacity for physical performance, HA 
native populations with the longest history of ancestry and residency have successfully adapted 
to their living situation. The extended time over which some populations have resided at HA 
means that natural selection may have led to beneficial genetic variants for optimal function 
under hypoxic conditions. A recent study reported that Tibetans, Andeans, and Ethiopian 
highlanders exhibit different adaptations to the hypoxic hypobaric situation, mediated in turn by 
different genes (Huerta-Sánchez et al., 2013). Consequently, different phenotypic responses of 
these populations to hypoxia have been observed. Andeans respond to HA primarily through 
hematological adaptations and Tibetans through respiratory changes. Both changes lead to the 
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same outcome of improved tissue oxygen delivery (Beall, 2007). These differences may 
contribute to varying benefits and risks related to the cardio-pulmonary health of HA 
populations. 
Most HA areas are rural and remote with very limited health care services and facilities. This 
contributes to late diagnosis or non-diagnosis of existing medical conditions, poorer outcomes of 
health conditions that are diagnosed, and limited accurate documentation of disease states and 
causes of death.  
1.2 Acclimatization to high altitude 
Acclimatization to HA is defined as the physiological adaptation of the body to a hypoxic 
hypobaric environment. Over generations, acclimatization may lead to 'adaptation', which 
involves genetic modifications (Lossio, 2006). 
A growing consensus among relevant scientists is that full acclimatization cannot be achieved 
because it is impossible to achieve full physiological compensation for the physical and mental 
impairments triggered by chronic hypoxia (Jourdanet, 1875). A prominent HA physiologist 
states: "it is a serious misconception on acclimatization that it will reverse all ill health effects of 
HA" (West, 2003b). Acclimatization significantly improves arterial hypoxemia, but despite this 
arterial oxygen levels remain far below those achieved at sea level (West, 2003a). This contrasts 
with the belief of some earlier scientists that a path to full acclimatization would be through 
changes in blood over generations of exposure to hypoxia (Bert, 1878). 
The distressing symptoms experienced by those living at or travelling to HA have been known 
for centuries. An example of a historical record is a report from the Himalayas of China by a 
Chinese official from between 37B.C. and 32B.C. (Gilbert, 1983b). There are reports of serious 
difficulties experienced by travellers over the western edge of the Himalayan Karakoram Range 
and in the Pamir Range during that period (Gilbert, 1983b). In the Andes, HA symptoms were 
first documented by Father Jose De Acosta in 1590 when he experienced nausea, headache, and 
heart and stomach pains while crossing the Andean Cordillera. He strongly suggested it might 
have been due to the thin air (Gilbert, 1983a). In 1878, a French physiologist, Paul Bert, 
scientifically demonstrated that distressing effects were indeed mainly attributable to the rarefied 
air (Rudolph, 1992), later confirmed by many other investigations. 
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It is not only reduced levels of inspired oxygen at HA that can induce health problems. Reports 
have documented that HA natives temporarily suffer health problems when descending to low 
altitude (LA) because of the 'excessive oxygen' (Lossio, 2006). Pulmonary edema is also found 
in HA residents when they return from LA back to their usual HA residence. This is termed 're-
ascent high altitude pulmonary edema' (Moore et al., 1998). Thus, the process of acclimatization 
seems to apply to both environmental hypoxia and hyperoxia. 
The main features of physiological adaptations to HA are hyperventilation, erythrocytosis and 
pulmonary vasoconstriction. The degree of these varies in different HA populations.  
Hyperventilation is the most commonly observed feature. Increased breathing rates and volumes 
of ordinary ventilation act to increase alveolar ventilation (Moore et al., 1998). Tibetans who live 
at HA have a two-fold higher hypoxic ventilatory response compared to Andeans who live at HA 
(Beall, Strohl, et al., 1997). When compared to HA permanent residents, sojourners from LA 
generally show a greater degree of hyperventilation (Stuber & Scherrer, 2010).  
Many HA populations produce a more erythrocytes; consequently hemoglobin concentration 
rises and both these act to offset oxygen deficiency by increasing the amount of oxygen carried 
by the blood. This phenomenon is particularly pronounced in Andean HA populations. Tibetan 
natives, on the other hand, compensate for their lower arterial oxygen by relatively a high flow 
rate of oxygen carrying blood to tissue and greater diffusion of oxygen from the blood stream 
into cells (Beall, 2007). Sherpa populations of Nepal, well-known HA dwellers of Tibetan 
ancestry, have a serum erythropoietin level at 3440 m similar to that in non-Sherpa at 1300 m 
(Hanaoka et al., 2012). An increased level of hemoglobin is not usually seen in populations 
living at an altitude of 1600 m or below when compared with those at sea level (Sullivan, Mei, 
Grummer‐Strawn, & Parvanta, 2008). Table 1.1 shows the oxygen saturated levels, hemoglobin 
levels, and arterial oxygen contents of major HA populations. 
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Table 1.1: Oxygen saturation levels, hemoglobin levels, and arterial oxygen contents of 
major high altitude populations 
 Oxygen saturation 
(%) 
Hemoglobin conc. 






Sea level 97 15.3 21.1 
Ethiopia (3530 m) 95 15.6 21.1 
Tibet (4000 m) 89 15.8 19.2 
Bolivia (4000 m) 92 19.1 24.4 
Abbreviations: g/dL, gram per decilitre; mLO2, millilitre of oxygen; mL, millilitre 
Adapted from: Beall, C. M. (2006). Andean, Tibetan, and Ethiopian patterns of adaptation to high-
altitude hypoxia. Integrative and Comparative Biology, 46(1), 18-24. 
 
There is strong genetic evidence for differences in blood hemoglobin concentrations in Tibetan 
and Andean HA populations. The gene EPAS1, for hypoxia-inducible factor 2α, stimulates 
erythrocyte production in HA Tibetans (Beall et al., 2010) but there is no evidence of enriched 
EPAS1 variants in Andean HA populations (Bigham et al., 2009). 
Pulmonary arterial vasoconstriction is another important characteristic of HA acclimatization. 
This acts to maintain alveolar perfusion and ventilation rate and to minimize systemic hypoxia 
(Stuber & Scherrer, 2010). However, excessive pulmonary vasoconstriction may lead to 
pulmonary hypertension (HT), right ventricular hypertrophy (RVH), right heart failure and 
pulmonary edema (Peñaloza & Arias-Stella, 2007). Pulmonary HT and consequent effects are 
more prominent in Andean HA populations than in Tibetans (Ostadal & Kolar, 2007). Hypoxic 
pulmonary vasoconstriction in Tibetan highlanders is minimal and pulmonary arterial pressure is 
the same as that of sea-level populations. This may be due to genetic adaptation to HA (Luobu, 
2012; Yang et al., 1987). The high level of nitric oxide gas in the lungs of Tibetan and Aymara 
HA populations might be one adaptation that contributes to pulmonary artery vasodilation (Beall, 
2007). 
Overall, the two largest HA populations at present, Tibetans and Andeans, demonstrate different 
physiological changes in response to environmental hypoxia. Usually, Tibetan HA populations 
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have better levels of hypoxic ventilation response, blood oxygen saturation, lung function, 
maximum cardiac output and sleep quality, and lower levels of pulmonary vasoconstriction and 
hemoglobin concentration when compared with Andean HA dwellers (West, 2011; Wu & 
Kayser, 2006). Tibetans show two major features that could have advanced their degree of 
adaptation further than Andeans; firstly, they have the longest generational history at HA, and 
secondly they have least a degree of genetic admixture. Andeans have substantial genetic 
admixture with South American Indian and European genes (Moore et al., 1998). The genetic 
basis of HA adaptation of Tibetan natives is relatively well understood (Wu & Kayser, 2006). 
There is little information on physiological responses of HA Ethiopians; however, available 
evidence indicates low levels of blood hemoglobin and pulmonary artery pressure, as in 
Tibetans, and higher levels of hemoglobin oxygen saturation and arterial oxygen content than in 
Tibetans and Andeans (Arestegui et al., 2011). Table 1.2 shows the comparison between 
physiological responses among the three major HA populations. 
Table 1.2: Comparisons of physiological characteristics of Tibetan, Andean, and Ethiopian 
high altitude populations 
 Tibetans Andeans Ethiopians 
Basal metabolic rate Normal Normal Unknown 
Maximum oxygen consumption Normal Normal Unknown 
Ventilation (litre/minute) 15 10.5 Unknown 
Hypoxia ventilatory response Higher Lower Unknown 
Oxygen saturation of hemoglobin Lower Higher Highest 
Hemoglobin Lower Higher Lower 
Arterial oxygen content Lower Higher Highest 
Pulmonary artery pressure Lower Higher Lower 
Pulmonary nitric oxide production Higher Lower Higher 
Peripheral capillary density Higher Lower Unknown 
Oxygen dissociation Normal Normal Normal 
Chronic mountain sickness 1.2% 8 to 15% Unknown 
Adapted from: Arestegui A. H., Fuquay R, Sirota J, Swenson E. R., Schoene R. B., Jefferson J. A., et al. 
(2011). High altitude renal syndrome (HARS). Journal of the American Society of Nephrology, 22(11), 
1963-8. 
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1.3 Health and disease at high altitude 
High levels of physical activity and some other features of a traditional lifestyle, as well as 
physiological adaptation to the hypoxemic hypoxia of HA, might be expected to be associated 
with better health for those living at HA. However, available data on mortality or life expectancy 
of HA populations is poor and inconsistent. A recent systematic analysis of the provincial level 
burden of disease in China estimated that in 2013, of all 33 provinces of China, Tibet province 
(mean altitude 4500 m above sea level) had the lowest life expectancy at birth (68.4 years) (Zhou 
et al., 2016). A similar finding of high mortality rate at HA for the period 1996 to 2000 was 
reported from the Andean region of Peru, which accounted for half of all mortality despite 
having only 32% of the total Peruvian population (Huicho, Trelles, Gonzales, Mendoza, & 
Miranda, 2009). The mortality rate in Bolivian highlanders is also higher than in other areas of 
Bolivia, increasing for every 1500 m elevation (Virues-Ortega et al., 2009). In contrast, the 
mortality rate is reported to be lower in mountainous region of Greece (950 m) than at sea level 
during the follow-up period of 15 years between 1981 and 1996 (Baibas, Trichopoulou, Voridis, 
& Trichopoulos, 2005). In the United States of America (USA), living at HA (equal to or greater 
than 1500 m) has no effect on net life expectancy (Ezzati et al., 2012). It may be that, as in other 
populations, lifestyle, genetic and environmental factors play an important role in health or 
disease at HA, rather than HA itself. This section will briefly discuss common health problems at 
HA.  
1.3.1 High altitude illness 
Chronic mountain sickness (CMS) and high altitude pulmonary hypertension (HAPH) are, by 
definition, seen in people in the HA environment, whether resident or visiting. Low birth weight 
in newborn children is observed in most HA populations. This sub-section will briefly discuss 
CMS, HAPH and low birth weight at HA. 
CMS (sometimes known as ‘Monge's disease’) is typically diagnosed in long-term HA residents. 
This disease is clinically characterized by a greater concentration of erythrocytes (blood 
hemoglobin: ≥21 g/dL (decilitre) for men and ≥19 g/dL for women) and clinical symptoms 
include dizziness, headache, insomnia, loss of appetite, breathlessness and/or palpitations, 
cyanosis, and mental and cognitive impairment (León-Velarde et al., 2005). Usually the 
prevalence of CMS is higher in men, smokers, older adults, and at higher levels of altitude 
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(León-Velarde, Villafuerte, & Richalet, 2010). Andean HA populations are particularly affected 
with CMS (8% to 15%) while Tibetans have a far lower prevalence (around 1.2%), and it has not 
been reported among Ethiopian highlanders (Beall, 2007; Beall et al., 2002). 
HAPH is often termed a CMS of a vascular type. Chronic or short-term hypoxia may induce an 
increased amount of smooth muscle cells in distal pulmonary arteries and arterioles, resulting in 
increased pulmonary vascular resistance, pulmonary vasoconstriction and consequent pulmonary 
HT (Ostadal & Kolar, 2007). Furthermore, these adaptations may lead to high altitude pulmonary 
edema (HAPE) and consequent fatal events (Lankford & Swenson, 2014). HAPH is generally 
considered to be present when mean pulmonary artery pressure exceeds 30 mmHg or systolic 
pulmonary artery pressure is >50 mmHg (measured at the residential altitude). Clinical signs are 
those of right heart failure such as dyspnoea, sleep disturbance or cyanosis (León-Velarde et al., 
2005). A large body of evidence shows increased levels of HAPH among HA Andeans but it is 
uncommon in Tibetan HA dwellers (Stuber & Scherrer, 2010). 
Low birth weight is another well-established effect of hypoxia at HA populations. From past 
studies conducted over 40 years, estimates are that birth weight declines by mean of 100 g for 
every 1000 m elevation of altitude (Moore et al., 1998). This is attributed to intra-uterine growth 
retardation due to oxygen deficiency in the fetal placenta (Moore, Charles, & Julian, 2011) rather 
than other risk factors like maternal age, prenatal care, or nutrition (Jensen & Moore, 1997). All 
HA populations have reduced birth weight compared to LA populations. However, this 
association is less prominent in populations with the longest ancestry at HA. For example, the 
association is least in Tibetans, intermediate in Andean HA populations, but most pronounced in 
populations with the shortest history of residence at HA, such as dwellers of the Rocky 
Mountains North America, Ladakh-India, and Han-China (Moore, Armaza, Villena, & Vargas, 
2002).  
Higher levels of neonatal, infant and maternal mortality are also reported in some HA 
populations, particularly in Peru and Bolivia (Gonzales, Tapia, & Carrillo, 2008; Pan American 
Health Organization, 1994). A large study of 22,662 residents of Peru reported five times higher 
odds for stillbirth rates at altitude of greater than 3000 m when compared to those at 150 m 
(Gonzales et al., 2008). However, there is some inconsistency in this association (Miller et al., 
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2007). Low birth weight at HA could also be due to other factors such as limited medical care, 
infectious diseases, and lack of good maternal education.  
Several studies report growth retardation in HA children. Growth stunting was reported to persist 
in HA children in Peru between 1964 and 1999 (Pawson & Huicho, 2010), and in children of 
Tibetan origin in Nepal (Pawson, 1977). Although intra-uterine growth retardation and 
suboptimal nutrition in remote areas at HA may be relevant, increasing altitude is detrimental to 
the growth of children even after accounting for related socio-economic factors (Dang, Yan, & 
Yamamoto, 2008). 
Taken together, these trends in HA-related diseases and morbidities generally show that HA 
residents with more favourable patterns of adaptation have fewer consequences from 
environmental hypoxia (Beall, 2007; Beall et al., 2002). 
1.3.2 Other major diseases 
Other important diseases related to HA-triggered body tissue hypoxemia and the HA 
environment are chronic obstructive pulmonary disease (COPD), cancer, and renal-related 
abnormalities. 
The reported increased prevalence of COPD in hypoxic environmental conditions of HA is not 
uniform across HA populations. The association between altitude and the prevalence of COPD 
was positive in Colombia (Caballero et al., 2008) but negative in Latin American cities (Menezes 
et al., 2005) and in Mexico (Laniado-Laborin, Rendón, & Bauerle, 2011). The vast majority of 
the prevalence studies of COPD at HA are based on studies from South America. There is some 
evidence of a positive association between COPD mortality and altitude (Cote, Stroup, Dwyer, 
Horan, & Peterson, 1993; Ezzati et al., 2012). The tendency to use biomass fuel for household 
energy among HA dwellers may precipitate COPD (Norboo, Yahya, Bruce, Heady, & Ball, 
1991; Pearce, Aguilar-Villalobos, Rathbun, & Naeher, 2009). CMS may also contribute to 
chronic respiratory illness because of decreased alveolar ventilation (León-Velarde et al., 2010).  
The majority of epidemiological studies report lower cancer mortality and prevalence at HA. 
Higher levels of vitamin D produced by higher ultraviolet radiation at HA is proposed to be one 
mechanism providing protection from cancer (Hayes, 2010). This is biologically plausible 
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because vitamin D could prevent cancer by inhibiting cell growth and increasing cell 
differentiation (van den Bemd, Pols, & van Leeuwen, 2000). Other adaptations, possibly related 
to increased levels of blood hemoglobin at HA, may intensify the progression of specific 
malignant tumours, including breast cancer (Bennett et al., 2008). However, large studies with 
samples from the USA (Youk, Buchanich, Fryzek, Cunningham, & Marsh, 2012) and another 
multi-national study (Burton, 1975) reported no particular association between cancer mortality 
and HA. The occurrence of some cancer types are reported to be higher in some HA populations. 
For example, the incidence and mortality from gastric cancer is associated with residence in HA 
areas of Central and Andean South America (Torres et al., 2013), and the prevalence of 
melanoma is also reported to be higher in mountainous regions of Spain (Aceituno-Madera, 
Buendía-Eisman, Olmo, Jiménez-Moleón, & Serrano-Ortega, 2011). There is no published 
evidence about cancer for the Himalayan region.  
In summary, the existing evidence suggests that HA populations are not generally at greater risk 
from cancer-related morbidity and mortality (Burtscher, 2014; Hayes, 2010), but rather than 
providing direct protection, HA could be a surrogate marker for host genetic, bacterial, dietary, 
and environmental factors that may increase the risk of some forms of cancer (Torres et al., 
2013). 
A new clinical syndrome, high altitude renal syndrome (HARS), has been proposed as an entity 
consequent on the combined effects of HA induced polycythemia, systemic HT, hyperuricemia 
and microalbuminuria on kidney function (Arestegui et al., 2011). A marked increase in 
hematocrit level and hypoxemia at HA seems to mediate adverse renal function through 
mechanisms such as decreased renal plasma flow and consequent lower glomerular filtration rate 
(Lozano & Monge, 1965), increased production of uric acid (Schoutsen, De Jong, Harmsen, De 
Tombe, & Achterberg, 1983) and decreased urate clearance (Johnson et al., 2003). These 
findings are supported by a large Tibetan study, which found a greater prevalence of 
hyperuricemia, microalbuminuria, and proteinuria among HA residents compared to LA 
residents of Tibet (W. Chen et al., 2011). Glomerular hypertrophy was also seen in HA children 
(Naeye, 1965), which is likely to be related to the low birth weight at HA (Brenner, Garcia, & 
Anderson, 1988).  
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1.4 Cardiovascular disease mortality and morbidity at high altitude 
Hypobaric hypoxia at HA directly affects the cardiovascular system because of the decline in 
arterial blood oxygen content and other physiological changes. A possible pathophysiological 
link between CVD and HA has always intrigued researchers, although studies over more than 
five decades have not resulted in any clear-cut resolution of benefits or risks to CVD health from 
living at HA (Ostadal & Kolar, 2007). 
Although the current pool of evidence is inconsistent as to the association between coronary 
heart disease (CHD) mortality and morbidity rates at HA, a majority of studies report an 
association between stroke and congenital heart disease at HA when compared to LA 
populations. The relationship between CVD and HA was first reported in the 1960s when 
Hurtado showed that residents living at an altitude of 4540 m in Peru had lower rates of 
myocardial infarction (MI) and coronary thrombosis compared to those at sea level. Remarkably, 
this report only recorded one case of MI at HA over a period of 30 years (Alberto Hurtado, 
1960). Subsequently, an analysis of 300 autopsies carried out on deceased who had lived at 4375 
m in Peru also did not find any case of MI or significant CHD (Ramos, Krüger, Muro, & Arias-
Stella, 1967). These Peruvian observations are consistent with a study at 4100 m in Milpo, which 
reported a significantly lower prevalence of HT, angina and electrocardiogram (ECG) 
abnormalities than at sea level (Ruiz, Figueroa, Horna, & Peñaloza, 1969). These earlier studies 
have not provided information on the role of possible confounding factors that might also lead to 
lower apparent rates of CHD.  
Studies on some other HA populations also report lower CVD mortality and morbidity rates 
compared to LA. A retrospective analysis of mortality data in counties of the USA suggest that 
living at HA might have a protective effect on ischemic heart disease (IHD) (Ezzati et al., 2012). 
However, the vast majority of this study’s data came from low to intermediate altitudes of lower 
than 2500 m. Similarly, a hospital-based retrospective study in Saudi Arabia also suggested a 
lower incidence and mortality of acute MI in HA regions compared to the rest of the country 
(Ashouri et al., 1993).  
The main proposed biologically plausible explanation for cardio-protection at HA is activation of 
a transcriptor modulator, hypoxia inducible factor (HIF-1), which induces the expression of 
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multiple genes with cardioprotective properties (Semenza, 2006). Proposed mechanisms include 
stimulating nitric oxide synthesis (Ding et al., 2005), boosting erythropoietin (Cai et al., 2003), 
angiogenesis (Sasaki et al., 2002), increasing the efficiency of mitochondrial energy production 
(Essop, 2007), and other anti-oxidant functions (Abdias Hurtado, Escudero, Pando, Sharma, & 
Johnson, 2012). High levels of vitamin D due to an exponential increase in ultraviolet B (UVB) 
light at HA (J. D. Anderson & Honigman, 2011), improvement in coronary vasculature through 
increased number of branches and peripheral vessels (Arias‐Stelalnad & Topilsky, 1971), 
increased levels of physical fitness and a low level of air pollution (Burtscher, 2014) have also 
been suggested as cardio-protective factors. A 'healthy individuals effect' is an alternative 
explanation for these findings from non-experimental studies of illness at HA because sick 
people often migrate away from HA to LA (Regensteiner & Moore, 1985). 
A number of studies also report higher CVD mortality and morbidity rates at HA. CVD related 
complications in Bolivia were more frequent in grandparents living at high (equal to or greater 
than 3000 m) and moderate (1500 m to 2999 m) altitude compared to LA counterparts (Virues-
Ortega et al., 2009). In a Yemeni study on acute coronary syndrome patients, HA (1500 m to 
3500 m) patients were more likely to have a history of IHD, younger age, hyperlipidemia and 
higher smoking rates (Al-Huthi, Raja'a, Al-Noami, & Rahman, 2006). A positive correlation 
between CHD morbidity and altitude was also found in an epidemiological study of CHD in 
provinces in China (D. Zhao, 1993). Higher hematocrit levels at HA were attributed for these 
adverse outcomes in some HA populations (Al-Huthi et al., 2006; Al Tahan et al., 1998). A 34-
year follow up in the Framingham study demonstrated that a higher hematocrit level was 
significantly associated with the incidence of CHD, MI, and stroke (Gagnon, Zhang, Brand, & 
Kannel, 1994). Furthermore, a high prevalence of certain risk factors (for example, HT in 
Tibetan HA dwellers (Mingji, Onakpoya, Perera, Ward, & Heneghan, 2015)) may contribute to 
the adverse CVD related outcomes. 
A preponderance of evidence suggests a greater risk of stroke and related morbidities in HA 
populations. A Pakistani hospital-based study showed that the relative risk of stroke among 
populations living at 4572 m was 10 times greater than for those living at 610 m (Niaz & 
Nayyar, 2003). The age-adjusted incidence of stroke in Tibet was one of the highest in China at 
450.4 per 100,000 population (G. Xu, Ma, Liu, & Hankey, 2013). Another study in the Tibetan 
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state of Ganzi using a representative sample of 7038 individuals reported the stroke morbidity 
rate was high at 1923 per 100,000 population (H.-T. Zhang, Gao, Ye, Pang, & Long, 2015). A 
very recent study estimated that age-standardized death rates from cerebrovascular diseases were 
highest among Tibetan women and second-highest in Tibetan men when compared with the 
populations of the other 32 provinces of China (Zhou et al., 2016). The rate of stroke was also 
observed to be high among those working at HA. A study in an army population deployed at an 
altitude of higher than 3000 m, with mean length of stay 10.2 months, reported 12.8 cases of 
stroke per 1000 hospital admissions as opposed to just 1.05 per 1000 hospital admissions in 
soldiers living at lower than 3000 m (S. K. Jha, Anand, Sharma, Kumar, & Adya, 2002). None of 
these studies reported lower mortality and morbidity rates of stroke at HA. One study at an 
altitude of greater than 3400 m in Peru reported stroke prevalence rates comparable to the world 
population (Jaillard, Hommel, & Mazetti, 1995). 
Both lifestyle and physiological changes due to hypoxia may contribute to a higher risk of stroke 
at HA. Lifestyle factors such as diet and consequent HT and hyperlipidemia were suggested as 
causal for higher stroke rates in Tibet (G. Xu et al., 2013; H.-T. Zhang et al., 2015), whereas 
increased levels of polycythemia were implicated for other HA populations (Al Tahan et al., 
1998; S. K. Jha et al., 2002). A Saudi Arabian study reported that of all stroke cases thrombotic 
stroke was 93.4% at an altitude of higher than 2000 m as opposed to 79.3% at an altitude lower 
than 2000 m (Al Tahan et al., 1998). HA polycythemia may increase blood viscosity and 
accelerate thrombosis (Fujimaki, Matsutani, Asai, Kohno, & Koike, 1986). Other factors such as 
dehydration caused by hyperventilation, cold temperature and lack of thirst (Basnyat et al., 
2001); hypercoagulability due to marked increment in plasma fibrinogen levels (Singh & 
Chohan, 1973); and platelet adhesiveness (S. C. Sharma, Vijayan, Suri, & Seth, 1977) may raise 
the risk of thrombosis and resultant thrombotic stroke at HA. A systematic review suggests that 
HA populations of the Himalayas have a higher cerebral blood flow than both Andean 
populations and sea-level residents, but Andean populations have a lower cerebral blood flow 
values compared to sea-level populations (Jansen & Basnyat, 2011). Therefore, it is likely that 
Andeans and other populations who are less adapted to HA may have an increased risk of 
thromboembolic stroke due to increased level of hematocrit and reduced availability of nitric 
oxide (Jansen & Basnyat, 2011). 
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Large studies report an increased risk of congenital heart disease in children born at HA. Studies 
comprising 32,578 (Jin et al., 2008), 288,066 (Q. H. Chen et al., 2009) and 5,790 children (J.-Y. 
Zheng et al., 2013) all found an association between congenital heart disease and HA. However, 
these studies have been carried out only in the Tibetan HA region and data for other HA resident 
populations are unclear. Hospital-based data in La Paz (mean altitude 3650 m), Bolivia, showed 
that 66% of all cardiac related surgery was for congenital heart disease, and of these patients 
91.5% were resident at altitude above 3000 m (Ponce-Caballero, Loma-Rodriguez, Villegas, & 
Laura, 1976). Lower oxygen tension and increased pulmonary vascular resistance at HA may 
result in impairment of normal neonatal development (Miao, Zuberbuhler, & Zuberbuhler, 1988; 
J.-Y. Zheng et al., 2013). 
A large body of evidence suggests beneficial effects on CVD health in populations living at 
intermediate levels of altitude (Baibas et al., 2005; Faeh, Gutzwiller, & Bopp, 2009; Faeh et al., 
2016; R. Gupta, Misra, Pais, Rastogi, & Gupta, 2006; Mahajan et al., 2004; Mortimer Jr, 
Monson, & MacMahon, 1977; Sinnett & Whyte, 1973; Voors & Johnson, 1979). IHD and stroke 
mortality was shown to be inversely and progressively related to altitude (259 m to 1960 m) in a 
retrospective data analysis of 1.64 million people in Switzerland (Faeh et al., 2009). Further 
analyses in Switzerland, encompassing 4.2 million people, reported that after accounting for all 
other environmental factors IHD mortality reduced by a significant 24% at an altitude higher 
than 1500 m compared to an altitude lower than 600 m (Faeh et al., 2016).  
Taken together, the evidence is inconsistent, although majority report cardio-protection from 
living at HA. The retrospective and hospital-based nature of these studies means other factors 
may explain the apparent association between lower rates of CHD and living at HA. Evidence 
for the increased risk of stroke and congenital heart disease at HA is more robust. Studies of 
populations living at intermediate altitudes report better cardiovascular health at this level of 
altitude. More studies are needed of populations living at HA taking account of different 
ethnicities to improve understanding of the consequences of HA for cardiovascular health. 
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1.5  Life expectancy at high altitude in Nepal 
The national health information system of Nepal is very rudimentary. Nepal is one of the 19% of 
the countries that do not have an established system to record cause-specific mortality (World 
Health Organization, 2014a). A vital registration system with sufficient information on causes of 
death is not in place. However, information on life expectancy is available. The Central Bureau 
of Statistics (CBS) reports that the mountain region of Nepal has the lowest life expectancy at 
birth (66.98 years) compared to the hilly region (69.02 years) or low-land region (68.85 years) 
(Central Bureau of Statistics, 2012). The proportion of people not expected to survive to age 40 
years has also been estimated to be higher in the mountain region (10.62%) compared to the hilly 
(7.11%) or low-land regions (7.44%) (Government of Nepal & United Nations Development 
Programme, 2014). Research initiatives on CVD and related risk factors in Nepal are scarce and 
the information that does exist is reviewed in Section 2.6.  
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1.6 Statement of the problem 
The risks and benefits for cardiovascular health in an environment of chronic hypobaric hypoxia 
induced by living at HA are uncertain. Increased angiogenesis and structural vascular changes 
caused by HA may be helpful in reducing blood pressure (BP) and promoting cardio-metabolic 
efficiency, but erythrocytosis (from chronically low inspired oxygen concentrations) and 
pulmonary HT among those living at HA may constitute important cardiovascular risk factors 
(Ostadal & Kolar, 2007; Stuber & Scherrer, 2010). The largest HA populations, Tibetans and 
Andeans, have different distributions of key CVD risk factors; for example, higher systemic HT 
in Tibetans (Mingji et al., 2015) but lower in Andeans (Makela, Barton, Schull, Weidman, & 
Rothhammer, 1978), and higher pulmonary HT in Andeans but lower in Tibetans (Beall, 2007). 
The differences in genetic, lifestyle and cultural factors among HA populations may all be 
relevant to this variation.  
In Nepal, almost 2 million people live permanently in mountainous areas, representing 7% of the 
national population (Central Bureau of Statistics, 2012). A large proportion of the population of 
the hilly districts are also resident at altitudes greater than 2500 m. According to earlier 
estimates, around 35% of the total Nepalese population permanently live at higher than 2500 m 
of elevation (Moore et al., 1998). Populations with Tibetan ancestry are the dominant HA 
population in Nepal: for example, Sherpa, Thakali, Tibetan Gurung and Lama. They migrated 
from the Eastern part of Tibet about 500 years ago (Eagle, 2000). 
No study has yet reported CVD incidence and there is little published information on diabetes, 
obesity, dyslipidemia and dietary risk in this group. A few studies have examined the prevalence 
of HT, mainly in Sherpas. 
Two large studies have reported the prevalence of HT in mountainous districts of Nepal and 
compared it with that in populations living at moderate altitude in the hilly region and in the 
lowest terrain of the low-land region. A national representative survey among those aged 
between 18 and 65 years and including five mountainous districts showed that the prevalence of 
HT in mountain districts was more than double (29.5%) of that in the hilly (14%) and low-land 
(13.7%) regions (Koju et al., 2015). This study also noted that those living at an altitude of equal 
to or greater than 2000 m had an adjusted odds ratio with 95% confidence interval (CI) of 1.3 
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(0.9 to 1.9) for being hypertensive compared to those living at below 2000 m. Also, living at 
equal to or above 2000 m was reported to be associated with HT after adjustment for possible 
confounding variables in this study. In contrast, the WHO STEPS survey conducted in 2013 
documented a slightly lower prevalence of HT in mountainous regions (22.2%) than in the hill 
areas (25.9%) or low-land areas (26.1%) (K. K. Aryal et al., 2015). It is likely that this 
discrepancy is caused by the confounding effect of sampling different ethnic populations and the 
consequent differential exposure to risk factors. In a study that compared BP and HT in 
opportunity samples of male Sherpas older than 18 years living at HA with those who migrated 
to a low-land area, the rate of HT was 25% in those living at between 3400 and 3900 m in the 
Everest region and 21.7% in Sherpas who migrated to Kathmandu (Smith, 1999). Diastolic blood 
pressure (DBP) was significantly higher in Sherpas currently living at HA. An earlier study 
reported the opposite association: that Sherpas and Tibetans living at HA (above 2980 m) had a 
lower systolic blood pressure (SBP) than those who were born at HA but later migrated to LA 
(Kathmandu) (Weitz, 1982). A very low prevalence of HT (3.8%) at HA (above 2650 m) among 
those aged over 14 years was also reported in the Humla district of Nepal (S. Shrestha, Shrestha, 
Shrestha, & Bhattarai, 2012). A proposed mechanism for an association between altitude and BP 
and HT is the tradition in Nepal for HA residents from Tibetan ancestry to consume large 
amounts of salty butter tea (Smith, 1999). 
Two studies have reported blood glucose levels at HA in Nepal and both found a lower 
prevalence at HA than at LA. A national survey reported the prevalence of raised blood glucose 
(fasting plasma glucose ≥126 mg/dL (≥7.0 mmol/L) or on medication) was 1.9% in mountainous 
areas compared to 3.5% in hilly regions and 3.9% in low-land areas (K. K. Aryal et al., 2015). 
Similarly, 14.3% of Sherpa population aged 30 to 70 years and living at altitudes equal to or 
higher than 2900 m in the Everest region were shown to have impaired fasting glucose (IFG) 
(100 to 125 mg/dL) (5.6 to <7 mmol/L) and 2 hours plasma glucose <200 mg/dL (<11.1 
mmol/L) compared to 42.1% in Sherpa living in the Kathmandu valley (Sherpa, Supamai, & 
Virasakdi, 2008). The adjusted odds ratio (95% CI) for IFG was 0.19 (0.08 to 0.44) for the 
Everest region compared to Kathmandu. 
Studies on the prevalence of obesity at different altitudes in Nepal report inconsistent results. A 
recent national study among 13,369 women aged between 15 and 49 years reported that the 
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prevalence of overweight (body mass index [BMI] ≥25 kg/m
2
) in women from mountainous 
regions (24.8%) was higher than in the hilly (18.7%) and low-land (6.3%) areas (S. Bhandari et 
al., 2016). In another study among Tibetans in Nepal, those living at HA of equal to or higher 
than 2900 m had a greater prevalence of central obesity (waist circumference [WC] >102 cm for 
men and >88 cm for women) than those at 1200 m (57.1% versus 53.5%) (Sherpa, Stigum, 
Chongsuvivatwong, Thelle, & Bjertness, 2010). A lower expenditure of calories in Tibetan HA 
residents has been documented (Sherpa, Stigum, Chongsuvivatwong, Nafstad, & Bjertness, 
2013), which transforms surplus calories into visceral fat. Another national survey reported a 
markedly lower prevalence of overweight or obesity (BMI ≥25 kg/m
2
) in mountainous 
populations (9%) compared to hilly (26.2%) and low-land (18.9%) residents (K. K. Aryal et al., 
2015). 
One previous study investigated the lipid profile of HA residents in Nepal. The WHO STEPS 
survey 2013 in populations 15 years and over reported that the proportion of elevated total 
cholesterol (TC) was lowest in mountainous regions (14.1%) compared to 21.7% in hilly and 
24.5% in low-land areas (K. K. Aryal et al., 2015). This study also reported a higher prevalence 
of current smokers (mountainous 24.6%, hilly 19.9%, low-land 16.5%), hazardous drinkers 
(mountainous 5.7%, hilly 3.1%, low-land 0.6%), but the least prevalence of low physical activity 
(mountainous 0.5%, hilly 2.2%, low-land 4.8%). A low consumption of fruit is more prevalent in 
mountainous regions. One study including 21,111 women of reproductive age from all ecological 
regions of the country showed that 4% of participants from mountainous districts, 16% from 
hilly districts, and 9.4% from low-land districts consumed fruit once a day (S. Bhandari et al., 
2016). Another nationally representative study also reported a low intake of fruit and vegetables 
in mountainous regions (mountainous 99.3%, hilly 98.7%, low-land 0.6%) (K. K. Aryal et al., 
2015). 
Dietary practices vary significantly between the two major ethnic populations living at HA in 
Nepal – Tibetans and Khas-Aryas. Those from Tibetan origins (such as Sherpa and Thakali) 
have culturally derived food practices of consuming large amounts of alcohol, salt, meat 
products and oil (Smith, 1999; Stevens, 1996). However, during the field surveys this author has 
observed that the Khas-Aryas at HA have gradually acquired Tibetan dietary practices, 
particularly in consuming salty butter tea. 
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In summary, there is little robust data from population-based studies on CVD and related risk 
factors among HA populations in Nepal. Such studies that do exist have inconsistent findings. 
Differences in CVD-related risk in Nepal may depend as much on ethnicity (Tibetans versus 
Khas-Aryas) as on altitude. More evidence on both ethnic populations is required to understand 
the degree of CVD risk in HA populations of Nepal. 
1.7 Significance of the study 
This study is significant because: 
First, it will be the first comprehensive survey of CVD and CVD risk factors in the population at 
HA in Nepal, which in turn may lead to development of important strategies to reduce this risk. 
Second, comparing the results of this study with results of studies in other HA populations will 
supply information on the potential role of altitude itself and other key environmental factors 
such as urban versus rural settings. Third, the comparison between Tibetan and non-Tibetan HA 
populations will enable understanding of whether HA itself has a protective or harmful effect on 
cardiovascular health or whether other factors such as ethnicity or lifestyle determine the risk. 
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1.8 Aims and objectives 
Research Questions 
This study investigates the following general research questions: 
1. What is the prevalence of CHD in HA populations in Nepal?  
2. What is the prevalence and distribution of key CVD risk factors among this group and do 
these differ by altitude? 
The detailed aims are: 
1. To estimate the prevalence of CHD by interpreting resting ECGs, to identify any distinct 
pattern of ECG abnormalities, and to estimate the association, if any, between changes consistent 
with CHD and altitude.  
2. To estimate the prevalence of cerebrovascular disease. 
3. To estimate the distribution of blood pressure and prevalence of HT and to determine the 
association, if any, between systolic and diastolic BP, and altitude.  
4. To estimate the distribution of key CVD risk factors: lipid profile, glycated hemoglobin, body 
mass index, waist and hip circumference, tobacco use, alcohol use, salt use, fruit and vegetable 
consumption, and physical activity. 
5. From this information, to determine the 10-year risk of fatal or non-fatal cardiovascular events 
using the WHO and International Society of Hypertension (ISH) risk prediction chart. 
6. To compare the estimates of CHD, BP, HT, CVD risk factors, and CVD risk at HA with 
similar data from those living at LA.  
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2 Literature Review 
The purpose of this chapter is to review and summarize the literature on cardiovascular disease 
(CVD) and related risk factors in high altitude (HA) populations. Five sections present various 
associations between CVD and risk factors and HA. Narrative reviews are presented for the 
associations between: (i) obesity, (ii) tobacco use, (iii) alcohol intake, (iv) diet, and (v) 
electrocardiogram (ECG) abnormalities; and altitude. There is a final section about CVD and risk 
factors specifically in Nepal. 
2.1 Obesity at high altitude 
Overweight and obesity are important public health concerns affecting both developed and 
developing countries. The World Health Organization (WHO) has considered it a global 
epidemic (World Health Organization, 2000). According to a recent WHO report, 13% of the 
world's adult population (men 11%, women 15%) were obese and 39% (men 38%, women 40%) 
were overweight in 2014 (World Health Organization, 2015b). Estimates for developed countries 
are that between 40% and 70% of the adult population are either overweight or obese (Ng et al., 
2014). A rapid rise in the prevalence of severe obesity (obesity III, body mass index (BMI) ≥40 
kg/m
2
) is of particular concern; for example it is at 6.4% in the United States of America (USA) 
(Ogden, Carroll, Kit, & Flegal, 2014). 
Obesity increases the risk of CVD, particularly via associated risk factors such as diabetes, 
hypertension (HT) and dyslipidemia (Solomon & Manson, 1997). Type II diabetes is particularly 
associated with obesity. More than 80% cases of type II diabetes can be ascribed solely to 
obesity (Napier, 2006). People with a BMI greater than or equal to 35 kg/m
2
 are 20 times more 
likely to develop diabetes compared to individuals with a normal BMI during a 10-year period 
(Field et al., 2001). The suggested mechanism of type II diabetes in most of those with obesity is 
insulin resistance due to the elevated levels of serum fatty acids in the obese state (Boden, 2011; 
Papaetis, Papakyriakou, & Panagiotou, 2015). 
It may be that obesity should be treated like any other chronic disease regardless of metabolic 
abnormalities (Hill & Wyatt, 2013). In a systematic review and meta-analysis of non-
experimental studies conducted between 1950 and 2013, the relative risk of all-cause mortality or 
cardiovascular events was 1.24 (95% CI 1.02 to 1.55) in obese participants compared to the 
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metabolically healthy normal weight participants (Kramer, Zinman, & Retnakaran, 2013). 
Obesity was a significant predictor of ischemic heart disease (IHD) in the Framingham study 
data involving 5209 participants (Hubert, Feinleib, McNamara, & Castelli, 1983). The 
INTERHEART study also showed that abdominal obesity could account for 20% of the 
population-attributable risk of first myocardial infarction (MI) (Joshi et al., 2007). Obesity-
related comorbidities could be improved with weight loss of 5% to 10% (Padwal & Sharma, 
2010). Although the net positive energy balance (overload less expenditure) is the most common 
cause of obesity, the etiology is highly complex and encompasses factors (among others) such as 
genetic, physiological, environmental and socio-economic (Napier, 2006; Wright & Aronne, 
2012). 
Obesity in HA populations 
The preponderance of evidence suggests that HA populations generally have a lower BMI and 
less general obesity compared to low altitude (LA) populations. However, the rates of central 
obesity as defined by high waist circumference (WC) were actually higher in most of the HA 
populations studied. In addition to the known risks for obesity such as lifestyle, dietary and 
socio-economic factors, other environmental conditions at HA could influence obesity in native 
populations. These include hypoxia, cold temperature-induced changes in energy balance and 
metabolic rate, low birth weight, growth stunting, and a high level of vitamin D. However, the 
role of these factors for obesity in HA populations has not been fully elucidated. This review will 
discuss key findings on obesity-related studies in adult HA permanent residents, explain possible 
causes and the possible mechanism of this relationship, and also briefly describe the effects on 
obesity from short-term exposure to HA. 
A large amount of evidence indicates an inverse association between BMI and altitude. In a 
nationally representative study comparing American adults living at lower than 500 metre (m) 
(n=322,681) and higher than or equal to 3000 m (n=236), LA residents had a greater risk for both 
men and women for obesity: odds ratio (95% CI) 5.1 (2.7 to 9.5), for men, and 3.1 (1.6 to 9.3), 
for women, after controlling for temperature, diet, urbanization, physical activity, smoking, and 
demographic factors (Voss, Masuoka, Webber, Scher, & Atkinson, 2013). Another study 
comparing Tibetan participants residing in Tibet and Nepal at three levels of altitude (1200 m, 
2900 m, and 3700 m) found that a higher altitude level was significantly associated with lower 
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BMI even after adjusting for physical activity and calorie intake (Sherpa et al., 2010) (Table 2.1). 
This relationship was not observed for WC or waist to height ratio (WHtR). An inverse 
relationship between altitude and BMI, WC and waist to hip ratio (WHR) was found in an Indian 
study comparing the anthropometric measurements in a HA population (2438 m) in Himanchal 
Pradesh and a LA population in Delhi (253 m) (Tyagi, Tungdim, Bhardwaj, & Kapoor, 2008). 
Another Indian study comparing the populations with Tibetan ancestry at low (701 m), 
intermediate (1861 m), and high (3493 m) altitude also reported an inverse relationship of BMI 
with altitude (Mandal, Adak, Biswas, & Bharati, 2011). A Peruvian study on 210 women with 
similar ancestry but living at different altitudes (>3800 m and <1500 m) showed a similar BMI 
and WC at both levels (Lindgärde, Ercilla, Correa, & Ahrén, 2004). 
Table 2.1: Prevalence of obesity and central obesity by altitude level 
Altitude 1200 m  
(N=127) 
2900 m  
(N=119) 
3660 m  
(N=371) 
 N (%) 
Obesity 25 (19.7) 14 (11.8) 36 (9.7) 
Central obesity 68 (53.5) 68 (57.1) 92 (24.8) 
Definitions: obesity, BMI ≥30 kg/m
2
; central obesity, WC >102 cm for men and WC >88 cm for women. 
(Adapted from Sherpa et al. 2010). 
Studies comparing the natives permanently living at different levels of HA populations also 
document a lower BMI with increasing levels of altitude (Negi et al., 2012; S. Shrestha et al., 
2012). Negi et al. 2012 reported that the prevalence of obesity was 17.4% and central obesity 
(WC: >90 cm for men and >80 cm for women) was 19.4% in the participants living at 3100-
3500 m but the corresponding values increased to 35.7% and 30.4% respectively in those living 
at higher than 3500 m in Spiti valley of India (Negi et al., 2012). In a Nepalese study of 137 
participants, BMI was significantly lower at 2950 m compared to 2670 m, especially in men (S. 
Shrestha et al., 2012). 
Studies carried out at a single altitude level of HA have also generally shown a low prevalence of 
obesity by BMI classification but higher central obesity. A study in Pakistan comprising 4203 
adults living at 2438 m reported obesity in just 1.8% of the participants (Shah, Nanan, Rahbar, 
Rahim, & Nowshad, 2004). A Peruvian study at 4100 m on a small sample of 102 estimated an 
obesity prevalence of 2.6%, 18.2%, and 14.3% for the age groups 30 to 39 years, 40 to 49 years, 
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and older than 50 years respectively (Mohanna, Baracco, & Seclén, 2006). The corresponding 
prevalence for central obesity (WC: >102 cm for men and >88 cm for women) were 36.8%, 
36.4%, and 47.6% respectively. A study on HA farmers and herdsmen at 3700 m in Tibet 
reported the prevalence of central obesity (WC: ≥90 cm for men and ≥80 cm for women) in 46% 
of the 692 participants aged 30 to 80 years (Sherpa et al., 2013). This prevalence was higher in 
women than in men (64.3% versus 25%). 
While the majority of the studies report lower BMI and general obesity at HA, studies conducted 
in Saudi Arabia have unequivocally shown a higher BMI, obesity, and central obesity at HA 
compared to LA populations. BMI levels were higher in both men and women at HA (3150 m, 
sample size 437) compared to LA natives (500 m, sample size 468) in the Asir province of Saudi 
Arabia (Khalid, 1995). This finding is corroborated by another study among 438 married and 
non-pregnant women born and permanently living at 2800 m to 3150 m in the Abha region of 
Saudi Arabia, which reported the prevalence of central obesity (WC: >88 cm) at 41.1% (Khalid, 
2007). Participants at LA were physically more active than HA counterparts in both of the above 
studies. Interestingly, Saudi Arabian school children and adolescents aged 6 to 15 years also had 
significantly greater odds for being overweight and obese at HA compared to LA counterparts 
(Khalid, 2008).  
Possible explanations for lower BMI and higher central obesity in HA populations 
Altered metabolic processes, low birth weight, and a greater concentration of circulating vitamin 
D have all been proposed to contribute to lower mean BMI and rates of general obesity at HA. 
Metabolic expenditure varies according to energy imbalance in either very hot or cold 
temperatures (McAllister et al., 2009). To cope with a reduction of ambient temperature of 5C, 
an increased annual calorie expenditure equivalent to 5.1 kg to 7.3 kg of adipose tissue is 
required (Hansen, Gilman, & Odland, 2010). The catabolic effect of physiological responses to 
cold temperature at HA may be responsible for lower body weight at HA.  
Evidence suggests low birth weight at HA may reduce later deposition of subcutaneous tissue 
(Galan et al., 2001) and lower BMI in adulthood (Sørensen et al., 1997). Higher levels of 
circulating vitamin D because of increased exposure to ultraviolet radiation at HA (Holick, Chen, 
Lu, & Sauter, 2007) may confer a benefit that lowers the obesity rates in HA populations. 
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Vitamin D is hypothesized to suppress inflammatory cytokines Tumor Necrosis Factor alpha 
(TNF-alpha) and Interleukin-6 (IL-6) (Khoo et al., 2011; B. Li et al., 2013), which are elevated 
in the obese state (Kahn, Hull, & Utzschneider, 2006). A recently published meta-analysis also 
showed that obese people had 35% greater risk of vitamin D deficiency (Pereira‐Santos, Costa, 
Assis, & Santos, 2015). In addition, there is also strong evidence that vitamin D may promote the 
outcomes of weight loss interventions (Rosenblum, Castro, Moore, & Kaplan, 2012; Villareal et 
al., 2011). It is thus plausible to argue that increased vitamin D levels may help prevent obesity 
in HA residents. 
The levels of leptin, an adipose tissue-derived hormone, increases in hypoxia and this hormone 
reduces appetite and increases energy expenditure (Yingzhong, Droma, Rili, & Kubo, 2006). 
However, there is little published literature about the leptin-altitude relationship in native HA 
populations. It is possible that levels of leptin at HA decrease (Santos, 2000; Woolcott, Castillo, 
Torres, Damas, & Florentini, 2002). Although hypoxia promotes leptin secretion, cold 
temperature inhibits it (Sherpa et al., 2010) and ambient cold temperature may moderate the role 
of hypoxia for leptin secretion during the long-term exposure. 
Despite having lower mean BMI and rates of obesity, a higher prevalence of central obesity 
(high WC) is observed in the majority of the studied HA samples compared to those seen in LA 
samples. This finding has important health implications because CVD risk factors are more 
prevalent in people with central adiposity than in those with fat in peripheral regions (National 
Institute of Health, 1998). Although BMI has a high correlation with body fat, it does not provide 
information on central fat deposition (Padwal & Sharma, 2010). 
Possible causes of increased rates of central obesity may include physical inactivity, high alcohol 
consumption, and social deprivation. In some studies, participants at HA were physically less 
active than those living at LA and centrally obese participants were also less active (Khalid, 
1995, 2007; Sherpa et al., 2013). A Tibetan study of residents at 3700 m found that only one-
fourth of the participants had energy expenditure of greater than 2000 kcal/week (Sherpa et al., 
2013), suggesting a low expenditure of calories. The surplus calories might have transformed to 
fat and accumulated in the visceral area. Outdoors ambient temperature is usually cold at HA 
and, particularly during the winter, people limit themselves to activities inside the house for 
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months. It has also been shown that elderly HA residents had lower basic activities of daily 
living compared to LA elders (Matsubayashi et al., 2009). 
Alcohol intake is very common in HA populations. In some HA populations, for example 
Tibetans, alcohol drinking is a cultural practice. The positive association between heavy or binge 
drinking and central obesity is reported in a number of studies (K. Lee, 2012; Wannamethee, 
Shaper, & Whincup, 2005). A plausible mechanism for this relationship may be alcohol-induced 
rise in appetite and consequent additive energy to that from other dietary sources (Yeomans, 
2010).  
Low socio-economic status or social deprivation has been linked to increased levels of 
anthropometric measurements including WC and WHR. A European study showed increasing 
rates of WC with increasing levels of socio-economic deprivation, particularly in women (R. 
Chen & Tunstall-Pedoe, 2005). Other studies also reported lower physical activity among men 
and women with lower socio-economic status (Ford et al., 1991). Because of limited 
opportunities and access, HA populations are more likely to be in a lower socio-economic 
stratum, which in turn may result in low levels of education and awareness about healthy 
lifestyle. 
Obesity in short-term exposure to HA 
Appetite suppression and body weight loss are frequently observed during an HA sojourn 
(Quintero, Milagro, Campion, & Martinez, 2010) and these are also components of chronic 
mountain sickness (CMS) (León-Velarde et al., 2010). The possible reasons include changes in 
leptin, glucagon-like peptide 1, protein synthesis, intestinal absorption and hypoxia-related genes 
(Quintero et al., 2010). There is also substantial evidence that people with a higher BMI or 
obesity lose more weight than people with normal BMI during short-term exposure to HA. For 
example, obese persons working temporarily at 4000 m reached their normal BMI level after 3 to 
5 months of HA exposure (Wu et al., 2007). Thus, working or trekking at HA might be an 
effective strategy for losing body weight – except in those with other co-morbidities like CVD, 
or sleep apnea (Kayser & Verges, 2013). However, more evidence is required to support a 




Collectively, HA populations generally have lower mean BMI levels and reduced rates of 
obesity. However, higher rates of central obesity may increase the risk of CVD, and metabolic 
risk factors. The multi-factorial nature of obesity and lack of research preclude reaching definite 
conclusions about the relationship between obesity and HA. However, it is conceivable that 
hypoxia and cold temperature at HA affect energy balance and other obesity-related factors in 
HA populations.  
2.2 Tobacco use at high altitude 
Tobacco consumption is one of the world’s biggest public health challenges. Tobacco causes the 
deaths of 6 million people every year and around 80% of more than one billion smokers in the 
world are from low and middle income countries (World Health Organization, 2015c). One 
estimate is that half of tobacco smokers will die prematurely due to their tobacco use (Peto, 
Boreham, & Lopez, 1996). Smoked tobacco accounts for about 65% to 85% of all tobacco 
produced globally and it causes more disease than the other forms of tobacco (World Health 
Organization, 1997). The prevalence of smoking is highest in Eastern Europe and Central, 
Southern, and Eastern Asia where 50% of adults smoke (P. Jha, Mony, Moore, & Zatonski, 
2010). In 2012, the age standardized prevalence of current smoking in WHO’s South-East Asia 
region was around 33% for men and 3% for women who were aged 15 years or over (World 
Health Organization, 2014b). The prevalence of smoking has reduced in developed countries in 
recent years but it is increasing in developing nations (Pipe, 2010). 
An estimated 1.6 million cardiovascular deaths in 2000 were attributed to smoking, accounting 
for 11% (of these, men 17% and women 5%) of all CVD deaths of people aged 30 years or more 
in the worldwide population (Ezzati, Henley, Thun, & Lopez, 2005). Among all CVD deaths 
attributable to smoking, IHD comprised the largest proportion (54%) and was similar in 
developed and developing countries (Ezzati et al., 2005). A prospective study of one million 
participants in the USA reported a smoking-associated risk ratio (RR) of 2.5 (men) and 2.9 
(women) for IHD, and 2.7 (men) and 3.4 (women) for cerebrovascular disease (Peto, Boreham, 
Lopez, Thun, & Heath, 1992).  
29 
Cigarette smoking directly contributes to the development of IHD, chiefly by impairing nitric 
oxide activity, increasing vascular inflammation, initiating and promoting deposition of 
inflammatory materials in vessel walls, contributing to plaque rupture, and oxidizing lipoproteins 
(Ambrose & Barua, 2004; Benowitz, 2003; Tonstad & Johnston, 2006). Smokeless tobacco users 
are more likely to have raised blood pressure (BP) levels compared with smokers and non-
tobacco users (Bolinder & de Faire, 1998) due to the high sodium content and the presence of 
two pharmacologically active ingredients: nicotine and licorice (Westman, 1995). 
Smoking prevalence and practices at HA 
Available literature suggests that HA populations have a lower prevalence of smoking compared 
with those living at LA. Factors such as a culturally driven preference for alcohol intake rather 
than tobacco products, lack of availability of tobacco products and low purchasing capacity may 
be the reasons. Reports of smokeless tobacco use in HA are extremely rare and so this review is 
mainly focused on smoked tobacco. 
Studies on HA populations of Tibetan ethnicity have mostly reported a smoking prevalence 
between zero and 15%. None of the 119 study participants in the age group of 30 to 70 years 
from the Sherpa population living at 2900 m in Nepal were smokers or past smokers (Sherpa et 
al., 2010). The prevalence of current smoking was 5.1% (of these, men 10.6%, women 1%) in a 
study among 701 members of a HA population living at 4300 m in Tibet, which was well below 
the national prevalence of China (X. Zhao et al., 2012). Another study among 692 farmers aged 
30 to 80 years and living at 3700 m in Tibet reported the prevalence of smoking as 15.3% (of 
these, men 33.1%, women 0.3%) (Sherpa et al., 2013). Two studies on HA populations with 
Tibetan ancestry but living at higher than 3000 m in the Himanchal state of India showed a 
prevalence of 15% for current smokers (Negi et al., 2012) and just 5.9% for current and past 
tobacco consumers (Negi et al., 2014). A systematic review concluded that the low smoking 
rates in Tibet accounted for its lowest crude mortality rate from lung cancer among all regions of 
China (She, Yang, Hong, & Bai, 2013). Nonetheless, the prevalence of smoking has increased in 
the urban HA Tibetan population; for example, the capital city of Lhasa (3660 m) has a rate of 
24.3% (Sherpa et al., 2010). Also, the prevalence of smoking was 25% in the older Tibetan 
population (≥60 years) living at greater than or equal to 3000 m in Qinghai, China; 43% and 25% 
for Mongolian and Han elders respectively (Matsubayashi et al., 2009).  
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There have been very few reports on tobacco use and smoking trends in Andean HA populations. 
In a study among 3246 participants aged 15 years or over in Peru (3380 m), 7.4% reported 
smoking at least one cigarette per day (Jaillard et al., 1995). The prevalence of smoking was 
similar, at 6.7%, among 506 participants (aged 35 to 75 years) living at 4100 m in Peru 
(Gonzales & Tapia, 2013). 
In contrast to the Tibetan and Andean populations, studies on other HA populations showed a 
higher smoking prevalence. The prevalence of smokers was 43.7% in men and 5.5% in women 
in a study of 4203 adults living at 2438 m in Pakistan (Shah, Arif, Delclos, Khan, & Khan, 
2001). In this study participants who reported consuming wine were 3.5 times more likely to be 
smokers. The odds ratio for smoking was 7.0 times higher in people aged 20 to 50 years living in 
a mountainous area of Taiwan compared to those living at low altitude (H.-W. Chen, Chu, Chen, 
& Yeh, 2014). In this study, a lack of tobacco control activities in mountainous areas was 
implicated for the higher smoking rates. A study conducted in the Appalachian mountains of the 
USA reported that adults generally showed a lesser degree of acceptance for adolescent tobacco 
consumption than for alcohol use (Meyer, Toborg, Denham, & Mande, 2008). 
Cultural norms and practices have an enormous influence on tobacco use in HA populations. For 
example, traditionally smoked tobacco is less common in Tibetan HA populations. Instead, nose-
snuffing of powdered tobacco is customary cultural practice. This is also used as a remedy for 
common cold and related illnesses. Chewing coca is a popular practice in the Andean HA 
population as they believe it helps to combat the hard climatic conditions of HA (Hanna, 1974). 
These factors may contribute to the comparatively lower rates of smoking in Tibetan and Andean 
HA populations.  
Effects of smoking at HA on sojourners and non-acclimatized populations  
The current literature on sojourners and non-acclimatized populations at HA shows that although 
smokers may have a decreased risk of acute mountain sickness (AMS) compared with non-
smokers, they may have impaired capacity to acclimatize at HA. A study on Han lowland 
individuals temporarily working in Tibet reported a lower incidence of AMS in smokers when 
compared to non-smokers, but they had an impaired capacity for long-term acclimatization 
compared to non-smokers (Wu et al., 2012). In a prospective cohort study among 1326 French 
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sojourners, the odds for having AMS were significantly lower in smokers than in non-smokers 
during their ascent to 4000 m (Richalet, Larmignat, Poitrine, Letournel, & Canouï-Poitrine, 
2012). However, during prolonged stays at HA smokers generally have more cases of mountain 
sickness. For example, a study among young Chinese male immigrants to Tibet showed a higher 
prevalence of CMS in the smoking group compared to the non-smoking group (Pei et al., 2012), 
and in Peru foreign workers who could not cope with work at 3200 m were all smokers 
(Lindgärde & Liljekvist, 1984), suggesting that smoking behaviour may impair long-term 
altitude acclimatization. Nonetheless, there are also studies showing no significant relationship 
between the prevalence of AMS and smoking status (Gaillard, Dellasanta, Loutan, & Kayser, 
2004; Schneider, Bernasch, Weymann, Holle, & Bartsch, 2002).  
Hypoxia-induced cerebral vasodilation, which is impacted by the increased levels of nitric oxide, 
is one of the main triggers of AMS headache. As nitric oxide levels go down in smokers, this 
may protect them from headache (Wu et al., 2012). Reduced levels of nitric oxide along with the 
effects of higher levels of nicotine and carbon monoxide in smokers may help to attenuate 
breathing instabilities and decrease sleep disturbance at HA (Wu et al., 2012).  
An increased risk of frostbite among smokers during a sojourn to HA has also been documented. 
A retrospective study of frostbite cases over a 10-year period among mountaineers in Karakoram 
Mountain Range in Pakistan reported that tobacco smoking was a contributing factor to 
susceptibility to frostbite (Hashmi, Rashid, Haleem, Bokhari, & Hussain, 1998). A graded 
relationship between smoking frequency and frostbite incidence was reported in LA population 
as well (Ervasti et al., 2004). 
Conclusion 
In summary, available evidence suggests that the prevalence of smoking tobacco in the larger 
HA populations, Tibetans and Andeans, is generally low, but other HA populations may have 
higher smoking rates than LA residents. Cultural norms and practices have an important role in 
tobacco use at HA. Among sojourners and non-acclimatized population at HA, smokers have a 
decreased risk of AMS compared to non-smokers but have impaired capacity to acclimatize 
during a prolonged stay. 
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2.3 Alcohol intake at high altitude 
Globally, 3.3 million deaths annually, or 5.9% of all deaths, are attributed to the harmful use of 
alcohol. A WHO report attributed these to alcohol-mediated CVD and diabetes (33.4%), cancers 
(12.5%), and gastrointestinal diseases (16.2%) (World Health Organization, 2014c). Alcohol 
consumption is causally implicated in more than 200 health conditions (Rehm et al., 2010).  
Cardiomyopathy, atrial fibrillation, HT, and haemorrhagic stroke are identified as the main CVD 
related risks from heavy alcohol consumption (World Health Organization, 2007b). The 
biological mechanisms for these associations are unclear. It has been hypothesized that alcohol-
induced toxicity in myocardial cells, cardiac conduction interference, refractory period 
shortening and increased sympathetic activity may be the possible reasons for alcoholic 
cardiomyopathy (Klatsky, 2015; Marchi, Muniz, & Tirapelli, 2014). 
The views on risks and benefits of alcohol consumption on CVD health are controversial. The 
vast majority of epidemiological studies suggest that light to moderate alcohol consumption is 
associated with reduced risk of CVD outcomes (Ronksley, Brien, Turner, Mukamal, & Ghali, 
2011; Smyth et al., 2015). A recent large prospective study on 114,970 participants from 12 
countries with different income regions showed that current drinking was significantly associated 
with reduced MI, hazard ratio (95% CI) of 0.76 (0.63 to 0.93) (Smyth et al., 2015). 
Approximately half of this benefit is suggested to be mediated by the increased level of high-
density lipoprotein-cholesterol (HDL) triggered by alcohol consumption (Rimm, Williams, 
Fosher, Criqui, & Stampfer, 1999). Nonetheless, there is robust evidence that episodic heavy 
drinking may raise the risk of IHD (Roerecke & Rehm, 2010), possibly due to an effect of 
increased triglyceride (TG) levels (Klatsky, 2015).  
Alcohol consumption trend at HA 
High alcohol consumption is common in some HA populations, particularly those of Tibetan 
origin. The trend has been inconsistent in other HA populations. 
In an Indian study on 242 participants (aged ≥19 years) of Tibetan origin from the Lepcha 
community living in the Sikkim Himalayas, 80.8% were currently drinking and 22.1% were 
heavy drinkers, defined as consuming more than two standard drinks per day (Mukhopadhyay, 
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Mukhopadhyay, & Majumder, 1996). Among farmers and herdsmen at 3700 m in Tibet, the 
prevalence of current drinking was 46.8% (Sherpa et al., 2013). The proportion of current 
drinkers in this study was similar for men and women. A study among 119 Sherpas of Tibetan 
origin living at 2900 m in the Everest region of Nepal found that 35.5% were drinking alcohol 
more than five times a week (Sherpa et al., 2008). Another study comparing two HA populations 
reported that 44.4% of Tibetans living at 3660 m and 56.3% of the Sherpas living at 2900 m 
were drinking alcohol more than five times a week (Sherpa et al., 2010). In an Indian study 
among 413 participants (age >20 years) of Tibetan ancestry living at 3100 m and 3900 m the 
prevalence of current drinking was reported to be 32.4% (Negi et al., 2012). A Tibetan study 
reported that of 701 herdsmen living at 4300 m and aged 40 years or older, 9.1% were drinking 
alcohol at least once a week (X. Zhao et al., 2012). Studies on an older HA Tibetan population 
aged greater than or equal to 60 years, however, reported a low prevalence of current drinking 
status (16%) compared to HA-living Mongolian (24%) and Han (22%) counterparts 
(Matsubayashi et al., 2009). 
A tendency towards high alcohol consumption among HA populations with Tibetan origin is 
associated with serious health consequences. Native Tibetans were found to have a higher 
incidence of alcoholic cirrhosis than LA populations and 60.9% of all cirrhosis was attributed to 
alcohol (G. Zhao & Li, 1989). A hospital-based study on acute first-ever stroke patients showed 
that the prevalence of heavy drinking was significantly higher in Tibetans compared to those 
from lowland areas (Fang et al., 2011). In a population-based study among 3171 participants in 
Lhasa (Tibet), 16.2% (of those, men 31.6% and women 9.6%) had alcohol use disorder (Guo et 
al., 2008). It has also been reported that alcohol drinking may exacerbate high altitude sickness 
among indigenous Tibetans who frequently travel between high and low or to extreme HA (S. Li 
et al., 2006). 
Very few studies have reported data on alcohol consumption in other HA populations. A 
Peruvian study on 3246 participants aged greater than or equal to 15 years and living at 3380 m 
showed that 12.3% were heavy drinkers (consuming 120 to 300 g/week) (Jaillard et al., 1995). 
More than one-third (34%) reported drinking alcohol at least once a week in a study among HA 
miners in Argentina (Schinder & Ruder, 1989). A qualitative study at Nahuala (2467 m) in 
Guatemala concluded that during festivals and holidays many drinkers, especially men, drink 
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until inebriation and the social environment encourages drinking (Kanteres, Lachenmeier, & 
Rehm, 2009). 
Possible reasons for high alcohol consumption in HA 
Although little research is available from which to draw conclusions about a general pattern of 
alcohol consumption in all HA populations, high consumption of alcohol has been consistently 
reported in populations with Tibetan ancestry, regardless of their living situation. There may be 
three strong reasons triggering alcohol consumption in HA: ancestral cultural habit, cold 
temperature, and physical hardship. 
Alcohol consumption is culturally embedded in some HA populations, mainly Tibetan and 
Andean (Kanteres et al., 2009; Luobu, 2012; Meyer et al., 2008; X. Zhao et al., 2012). In these 
populations, alcohol is consumed for hours and in large quantities during social and religious 
functions (Kanteres et al., 2009; Mukhopadhyay et al., 1996). The use of alcohol by adolescents 
is also socially tolerated by adults (Meyer et al., 2008), which further develops alcohol use as a 
culturally and socially preferred norm. Alcohol is widely available in HA areas and brewed in 
most of the homes from HA crops such as millet and barley. There is also a strong belief that 
locally brewed alcohol has medicinal properties (Gorer, 1938). 
HA is associated with cold temperatures and many HA populations believe that alcohol has 
thermogenic effects and helps to keep a body warm. Although alcohol consumption in cold 
weather has minor effects on core body temperature, it is well-established that perception of cold 
and concomitant discomfort from cold decrease after alcohol intake (Graham & Baulk, 1980; 
Martin, Diewold, & Cooper, 1977). The biological mechanism of this is unclear; however, 
vasodilation of the blood vessels after alcohol intake and consequent warming of the skin 
(Wasielewski & Holloway, 2001) or the direct effect of ethanol on the central nervous system 
(Yoda et al., 2008) may play a role in reducing cold sensation. 
Because of environmental and physical adversities, HA living generally implies difficult working 
conditions and physical hardship. Previous reports suggest that these factors are strongly 
associated with alcohol consumption (Littman, 1970; Schinder & Ruder, 1989). 
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Impact of alcohol on HA sojourns 
Few studies have examined the impact of alcohol consumption on health during HA sojourns. 
Alcohol consumption reduced acute ventilatory response in the initial stages of ascent to 3000 m 
from 171 m in a randomized crossover trial (Roeggla, Roeggla, Roeggla, Binder, & Laggner, 
1995). In a study among construction workers on the Qinghai-Tibetan highway, gastrointestinal 
bleeding was higher among frequent drinkers compared to those drinking less (Wu, 2001). 
Another study suggested that the combination of alcohol drinking and smoking may inhibit HA 
long-term acclimatization but not AMS (Lindgärde & Liljekvist, 1984). Avoidance of alcohol 
has also been suggested to HA travellers as a preventive measure for high altitude pulmonary 
edema (HAPE) (Paralikar, 2012) and especially for cardiac patients aiming to go to HA 
(Higgins, Tuttle, & Higgins, 2010). 
There are also some reports that AMS incidence may not differ between drinking and non-
drinking HA sojourners (Honigman et al., 1993; Schneider et al., 2002), and alcohol intake may 
not be associated with high-altitude headache, the most common symptom in HA sojourners 
(Burtscher, Mairer, Wille, & Broessner, 2011). 
Conclusion 
Overall, some HA populations have a high rates of alcohol consumption, for example more than 
one-third of the adult Tibetan populations. It may be due to the combination of cultural, social 
and environmental factors. Hence, interventions through only health centers and educational 
institutions may be not sufficient to change these trends. Culturally and religiously driven 




2.4 Dietary habits at high altitude 
A healthy diet is protective for CVD, cancer, obesity and diabetes (World Health Organization, 
2015a). Up to 30% of deaths from coronary heart disease (CHD) are attributable to unhealthy 
diets (Lichtenstein et al., 2006). The WHO expert consultation on diet and prevention of chronic 
disease recommends that daily dietary edible fat intake should not exceed 40 g, dietary 
cholesterol less than 300 milligram (mg), salt consumption no more than 5 g, fruit and vegetables 
around 400 gram (g) to 500 g and the sodium to potassium intake ratio be equal to or lesser than 
1 (Joint WHO/FAO Expert Consultation on Diet & Nutrition and the Prevention of Chronic 
Diseases, 2002). 
The Global Burden of Disease study estimates that 1.65 million people die each year from 
conditions related to the excessive consumption of sodium (more than 2 g per day) (Mozaffarian 
et al., 2014). The INTERSALT study, which was conducted in 52 samples of population groups 
across 32 countries, reported a positive association between BP and salt intake in adults aged 
between 20 and 59 years (Elliott et al., 1996; Rose et al., 1988). One estimate is that reducing 
dietary salt intake by 1.15 g per day would lead to a 16% reduction in CHD deaths, a 22% 
reduction in stroke related deaths, and a marked 50% reduction in the number of people requiring 
antihypertensive medications (M. R. Law, Frost, & Wald, 1991). There is a controversy about 
the optimal amount of sodium intake, as several large and international prospective studies have 
reported an increased risk of cardiovascular events in people consuming both high (>5 g/day) 
and low amounts of sodium (<3 g/day), compared to those with moderate intake (3 g to 5 g/day) 
(O'Donnell et al., 2014; O'Donnell et al., 2011). 
It has been suggested that total fat intake should not exceed 30% of total energy consumed 
(Grundy, 1997) and foods with high unsaturated fat (such as nuts, avocados, fish, olive, canola 
oils) are preferable to saturated high-fat foods (such as animal products, butter, cheese, fatty 
meats) (Reddy, 2010). The relationship between dietary fats and CVD may be due to atherogenic 
effects of plasma lipids, but fats may also have direct effects on thrombosis, endothelial function 
and inflammatory pathways (Ghafoorunissa, 1994; Kris-Etherton et al., 2001).  
Existing evidence does not indicate any important association between carbohydrate intake and 
CVD (National Heart Foundation of Australia, 2006). However, excessive dietary carbohydrate 
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may raise the CVD risk indirectly through overweight, obesity, and effects on lipids and blood 
glucose (Reddy, 2010). 
Dietary patterns at HA 
HA encompasses difficult climatic and agronomic conditions resulting in very limited food 
choice options. Potatoes, barley and buck-wheat are the staple foods in major HA communities 
such as Tibetan and Andean communities (Berti et al., 2010; Stevens, 1996). In the Everest 
region of Nepal, adult Sherpas consume more than one kilogram (kg) of tubers per day, of which 
0.72 kg is potato, and more than 75% of crop land is dedicated to potato farming (Stevens, 
1996). In the HA region of Ecuador more than two-thirds of daily food comprises potato and 
maize (Oyarzun, Borja, Sherwood, & Parra, 2013) and in the Bolivian Andes potatoes and tubers 
fulfill 54% of total dietary energy (Berti et al., 2010). In three large prospective studies in LA 
areas in the USA, a higher intake of baked, boiled or mashed potatoes was positively associated 
with an increased incidence of HT (Borgi, Rimm, Willett, & Forman, 2016). However, no 
research has been published on the association between BP and potato consumption at HA. In 
HA residents of both the Himalaya and Andes regions, fruit and vegetables are grown in small 
quantities due to adverse agronomic conditions (Berti et al., 2010; Stevens, 1996). One report 
states that Andes HA natives prioritize less nutritionally rich crops in terms of both production 
and consumption (Oyarzun et al., 2013).  
The most striking difference in dietary habits between two major HA populations, Tibetan and 
Andean, is the amount of fat intake. Related literature unequivocally suggests that HA residents 
of Tibetan origin generally consume a high amount of fat, whereas Andean HA populations have 
a very low consumption. Tibetans consume an estimated 3 to 4 litres of yak butter tea daily (Cao 
et al., 2003) and meat consumption is also very high (Smith, 1999; Sun, 1986). Yak herding is a 
key subsistence activity in Tibetan cultural regions as the animals are used for both meat and 
transportation purposes (Stevens, 1996). Nak (female yak) are also prized sources of butter, 
cheese and meat. Butter is so popular in Tibet that formerly it was an acceptable currency for 
hiring workers and it was also used to pay taxes (Stevens, 1996). In contrast, fat intake is low in 
Andean HA regions. A systematic review of the nutritional adequacy of the diets in the Central 
Andes range reported that fat intake comprises less than 20% of total calories and in some 
settings less than 10% (Berti, Fallu, & Cruz Agudo, 2014). Although some Andean HA natives 
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rear animals like cows, pigs, chickens, and guinea pigs, they rarely consume them (Oyarzun et 
al., 2013). An earlier report showed that about the half of the population in the Peruvian Andes 
region suffered from calorie deficiency and available food was unable to meet the calorie needs 
of the family (Ferroni, 1982). 
Excessive consumption of salt is very common and embedded in Tibetan cultural dietary 
practices. This is largely influenced by the daily use of salty yak butter tea (Smith, 1999; Sun, 
1986). Tibetan adults consume nearly four to five times the WHO recommended amount of 5 g 
of salt per day (Liu et al., 2001; Sun, 1986). 
Consequences of poor diets in HA populations 
Stunted growth is the predominant consequence of malnutrition problems observed in both 
Tibetan and Andean HA populations. A study reported that the prevalence of stunting and 
underweight in younger Tibetan children was 39% and 23.7% respectively (Dang, Yan, 
Yamamoto, Wang, & Zeng, 2004). The prevalence of malnutrition, and especially stunting, is 
higher in pre-school and school children in Tibet compared to the overall prevalence in China 
(Harris et al., 2001; National working committee on children and women, 2001). Studies in 
Andean regions also suggested stunting is a serious nutritional problem in children and 
adolescents (Bassett, Gimenez, Romaguera, & Sammán, 2013; Cossio-Bolaños et al., 2015). 
Other factors such as altitude (Dang et al., 2008) and poor socio-economic conditions (Leonard, 
1989) may also contribute to child stunting at HA. Retarded growth, height, weight and BMI in 
early life may lead to the development of CVD in later life (Barker, Osmond, Forsén, Kajantie, 
& Eriksson, 2005; van Rooyen et al., 2005). 
The high fat intake of Tibetan populations confers risk for CVD health. A worldwide 
longitudinal modeling study comprising data from 124 countries over the period 1980 to 2009 
showed that availability of meat and dairy products as a proportion of the diet was independently 





HA natives have dietary habits that are associated with poor nutrition, possibly contributing to 
CVD risk. In addition to the limited food options because of the harsh weather and altitude, lack 
of proper utilization of available nutritional options is also important. A high risk of CVD due to 
the high intake of salt and a high-fat diet may be particularly relevant to HA populations of 
Tibetan ancestry. 
2.5 Electrocardiographic abnormalities at high altitude 
The most common ECG abnormalities in HA populations are right axis deviation (RAD), right 
bundle branch block (RBBB), and right ventricular hypertrophy (RVH). Research carried out on 
ECG abnormalities in HA residents reports a right-ward shift of the QRS frontal plane axis 
during both acute and chronic exposure to HA. RAD increased with increasing altitude levels in 
a Bolivian study, with mean levels of deviation of: +39 at 400 m, +70 at 3800 m, and +104 at 
4780 m (Raynaud, Valeix, Drouet, Escourrou, & Durand, 1981). Another study comparing mean 
RAD among residents aged 13 to 20 years at different altitude levels reported +55 at sea level, 
+67 at 1600 m, +83 at 3100 m, and +125 at 4500 m (Pryor, Weaver, & Blount, 1965). A 
Peruvian study on children aged up to 14 years showed that RAD was frequently observed at 
4540 m compared to their sea level counterparts (Peñaloza, Gamboa, Dyer, Echevarría, & 
Marticorena, 1960). 
RAD is also commonly reported during short-term exposure to HA and in studies conducted in 
simulated HA chambers. For example, in a hypobaric chamber study, frontal plane QRS axis of 
eight volunteers deviated right-ward from +55 at sea level to +107 at a barometric pressure 
equivalent to that at 8848 m during the exposure of 40 days (Malconian et al., 1990). Another 
hypobaric chamber study in India reported that 15% of the 200 LA residents, when exposed to 
barometric pressure equivalent to 4500 m, showed a rise in RAD of between +20 and +30 
during just 45 minutes of exposure (Akhtar, Bandopadhaya, Chatterjee, & Krishnamurti, 1978). 
RAD increased by more than 10 compared to RAD at sea level for more than half of 202 Indian 
soldiers deployed at 3600 m and 4200 m for around two years, but this change completely 
reversed in the majority of them within a month of returning to sea level (Kapoor, 1984). 
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Studies report frequent occurrence of RVH and RBBB in HA residents. In a study of 74 men the 
prevalence of RVH was 17% in Tibetans and 29% in Han natives living at 3658 m in Tibet 
(Halperin, Sun, Zhuang, Droma, & Moore, 1998). In another study among 120 healthy men 
living at 4540 m in Peru, the prevalence was 19.2% for RVH and 30.8% for RBBB (Rotta & 
Lopez, 1959). However, an Indian study of 984 healthy Tibetan participants living at 2745 m 
reported a prevalence of RVH of just 0.9% (Kaushal, DasGupta, Prashar, & Bhardwaj, 1995). A 
similar phenomenon of right heart burden has also been reported during short-term exposure to 
HA. For example, RSR pattern in ECG suggestive of RBBB was reported among 26% of 19 
members of an American Medical Research Expedition to Mount Everest (Karliner, Sarnquist, 
Graber, Peters, & West, 1985). A sign of right ventricular overload was observed in all 10 
participants, usually residents at sea level, during their one-year stay at an altitude of 4540 m in 
Peru (Peñaloza & Echevarría, 1957). 
The main reason for right heart abnormalities during acute or chronic exposure to HA is likely to 
be hypoxia-induced increases in pulmonary vascular resistance and pulmonary HT. Depending 
on the levels of HA, pulmonary vascular resistance is reported to increase, perhaps by between 
100% and 500% of baseline levels (Swenson, 2013). The magnitude and nature of the changes in 
pulmonary vascular resistance and right heart abnormalities vary in different HA populations. 
For example, pulmonary vascular resistance and pulmonary HT are well reported as being at a 
higher level among HA dwellers such as Andeans or North Americans (Pryor et al., 1965; Rotta 
& Lopez, 1959) but at a lower level in those with high degree of adaptation such as Tibetans 
(Groves et al., 1993; M. Gupta, Rao, Anand, Banerjee, & Boparai, 1992). This may suggest that 
natural selection of genetic traits providing protection from pulmonary vascular resistance might 
have occurred for populations with longer generational history at HA, such as Tibetans.  
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2.6 Cardiovascular disease and risk factors in Nepal 
Cardiovascular diseases are the most common non-communicable diseases (NCDs) in Nepal 
(Vaidya, 2011). According to the WHO NCDs country profile 2011, CHD is the single most 
common cause of premature deaths in Nepal, responsible for 14.2% of all deaths with an age-
standardized mortality rate of 152.6 per 100,000 population; stroke (age-standardized mortality 
rate of 82.6 per 100,000) and HT (age-standardized mortality of 40.4 per 100,000) being the 
third and fifth top causes of mortality respectively (World Health Organization, 2011). The 
annual death rate per 100,000 from CVDs and diabetes combined was estimated to be 400.2 per 
100,000 for men and 301.3 per 100,000 for women (World Health Organization, 2011). The 
number of patients treated at the Shahid Gangalal National Heart Centre, the only government 
heart specialty hospital in Nepal, doubled between 2001 and 2008 (Shahid Gangalal National 
Heart Centre, 2008). A hospital-based cross-sectional study across 31 health institutions in Nepal 
reported that 40% of the hospital admissions among patients aged 35 years or older were related 
to CVD (Nepal Health Research Council, 2010). CVD is a substantial and growing public health 
problem in Nepal. 
There are few large-scale representative studies of CVD in Nepal. The first case of MI in Nepal 
was documented in 1945 (Maskey, Sayami, & Pandey, 2003). A further 150 cases were 
identified between 1960 and 1968; 81.3% were smokers, 28% were hypertensives, 25.4% had 
hypercholesterolemia, and 14.3% were diabetics (Pandey, 1970). In 2003 an estimate based on 
hospital data was that 5% of the adult population in Kathmandu had IHD (Maskey et al., 2003). 
A population-based cross-sectional study of 1000 men aged 35 years or older using the WHO 
Rose angina questionnaire and ECG assessments estimated the prevalence of CHD in this group 
was 5.7% (Vaidya et al., 2009). The most significant risk factors identified in that study were 
tobacco use and a history of HT. No literature has been published about stroke prevalence in 
Nepal. Hospital audits of stroke cases report that ischemic stroke comprises around two-thirds of 
all stroke cases, stroke appears more frequently in men, and smoking is likely to be the main 
identifiable risk factor (Devkota, Thapa Magar, & Malla, 2006; Oli & Agrawal, 2001; A. 
Shrestha, Shah, Adhikari, Sapkota, & Regmi, 2011). An analysis of hospital data of stroke cases 
collected over five years reported that 15.3% of all stroke patients were below 45 years of age. 
This suggests that age of stroke onset may be younger in Nepal than in developed nations 
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(Devkota et al., 2006). Rheumatic heart disease (RHD) was a major cause of cardiac-related 
admissions, accounting for 22% cases in a specialist hospital (G. P. Bhandari, Angdembe, 
Dhimal, Neupane, & Bhusal, 2014). The prevalence of RHD is estimated to be two per 1000 
school children in Nepal (Regmi & Wyber, 2013). 
Nepalese also have a poor knowledge of heart-related diseases, their symptoms and risk factors. 
In a community-based study in two villages near Kathmandu, 60% of the respondents were not 
aware of any symptoms of heart attack and just 29.7% knew HT was a major risk factor for CVD 
(Vaidya, Aryal, & Krettek, 2013). 
CVD risk factors in Nepal 
HT: HT is the most studied risk factor of CVD in Nepal. A meta-analysis of population-based 
HT studies with a sample size of greater than 1000 estimated that nearly one-third (29.7%) of the 
adult Nepalese population had HT (SBP/DBP: ≥140/90 mmHg or were on treatment) (Neupane 
et al., 2014). A repeat cross-sectional study in the same community showed that the prevalence 
of HT increased three-fold over 25 years, from 6% in 1981 to 18% in 2006, using old WHO 
criteria for HT (SBP/DBP: ≥160/95 mmHg) (Vaidya, Pathak, & Pandey, 2012). Increased intake 
of salt and higher BMI were blamed for this rising trend. The growing prevalence of HT in Nepal 
was also corroborated by nationally representative NCD risk factors surveys of the population 
aged 15 years or older, which have noted the prevalence of HT increasing from 21.5% in 2007 
(Ministry of Health and Population, Government of Nepal, Society for Local Integrated 
Development Nepal (SOLID Nepal), & WHO, 2008) to 25.7% in 2013 (K. K. Aryal et al., 2014). 
A huge unmet need for effective prevention and treatment of HT has been demonstrated by a 
nationally representative study, which showed 90% of participants with elevated levels of BP 
were not receiving any treatment (K. K. Aryal et al., 2014). 
Obesity: Although population-based studies of overweight or obesity have been sparse in Nepal, 
trend analysis clearly indicates the rapid escalation of prevalence in recent years. Nationally 
representative studies noted that the prevalence of obesity (BMI ≥30 kg/m
2
) was 1.7% in 2007 
(Ministry of Health and Population et al., 2008) but increased by more than double in 2013 to 
4% (K. K. Aryal et al., 2014). The prevalence rates for overweight (BMI ≥25 kg/m
2
) tripled from 
7.2% to 21.6% during this period. This is comparable to the nationally representative Nepal 
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demographic health surveys repeated after a 10-year interval, which documented that the 
prevalence of overweight (BMI ≥25 kg/m
2
) among women aged between 15 and 49 years rose 
from 6.4% in 2001 to 14% in 2011 after adjusting for age, parity and education (Kinnunen & 
Neupane, 2014). A large study including 14,425 participants from the community-based 
screening programmes in Eastern Nepal reported the prevalence of abdominal obesity at 34.7% 
according to the International Diabetes Federation (IDF) criteria for South Asians (WC >90 cm 
in men and >80 cm in women) (S. K. Sharma et al., 2011). The prevalence of overweight or 
obesity in specific population groups was also reported to be high; for example, 25.9% in school 
children from private schools studying in grades 1 to 6 (Koirala, Khatri, Khanal, & Amatya, 
2015), 33.4% in civil servants (Simkhada, Poobalan, Simkhada, Amalraj, & Aucott, 2009), and 
32.9% in men from the relatively well-off community (Vaidya et al., 2005). All of these studies 
identified higher family income and sedentary lifestyle as the main causes for the rise in obesity. 
Among Jhaukel-Duwakot Health Demographic Survey site participants, 43.3% had a low level 
of physical activity in their daily lives, particularly those with obesity, HT or diabetes (Vaidya & 
Krettek, 2014). 
Almost all of these studies in Nepal followed the WHO guidelines on BMI classification (World 
Health Organisation, 1995). However, in the recent years, ethnicity specific BMI cut-points have 
been proposed for non-Caucasian populations. For example, BMI equal to or greater than 23 
kg/m
2
 and 25 kg/m
2
 have been recommended as cut-points for overweight and obesity 
respectively for Asian Indian population (Misra et al., 2009). While considering these cut-points, 
overweight and obesity rates of Nepalese populations in published studies could have been 
significantly higher compared to commonly used WHO international classification. 
Diabetes: IDF national estimates of diabetes prevalence for Nepal in the population aged 
between 20 and 79 years were 1.6% in rural areas and 10.7% in urban areas (International 
Diabetes Federation, 2015). Studies on type II diabetes in Nepal report the prevalence ranging 
from 4.1% to 9.5% (Mishra, Neupane, Bhandari, Khanal, & Kallestrup, 2015). A meta-analysis 
of diabetes studies in Nepal published between 2000 and 2014 with 30,218 subjects suggested 
the pooled estimate of type II diabetes prevalence (95% CI) of 8.4% (6.2 to 10.5), and pre-
diabetes (impaired glucose tolerance) of 10.3% (6.1 to 14.4) (Gyawali et al., 2015). This study 
also estimated the pooled prevalence (95% CI) of type II diabetes at 1% (0.7 to 1.3%) in rural 
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areas and 8.1% (7.3 to 8.9) in urban areas. Another systematic review and meta-analysis 
including only recent or nationally representative studies with a larger sample size estimated the 
prevalence of diabetes and pre-diabetes to be 9.5% and 19.5% respectively (Jayawardena et al., 
2012). Notably, this report showed that the prevalence of pre-diabetes in Nepal was the highest 
among all South Asian countries. 
From hospital-based data, it has been projected that diabetes prevalence will reach 17.5% in 
Nepal in 2025 (Dulal & Karki, 2009). In contrast to these estimations, a nationally representative 
study in 2014 of populations aged 15 years or older showed that 3.6% had raised fasting glucose 
(≥126 mg/dL) (≥7 mmol/L) or were on treatment (K. K. Aryal et al., 2014). Due to the lack of 
easy access to health care services and screening programmes a significant number of Nepalese 
populations may not be aware of their diabetic status. One study on 1012 participants from seven 
urban populations found that 54.4% of diabetics were not previously aware of their status (U. 
Shrestha, Singh, & Bhattarai, 2006). A high rate (25.9%) of diabetes has also been observed in 
elderly populations aged 60 years or more (M. Chhetri & Chapman, 2009). Studies have usually 
shown a greater risk of diabetes in women than in men (Gyawali et al., 2015). 
Dyslipidemia: Population-based reports on lipid profile have been very limited in Nepal. The 
WHO STEPS survey for NCD risk factors 2013 has been the only representative study with data 
on lipid profiles for the country so far. This survey comprising participants aged 15 years or 
older and from 15 (of 75) randomly selected districts in Nepal showed that 22.7% had raised 
total cholesterol (TC) (≥190 mg/dL [4.9 mmol/L] or were on treatment), 79.3% of women and 
61.2% of men had low HDL (<40 mg/dL [<1.0 mmol/L] for men and <50 mg/dL [<1.3 mmol/L] 
for women), and 25.2% were affected with raised TG (≥150 mg/dL [≥1.7 mmol/L]) (K. K. Aryal 
et al., 2014). This study noted that those with higher education levels were more likely to have a 
higher prevalence of raised TC than those with no formal education. Another large study 
conducted in the Eastern part of Nepal reported a slightly lower prevalence of high TC (17.2%) 
and low HDL (56.7%) but a higher rate of high TG (48.3%) compared to national data (S. K. 
Sharma et al., 2011). A study among 4279 adolescents and young adults from rural Nepal found 
that a high TC/HDL ratio (>5.0) was prevalent in 17.4% of the cohort of those aged between 9 
and 13 years, and 16% in those aged between 15 and 23 years; the prevalence of low HDL being 
strikingly high at 70.6% and 80.4% respectively for men and women (Stewart et al., 2013). 
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Although population-based studies have indicated that a low level of HDL is the most common 
lipid abnormality, hospital-based data from the urban areas have shown high TG to be most 
common (Karki, Neupane, Pradhan, & Magar, 2003; Takhelmayum, Thanpari, Kumar, Singh, & 
Sinha, 2014). None of the studies have investigated significant CVD risk associated with 
abnormal lipid components. 
Smoking: Periodic evidence has demonstrated that smoking prevalence in Nepal has been falling 
dramatically in recent years. The comparison of two national surveys six years apart shows that 
the prevalence of current smoking had declined from 26.2% (of those, men 35.5%, women 
15.9%) in 2007 (Ministry of Health and Population et al., 2008) to 18.5% (of those, men 27%, 
women 10.3%) in 2013 (K. K. Aryal et al., 2014). A national estimate of smoking prevalence for 
population aged 30 years or more in Nepal is 24.7% (of those, men 32.8% and women 16.8%) 
(K. K. Aryal et al., 2014). Nonetheless, the decreasing rate for the use of smokeless tobacco was 
marginal, from 18.6% down to 17.8%. This remarkable improvement in tobacco smoking 
prevalence can be substantially attributed to the Tobacco Control and Regulation Act 2011, 
which provided stringent measures such as a ban on smoking in public places, work places and 
public transport, and prohibition of all forms of tobacco advertising. At one time in the past, 
Nepal was one of the countries in the world with an alarmingly high prevalence of smokers with 
73.7% daily smokers (of those, men 85.4%, women 62.4%) (Pandey, Neupane, & Gautam, 
1988). Even today, the tobacco consumption rate is very high in some areas. For example, 43.6% 
of rural women in remote districts self-reported being a current tobacco user (Khatri, Mishra, & 
Khanal, 2015). A Nepal demographic health survey in 2011 identified a lack of formal 
education, older age, manual occupation and residency in low-land Terai as key determinants for 
tobacco use in men (Khanal, Adhikari, & Karki, 2013).  
Alcohol intake: Like many others, Nepalese society has ambivalent views regarding alcohol 
consumption as many ethnic groups traditionally brew alcohol at home and alcohol consumption 
has been a preferred traditional cultural practice. Furthermore, alcohol is easily available in the 
market and there are no age restrictions on purchase. However, national surveys in recent years 
have shown a dramatic decline in alcohol consumption. The prevalence of ‘reported drinking in 
the past 30 days’ has gone down to 17.4% (of those, men 28%, women 7.1%) in 2013 (K. K. 
Aryal et al., 2014) from 28.5% (of those, men 39.3%, women 16.5%) in 2007 (Ministry of 
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Health and Population et al., 2008). The proportion of harmful use of alcohol (≥60 and ≥40 g 
mean consumption of pure alcohol per day for men and women respectively) was six times 
greater in mountain regions (6%) than in low-land areas (<1%) (K. K. Aryal et al., 2015). The 
influence of cultural practices on alcohol consumption has been shown to result in high alcohol 
intake in new generations as well. A study on adolescents (aged 11 to 17 years) in Kathmandu 
showed that those from ethnic groups that are traditionally alcohol users were twice as likely to 
have ever consumed alcohol (40.1%) compared to those from ethnic groups that were 
traditionally non-users of alcohol (19.4%) (Parajuli, Macdonald, & Jimba, 2015). Several studies 
have reported that parental alcohol use is the most significant predictor of alcohol consumption 
in youth (Dhital, 2001; A. Sharma & Khandelwal, 2000), and Nepalese initiated alcohol intake 
from a median age of just 10 years (Dhital, 2001). 
Diets: The few available reports have shown that the consumption of fruit and vegetables in the 
Nepalese population is extremely low. The latest national survey found that 98.9% of the 
participants consumed less than five mean portions of fruit and vegetables per day (K. K. Aryal 
et al., 2014). This is much higher than in the national survey conducted in 2007, which reported a 
prevalence of 61.9% (Ministry of Health and Population et al., 2008). An earlier WHO STEPS 
survey conducted among 2030 participants in Kathmandu also noted that almost all (99.3%) 
participants self-reported consuming less than five portions of fruits and vegetables per day 
(World Health Organization, 2003). Nepal is hugely dependent on India for fruit and vegetables 
due to low production in Nepal. Increasing market prices often makes them difficult to afford. 
Very few studies report quantitative salt consumption and trends in the general Nepalese 
population. A door-to-door survey, repeated in the same community after 25 years, showed that 
55.9% (n=1405) of the participants aged 21 years or older reported consuming more than 5 g of 
salt per day in 1981, increasing to 89.5% (n=1218) in 2006 (Vaidya et al., 2012). A national 
survey in 2013 also documented that 10.9% of the participants thought they were consuming an 
excessive amount of salt (K. K. Aryal et al., 2014). 
Conclusion 
Collectively, CVD and its risk factors are significant health problems and causes of mortality in 
Nepal. The actual burden and likely causes and risk factors are difficult to establish from the 
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current literature. However, available evidence suggests that the rates of HT, obesity and 
diabetes have been increasing over time and a significant proportion of the population has 
undiagnosed disease and risk factors, and is unaware of its CVD health-related risk status. A low 
level of HDL and low intake of fruit and vegetables may be particular features of CVD risk 
factors in Nepal. Tobacco smoking has declined in Nepal recently, which is a positive factor for 
CVD prevention. Although alcohol intake is also decreasing, customary practice and social 
acceptance of drinking alcohol is a major challenge to healthy lifestyles in Nepal.  
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3 Systematic Literature Review 
The purpose of this chapter is to systematically review and summarize the literature for the 
associations between: (i) blood pressure (BP), (ii) blood glucose, and (iii) lipid profile; and 
altitude. Meta-analyses of the association between BP and blood glucose and living at high 
altitude (HA) are also shown. These variables were selected for systematic review and meta-
analysis because they are the key cardiovascular disease (CVD) risk factors that have direct 
impact from hypobaric hypoxic conditions of HA. 
3.1 Blood pressure and hypertension at high altitude 
Hypertension (HT) is an important risk factor for adverse health outcomes such as stroke and 
myocardial infarction (MI) and contributes globally to an estimated 9.4 million deaths and 7% of 
disease burden annually (Lim et al., 2012). Depending on the definition used, HT affects 
between 20% and 30% of the global population (Asia Pacific Cohort Studies Collaboration, 
2003; Prospective Studies Collaboration, 2002). The world-wide prevalence of HT is likely to 
rise with time, in part because of the ageing of the global population but also because of the 
increasing prevalence of obesity. One estimate is that the current prevalence will increase from 
26.4% currently to 29.2% by 2025 (Kearney et al., 2005). Regardless of any threshold, 
increasing BP has a graded relationship with the risk of CVD. One estimate is that for each 
increment of 20 mmHg in systolic blood pressure (SBP) or 10 mmHg in diastolic blood pressure 
(DBP) the risk of CVD doubles across the entire range of BP from 115/75 mmHg to 185/115 
mmHg, even in the absence of other risk factors (Prospective Studies Collaboration, 2002).  
The effect of chronic hypoxic hypobaric conditions, induced by living at HA, on BP is uncertain 
and may vary in different populations. Research on this relationship and other cardiopulmonary 
changes at HA has been ongoing for more than 50 years (Ostadal & Kolar, 2007), without a 
clear-cut resolution on whether the relationship between BP and HT and HA is causal, or a result 
of coincident lifestyle factors. An inverse association between altitude and systemic BP may be 
due to, separately or in combination with, structural changes in vasculature; and a number of 
socio-cultural, biological, chemical and physical factors (León-Velarde et al., 1993; Ruiz & 
Penaloza, 1977). However, the possible benefit from altitude related hypoxia on systemic BP 
may diminish when genetic and lifestyle related risk factors become dominant, as seen in Tibetan 
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origin populations (Gesang et al., 2002; Mingji et al., 2015). An increased amount of smooth 
muscle cells in the distal pulmonary arteries in those living at HA may directly increase 
pulmonary BP (Arias-Stella, 1966). This may not be true for all HA residents, such as Tibetans 
and Ethiopians, possibly because of the higher levels of exhaled nitric oxide compared with 
Andeans or low altitude (LA) populations, suggesting different, possibly ancestry-based, 
physiological responses to HA (Beall, 2007; Beall et al., 2001).  
This section of the literature review is a systematic review and meta-analysis that aims to 
estimate the association between BP and HT and altitude in adults permanently living at HA. 
This has been published in a peer-reviewed journal.  
Methods 
This section comprises a systematic review and meta-analysis. 
Study inclusion and exclusion criteria 
Inclusion criteria for the systematic review were: studies of BP and/or HT in populations living 
at an altitude of greater than or equal to 2400 metre (m), with a minimum sample size of 100 
permanent residents, and in those aged 18 years or older. Only English language articles 
available in the full text were included. Studies on patients, not at population level, and not 
denoting the specific altitude level, were excluded. The search was completed on 1 December 
2014.   
Search and selection methods 
A search was conducted in three major biomedical databases: PubMed, OvidSP (MedLine and 
EMBASE) and Scopus. The search terms: ‘blood pressure’ or ‘hypertension’, were combined 
with the words ‘altitude’ or ‘mountain’ or ‘himalaya’ or ‘highland’. These combinations were 
also assessed along with the names of major populations at HA: ‘Tibetans’ and ‘Andeans’, and 
the names of seven South American countries with HA areas – 'Bolivia', 'Chile', 'Colombia', 
'Ecuador', 'Mexico', 'Peru', and 'Venezuela'. Studies were searched by title and/or abstract. In 
addition, reference lists from identified articles were scrutinized to find relevant published 
articles. The studies that published data on SBP and DBP or prevalence of HT were considered. 



















Figure 3.1: Flow diagram of identification and selection of the articles on blood pressure 
and hypertension at high altitude 
Data extraction and quality appraisal 
A data extraction table was developed using the Centre for Reviews and Dissemination guidance 
template (Khan, Ter Riet, Glanville, Sowden, & Kleijnen, 2001). The eligibility of identified 
papers was assessed and authors, year of publication, geographical locations, sample size, 
altitude of the study site, mean BP values and rates of HT were recorded. The Meta-analysis of 
Observational Studies in Epidemiology (MOOSE) checklist was followed for reporting (Stroup 
et al., 2000). Important and relevant risk-of-bias components are shown separately for each 
study. 
  
Titles / abstracts excluded 
       (n=3304) 
- Not original research articles 
- Studies on patients 
- Not having BP measurement                   
 - Sample size <100 
- Altitude level <2400 m 
- Studies on children 
- Duplicates across the databases 
 
 
Total articles retrieved 




Articles selected for full  
text review (n=71) 
 
Articles excluded  (n=50) 
- Full text not available (13) 
- Altitude <2400 m (8)           
 - Altitude level not mentioned (6) 
- Data not available on ≥18 yrs (6) 
- Sample size on high altitude         
<100 (7) 
- Not permanent residents (4) 
- Inadequate information (6)  
Final articles included (n=21) 
 
(China 6, India 4, Peru 4, India & 
China 1, Nepal 1, Pakistan 1, Chile 
1, Colombia & Ecuador 1, Ethiopia 





Random effects meta-regression was used to evaluate the association between mean BP and HT 
prevalence by altitude. BP levels were treated as continuous Gaussian variables and a binomial 
distribution was used for the prevalence of HT. If a study reported an altitude range rather than a 
specific level, the mean of the range was recorded. For the meta-regression the reported mean BP 
was used as a response variable in a mixed linear model that used the particular study as a 
categorical variable, as a random effect, and the inverse variance of the mean BP as a weight. A 
pooled estimate of mean systolic and diastolic BP was estimated per 1000 m increment in 
altitude. For the meta-regression of HT prevalence a pooled odds ratio for HT per 1000 m 
increment in altitude was estimated using a similar random effects model. Sensitivity testing and 
sub-group analysis was also performed. Studies that reported data at different levels of HA, or 
from different ethnic populations, were treated independently during the analysis. Analysis was 
performed separately for the studies with participants from Tibetan and non-Tibetan origins 
because of well-known differences in genetics and physiological responses to environmental 
hypoxia.  
Comprehensive Meta-analysis (CMA) version 3.0 was used.  
Results  
The search identified 3375 papers: 1612 from Scopus, 719 from Embase, 565 from Medline, 479 
from PubMed, and 10 from a reference search. A search of the listed references was performed 
for 71 articles selected for full text review. 
Twenty one studies were included in this review, including two studies published in each of the 
1970s, 1980s and 1990s; four studies in the 2000s and eleven studies after 2010. The total 
number of participants was 40,854: nine studies including less than 500 participants, six studies 
with 500–1000 participants, five studies with 1000–5000 participants, and one with more than 
5000 participants. Six studies were based in China (five on Tibetans); four in India (all on 
Tibetans); four in Peru; and one each in Colombia & Ecuador, China and India (including 
Tibetans); Chile; Pakistan; Ethiopia; Nepal (Tibetans); and Saudi Arabia. Ten studies each had 
Tibetan and non-Tibetan participants and one study had participants from both groups. All 
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studies were cross-sectional. The altitude level ranged from 2438 to 4300 m. The key features of 
the selected studies are shown in Table 3.1.  
Table 3.2 shows the risk of bias of each study, including sampling process, HT cut-points, BP 
measuring devices, number of BP readings, and body position during BP measurements. Briefly, 
participants were randomly selected in eleven studies, non-randomly in six studies, completely 
surveyed in two studies, and the sampling process was unclear in two studies. Fourteen studies 
reported the prevalence of HT, of which eleven used a cut-off point of greater than or equal to 
140/90 mmHg, one considered a cut-point of greater than or equal to 130/85 mmHg, while two 
older studies adopted the cut point of greater than or equal to 160/95 mmHg for HT. The 
measurement device for BP was a standard mercury sphygmomanometer in ten studies, an 
aneroid sphygmomanometer in one study, an automated device in five studies, and the BP 
measuring device was unclear in five studies. Two readings of BP were taken and mean value 
was considered in seven studies, three readings were taken in four studies, and the number of 
readings was not mentioned in seven studies. In two studies, a second reading was only 
considered if HT was observed in the first reading. One study repeatedly measured BP until 
readings were stable within 2 to 3 mmHg. Body position during the BP measurements was sitting 
in 14 studies, supine in one study, and unclear in six studies. 
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Author  Location  Sample Size  Altitude  HT (%)  BP values (mean)  
       (m)     (mmHg)    
Clegg    Ethopia/  142   3000 m  Not reported  3000 m (Debarek)                  
et al. 1976  Siemien mountains (18-65 yrs)       SBP:122.9, DBP:76.6 (M) 
              SBP:120, DBP:75.7 (W) 
Makela   Chile/   139   >4000 m Not reported  > 4000 m (Altiplano)                            
et al. 1978  Andean mountains (18-84 yrs)       SBP: 119.45, DBP: 78.23 (M) 
              SBP: 112.23, DBP: 72.94 (W)                                                   
                                                    
Dasgupta  India/   857   3050 m  1.9*   SBP:111.28, DBP:74.88 (M)                     
et al. 1982  Himachal  (20-74 yrs)    (including  SBP:111.72, DBP:74.20 (W) 
   Pradesh        ≥ 15 yrs sample)      
Sun 1986  China/   25050   2500 m - 15.2   Not reported   
   Tibet   (≥ 25 yrs)  5000 m  M:13.4, W:16.6      
                                
Khalid &  Saudi   189 (M)  >3150m Not reported  > 3150 m (AlSoda& AlSoga) 
Adzaku  1995  Arabia/Assir  (21-60 yrs)       SBP:114.79, DBP:76.38 (M) 
   Province 
Smith 1999  Nepal/   133 (M)  3400-3900 m  25   3400-3900 m (Khumbu) 
   Khumbu  (>18 yrs)                   SBP:122.9, DBP:79.7                     
Shah et al.  Pakistan/  4203   2438 m  15   SBP:124.5, DBP:79.8 (M)                      
2001   Ghizar   (> 18 yrs)    M: 13.7, W:15.4 SBP: 124.9, DBP: 77.8 (W) 
Liu et al.  China/   125   3760 m  39.7   3760 m (Tibetan)                        
2001   Tibet   (48-56 yrs)    M:28.8, W:50.7  SBP: 127.7, DBP:81.9 (M) 
              SBP: 132.6, DBP:83.7 (W)  
Lindgarde  Peru/   105 (W)  3800 m  Not Reported  3800 m (Cuzco)                             
et al. 2004  Cuzco   (≥ 35 yrs)       SBP:97, DBP:59  
                                
                                   
                                               
Table 3.1: Key features of included studies on blood pressure and hypertension at high altitude 
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Tripathy &  India/   158   3521 m  39.9   3521 m                  
Gupta 2007  Leh   (> 20 yrs)    M:43.8, W:38  SBP:134.55,DBP:81.59(M) 
              SBP: 131.92, DBP:80.58 (W)  
Matsubayashi  China/   247   3000-  Han: 58  Han                  
et al. 2009  Qinghai  (≥ 60 yrs)  3300 m     SBP:141, DBP:86  
                                                                        
Okumiya   China &  Tibet:209  3700 m, Tibet: 72  3700 m (Tibet)                                      
et al. 2010  India   Ladakh:117  2900-3800 m Ladakh:53   SBP:142, DBP:91  
      (≥ 60 yrs)        2900-3800 m (Ladakh)  
               SBP:137, DBP:87                     
Hernandez-  Colombia,  Bogota:1553  2600 m, Bogota:13.4  2600 m (Bogota)                      
Hernandez  Ecuador  Quito:1638  2850 m  M:14.6,W:12.4  SBP:114, DBP:76.2(M)                          
et al. 2010          Quito :8.6  SBP:111.4,DBP:73.1 (W) 
           M:7.2,W:10.1  2850 m (Quito)   
              SBP:114.5,DBP:72.7(M) 
              SBP:112.3,DBP:70.5 (W) 
Negi   India/   3100m:  171  3100 m,  3100m: 27.5  3100 m                                                 
et al. 2012  Himachal  3900m: 242  3900 m  3900m: 19  SBP:130.7, DBP:83.1  
   Pradesh   (> 20 years)       3900 m    
              SBP:120.98, DBP:80.05 
                                  
Zhao et al.  China/   701   4300 m  55.9   SBP:151.6,DBP: 95.9(M)             
2012   Tibet   (≥ 40 yrs)    M:66.1, W:48.3  SBP: 142.8, DBP: 89 (W) 
                               
Zheng   China/   1370   3650 m  51.2   SBP:141.80, DBP:92.38 (M)                                
et al. 2012  Tibet   (≥ 18 yrs)    M:56, W:48  SBP:133.76, DBP:87.33 (W) 
                                        
Sherpa et al.  China/   692   3700 m  37   Not reported                                   
2013   Tibet   (30-80 yrs)    M: 35.3, W: 38.4     
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Gonzales et al.  Peru/   506   4100 m  Not reported  SBP:117.4, DBP:74.7(M)              
2013   Junin   (35-75 yrs)       SBP:114.2,DBP:72.38(W) 
Caravedo et al.  Peru/   519   3825 m  Not reported  SBP:115.31                  
2014   Puno   (≥35 yrs) 
Ojeda et al.  Peru/   Hispanic:395 (W) 2577-  Hispanic:10.9  Not reported                    
2014   Cusco   Quechas:376 (W) 3570 m  Quechas:1.1 
Negi et al.  India/   1017   3000-  27.3   Not reported                                    
2014   Himachal  (>20 yrs)  4000m  M: 27.9, F:27      
   Pradesh       
Abbreviations: m: metre, M: men, W: women, BP: blood pressure, HT: hypertension, SBP: systolic blood pressure, DBP: diastolic blood pressure, 
HA: High altitude. *Excluded from the HT analysis. 
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≥140/90 Unclear One (if HT in 
first then two) 
Sitting 
Shah et al. 
2001 
Random ≥140/90 Mercury 
sphygmomanometer 
Three Sitting 
Liu et al. 2001 Random ≥140/90 Automated device Three Unclear 
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≥140/90 Automated device Two Sitting 
Hernandez- 
Hernandez 
 et al. 2010 
Random ≥140/90 Mercury 
sphygmomanometer 
Two (or until 
readings close 
to within 5 
mmHg) 
Sitting 
Negi et al. 
2012 
Random ≥140/90 Mercury 
sphygmomanometer 
Two Sitting 




≥140/90 Automated device Three Sitting 
Zheng et al. 
2012 
Random ≥140/90 Mercury 
sphygmomanometer 
Two Sitting 
Sherpa et al. 
2013 
Random ≥130/85 Automated device Three Unclear 
Gonzales et al. Random Not Aneroid Unclear Sitting 
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2013 relevant sphygmomanometer 
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Ojeda et al. 
2014 
Unclear ≥140/90 Unclear Unclear Unclear 




Unclear Unclear Unclear Unclear 
 
BP in relation to HA 
Seven studies compared the mean BP at HA (≥2400 m) and LA (<2400 m). Of these, five 
reported higher mean SBP and DBP values in HA for both genders (Clegg, Jeffries, & Harrison, 
1976; Hernandez-Hernandez et al., 2010; Khalid & Adzaku, 1995; Liu et al., 2001; Smith, 1999). 
In one study, mean BP values were higher at HA except for DBP in women (Tripathy & Gupta, 
2007). In a Peruvian study, mean SBP was marginally high at HA, but DBP was significantly 
lower (Lindgärde et al., 2004). For individual studies the mean difference was statistically 
significantly higher at HA for both SBP and DBP in three studies (Hernandez-Hernandez et al., 
2010; Khalid & Adzaku, 1995; Liu et al., 2001), in DBP in a Nepalese study (Smith, 1999), and 
in DBP only for young female adults in an Indian study (Tripathy & Gupta, 2007). One study 
reported marginally higher mean values for both SBP and DBP at LA (Tripathy & Gupta, 2007). 
Five studies reported mean BP values at different levels of HA (≥2400 m). Two showed 
decreasing BP values (Makela et al., 1978; Negi et al., 2012), and increasing BP values (Clegg et 
al., 1976; Okumiya et al., 2010) with higher elevation. In one study, SBP increased marginally 
but DBP decreased with altitude (Hernandez-Hernandez et al., 2010). Mean SBP levels varied 
from 97 mmHg (Lindgärde et al., 2004) to 146.6 mmHg (X. Zhao et al., 2012) and DBP from 59 
mmHg (Lindgärde et al., 2004) to 92 mmHg (X. Zhao et al., 2012) at HA.  
Fourteen studies reported the prevalence of HT in HA, in which seven studies showed the 
prevalence at over 30% (Liu et al., 2001; Matsubayashi et al., 2009; Okumiya et al., 2010; 
Sherpa et al., 2013; Tripathy & Gupta, 2007; X. Zhao et al., 2012; X. Zheng et al., 2012), 
including four where the prevalence was greater than 50% (Matsubayashi et al., 2009; Okumiya 
et al., 2010; X. Zhao et al., 2012; X. Zheng et al., 2012). Interestingly, all seven of these studies 
had participants of Tibetan race. Similarly, five studies reported a prevalence of HT between 
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15% and 30% (Negi et al., 2012; Negi et al., 2014; Shah, Luby, Rahbar, Khan, & McCormick, 
2001; Smith, 1999; Sun, 1986), and two South American studies reported a prevalence of less 
than 15% (Hernandez-Hernandez et al., 2010; Ojeda, Blümel, Vallejo, & Lavín, 2014). The 
prevalence of HT by local definition ranged from 15.2% (Sun, 1986) to 71.8% (Okumiya et al., 
2010) for Tibetan participants and between 1.1% (Ojeda et al., 2014) and 57.9% (Matsubayashi 
et al., 2009) in non-Tibetans. 
Gender and BP in HA  
Among the 10 studies that reported mean BP for genders separately, men had a higher value of 
both systolic and diastolic BP in seven studies (Clegg et al., 1976; Gonzales, Rubio, & Gasco, 
2013; Hernandez-Hernandez et al., 2010; Makela et al., 1978; Tripathy & Gupta, 2007; X. Zhao 
et al., 2012; X. Zheng et al., 2012). Only one Tibetan study had a high mean of both systolic BP 
and diastolic BP in women (Liu et al., 2001). Of eight studies reporting HT for men and women, 
an equal number of studies found high prevalence in men (Negi et al., 2014; Tripathy & Gupta, 
2007; X. Zhao et al., 2012; X. Zheng et al., 2012) and in women (Liu et al., 2001; Shah, Luby, et 
al., 2001; Sherpa et al., 2013; Sun, 1986). 
In four studies the differences were significantly higher in men for at least one of SBP, DBP and 
HT (Clegg et al., 1976; Gonzales et al., 2013; X. Zhao et al., 2012; X. Zheng et al., 2012). By 
contrast, the differences were not significantly higher in the studies where women had higher 
values for mean SBP, DBP or HT. Overall, men tended to have a higher mean BP than women 
but no clear gender-based pattern was observed for HT. 
Age and BP in HA 
Thirteen studies reported an analysis of any relationship between BP at HA and age (Clegg et al., 
1976; Dasgupta et al., 1982; Hernandez-Hernandez et al., 2010; Khalid & Adzaku, 1995; Makela 
et al., 1978; Negi et al., 2012; Shah, Luby, et al., 2001; Sherpa et al., 2013; Smith, 1999; Sun, 
1986; Tripathy & Gupta, 2007; X. Zhao et al., 2012; X. Zheng et al., 2012). Among these only 
three did not show a positive association between age and BP (Clegg et al., 1976; Dasgupta et 
al., 1982; Makela et al., 1978). An Indian study showed a rise of BP at a younger age in women 
(Dasgupta et al., 1982), while a Pakistani study showed a more gradual increment between age 
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and DBP (Shah, Luby, et al., 2001). An Ethiopian study showed no impact of age at HA except 
in high socio-economic status populations (Clegg et al., 1976). 
Predictors of high BP in HA 
Among the 10 studies that reported statistical analysis of predictors of BP in HA, six found body 
mass index (BMI) the best predictor (Negi et al., 2012; Shah, Luby, et al., 2001; Smith, 1999; 
Tripathy & Gupta, 2007; X. Zhao et al., 2012; X. Zheng et al., 2012). Likewise, body weight 
explained the rise of BP levels in two studies (Khalid & Adzaku, 1995; Makela et al., 1978). 
Other predictors were family history of HT (Shah, Luby, et al., 2001), higher socio-economic 
group (Clegg et al., 1976), alcohol intake (Smith, 1999), and packed cell volumes (Khalid & 
Adzaku, 1995). 
Results from the closely relevant but excluded studies  
There were six studies that would have met the criteria for this review, but included data from 
participants younger than 18 years (Baker, 1969; Beall, Gebremedhin, Brittenham, Decker, & 
Shamebo, 1997; He, Tell, Tang, Mo, & He, 1991; Murillo, Barton, Palomino, Lenart, & Schull, 
1980; Otsuka et al., 2005; Ruiz & Penaloza, 1977). Of these, three studies from South America 
(Baker, 1969; Murillo et al., 1980; Ruiz & Penaloza, 1977), one study from Ethiopia (Beall, 
Gebremedhin, et al., 1997), and one study from China (He et al., 1991) showed low levels of BP 
in HA, whereas an Indian study found high levels (Otsuka et al., 2005). 
Association of mean BP with altitude 
Twenty population samples from 17 studies were included in the meta-regression of BP. Eleven 
samples were from non-Tibetan and nine from Tibetan origin participants. In Tibetans mean SBP 
(95% confidence interval (CI)) increased by 17 mmHg (0.2 to 33.8) per 1000 m, P=0.05, but 
decreased by 5.9 mmHg (-19.1 to 7.3), P=0.38, in non-Tibetans (Figure 3.2). The mean DBP 
(95% CI) also increased by 9.5 mmHg (0.6 to 18.4), P=0.04 in Tibetans but decreased by 4 
mmHg (-13 to 5), P=0.38 in non-Tibetans, per 1000 m higher altitude. Compared to women both 
Tibetan and non-Tibetan men had higher mean values for both SBP and DBP. However, this 
difference was statistically significant for non-Tibetan participants only, with mean SBP 
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difference (95% CI) of 2.5 mmHg (0.78 to 4.15), P=0.004 and DBP difference (95% CI) of 2.5 
(1.78 to 3.19), P<0.001. 
Six studies measured BP at both high (≥2400 m), N=7, and low (<2400 m), N=10, altitude 
levels. Random-effects meta-regression of this data showed that both mean SBP and DBP 
decreased with similar magnitudes per 1000 m higher altitude; SBP (95% CI) by 1.1 mmHg (-5.1 
to 2.9), P=0.58; and DBP (95% CI) by 1.3 mmHg (-3.6 to 1), P=0.27. The point estimates 
suggested that SBP decreased more rapidly below 2400 m, -4 mmHg compared to -1.2 mmHg 
per 1000 m elevation, whereas DBP fell steeply above 2400 m (-3.7 mmHg vs. -2.5 mmHg per 
1000 m elevation). However, no definite inflection points were noted. 
Association of HT prevalence with altitude 
Random-effects meta-regression of HT by altitude was performed in 18 population samples 
(from 14 studies); 11 had Tibetan and 7 had non-Tibetan origin. The estimated odds ratio (95% 
CI) for the association of the probability of HT in relation to altitude in participants of Tibetan 
origin was 2.01 (0.37 to 11.0) per 1000 m, P=0.45. For those of non-Tibetan origin the 
association was 4.05 (0.07 to 244.7) per 1000 m, P=0.49. The model-based point estimates 
reflect the gradient seen for the prevalence of HT by altitude of: 16.5% (2000 m), 28.5% (3000 
m), and 44.6% (4000 m) for Tibetans; and 4.1% (2000 m), 14.9% (3000 m), and 41.4% (4000 m) 
for non-Tibetans. Sensitivity analysis excluding two studies with older populations (≥60 years) 
(Matsubayashi et al., 2009) (Okumiya et al., 2010) showed a similar result for Tibetans but for 
non-Tibetans the direction of the effect was reversed with odds ratio (95% CI) of 0.10 (0.004 to 
2.22) per 1000 m, P=0.14. The estimated effect sizes were similar after excluding six studies that 
presented an altitude range, rather than an exact altitude. The point estimates from the individual 
studies were not combined for both BP and HT analysis because the heterogeneity statistics 
examined by tau, I
2
, and the Q statistics showed a considerable degree of heterogeneity across 




Figure 3.2: The relationship between altitude and mean systolic blood pressure in Tibetan 




This systematic review and meta-analysis of adult populations living at HA found weak evidence 
of a positive association between SBP and DBP and altitude in participants of Tibetan origin. In 
the analysis of non-Tibetan origin participants, both mean SBP and DBP tended to decrease with 
elevation, but the associations were not statistically significant. For HT, both Tibetan and non-
Tibetan populations showed increasing prevalence with increasing altitudes. However, 
sensitivity analysis by excluding two studies with older participants gave a point estimate 
consistent with a reduction in HT prevalence in non-Tibetan participants. Model-based estimates 
were that more than a quarter of the Tibetan origin populations and less than 15% of the non-
Tibetan origin populations had HT (by local definitions) at 3000 m. The estimated prevalence of 
HT for Tibetan populations at 3000 m is consistent with the estimated global rate of HT in the 
general population (Kearney et al., 2005). However, the prevalence is higher at higher altitudes; 
e.g., 44.6% for Tibetans at 4000 m. The analysis showed the known association that men have a 
higher value of SBP and DBP than women but the prevalence of HT was similar. BMI and body 
weight were the best predictors of higher BP in HA residents. 
Tibetan and non-Tibetan (mainly Andean) ancestry populations have different physiological 
responses to environmental hypoxia and this may be because these populations have different 
genetic variants and adaptive phenotypic consequences for HA (Huerta-Sánchez et al., 2013). 
Physiological studies in Andean populations show a reduction of systemic BP under hypoxic 
hypobaric conditions due to the relaxation of smooth muscles, increase in collateral circulation 
and vascularization (León-Velarde et al., 1993; Ostadal & Kolar, 2007). Evidence from genetic 
studies in Tibetans also suggests associations between the D allele of the angiotensin-converting 
enzyme gene and HT, and higher frequency of the G allele in hypertensive Tibetans (Gesang et 
al., 2002; Kumar et al., 2003). Usually, Tibetan HA populations have a higher level of hypoxic 
ventilation response and blood oxygen saturation, better lung function, maximum cardiac output, 
better sleep quality and lower levels of pulmonary vasoconstriction and hemoglobin 
concentration compared with Andean HA populations (Wu & Kayser, 2006). Tibetans have also 
longer generational history at HA and a lesser degree of genetic admixture than Andeans, which 
could have advanced their degree of adaptation (Moore et al., 1998). The differences in the 
relationships between BP and HT and altitude between Tibetan and non-Tibetan HA populations 
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in this systematic review and meta-analysis may also be related to lifestyle factors. The diet of 
Tibetans traditionally consists of high levels of salt, a minimum 20 to 30 gram (g) per day 
(Sehgal et al., 1968; Sun, 1986), which is five times more than the WHO recommendation. 
Traditional food consumption also comprises high amounts of meat and fat, high alcohol 
drinking, and low consumption of potassium, fruit and vegetables (Luobu, 2012; X. Zhao et al., 
2012). These factors are associated with increased BP levels and the prevalence of HT (Furberg, 
Psaty, & Soliman, 2010). Lower mean BP in Andes HA population has also been suggested due 
to low socio-cultural status, increased intake of minerals such as zinc, healthier diets, lesser 
thickness of aorta and probable elasticity, and lower cardiac output (Ruiz & Penaloza, 1977). 
Earlier studies report a low prevalence of risk factors for HT, such as obesity and smoking, in 
Andean samples (Ruiz et al., 1969).  
A recent systematic review estimates the prevalence of HT in HA populations of Tibet ranges 
between 23% and 56% and that there is a 2% increment in the prevalence of HT for every 100 m 
increment of altitude (Mingji et al., 2015). The same review suggests that rates of HT may be 
increasing over time in some populations living at HA. For example, the prevalence of stage II 
HT has increased by two to three times in Tibet between 1979 (Sun, 1986) and 2009 (X. Zhao et 
al., 2012). This is consistent with the impact of lifestyle factors rather than genetic factors for 
raised BP and HT.  
Despite this latter suggestion, population origin, reflecting ancestry, rather than the country of 
residence seems to be an important factor for BP variation in those living at HA. Populations 
with Tibetan ancestry living at HA in China, India and Nepal, but following their traditional 
cultural practices, have elevated BP (Matsubayashi et al., 2009; Okumiya et al., 2010; Sherpa et 
al., 2013; Smith, 1999; Tripathy & Gupta, 2007; X. Zhao et al., 2012; X. Zheng et al., 2012). 
One large Tibetan study of 25,000 adults reported stage II HT (≥160/95 mmHg) among 15% of 
the participants (Sun, 1986). Studies based on populations from South America have identified a 
low prevalence of HT and lower mean BP (Hernandez-Hernandez et al., 2010; Lindgärde et al., 
2004; Makela et al., 1978). In Nepal, highland residents of Tibetan origin had a HT prevalence of 
25%, as opposed to just 3.7% in other HA population groups (S. Shrestha et al., 2012; Smith, 
1999). 
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An environmental factor that may influence systemic BP is ambient temperature. A large British 
study reported exposure to the colder climate, combined with poor housing quality, is associated 
with diastolic HT (Mitchell, Blane, & Bartley, 2002). By contrast, hot and humid conditions may 
cause vasodilation and lower BP (Ladell, 1964). Thus, BP could be related to both altitude and 
the temperature at any particular altitude. 
Obesity is an important risk factor for HT (Furberg et al., 2010). This was also found in the 
studies identified in this systematic review. The mechanism by which obesity is linked with HT 
is not properly understood. However, an increase in sympathetic activity, sodium retention, 
insulin resistance, hyperleptinemia, and renal abnormalities are thought to be the likely 
underlying pathways (Hall, 2000; Mark, Correia, Morgan, & et al., 1999). Among the studies 
included in this review that compared BMI at high and low altitude levels, BMI was similar at 
both levels in four studies (Khalid & Adzaku, 1995; Lindgärde et al., 2004; Negi et al., 2012; 
Smith, 1999), lower in HA in one study (Hernandez-Hernandez et al., 2010), and no specific 
trend was observed in one study (Okumiya et al., 2010).  
Limitations of this review were that it was limited to published and electronically available 
studies written in English. The 'grey literature' and in particular theses, conference papers and 
government reports were not sought. Publication bias may be present, specifically with regards 
to Chinese language papers and studies from Andean countries published in Spanish. 
Implications for clinical practice, policy and research 
The major implications of these findings for clinical practice, policy and research are that 
clinicians and those concerned with public health should note an increased HT risk in HA 
populations of Tibetan origin, whatever their current living situation. Culturally driven excessive 
consumption of salt, alcohol and dietary fats may be the key reasons behind the increased levels 
of BP among HA Tibetans. Thus, health education and lifestyle modification interventions may 
be particularly important in this population. For example, strategies to reduce sodium and 
increase potassium, e.g. with salt substitutes, might be appropriate (X. Zhao et al., 2014). In light 
of the relatively poor availability of health care services at HA, it is recommended that health 
policy planners consider strategies such as health camps to identify and treat individuals with 
high risk of HT.  
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Conclusions and unanswered questions 
This study presented the evidence of a positive association of BP and altitude in adult HA 
populations of Tibetan origin. This could be due to the additive effects of hypoxia, lifestyle 
habits (particularly diet), and genetic predisposition. Non-Tibetan HA populations were 
generally found to have a low risk of raised BP. In both population groups, men were more likely 
than women to have increased BP. Regions with HA countries, particularly South Asia, Central 
Asia, and Africa, have insufficient epidemiological data on BP and other cardiovascular risk 
factors in their HA residents. More population-specific prevalence studies are needed to estimate 
the comprehensive risk of CVD in these regions.   
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3.2 Blood glucose levels and diabetes at high altitude 
Diabetes mellitus (DM) is a key global public health problem. A recent estimate is that the global 
age-standardized prevalence of DM has increased from 4.3% in 1980 to 9.0% in 2014 among 
men, and from 5% to 7.9% among women (NCD Risk Factor Collaboration, 2016). During this 
period the number of people living with DM has also increased four-fold, from 108 million to 
432 million (NCD Risk Factor Collaboration, 2016). Another estimate reports that a large 
proportion of those with DM remain undiagnosed and this is particularly so in low and middle 
income countries (Beagley, Guariguata, Weil, & Motala, 2014). Blood glucose levels have a 
continuous dose-response relationship with the risk of CVD (Meigs, Nathan, Wilson, Cupples, & 
Singer, 1998). This incremental risk does not depend on a formal diagnosis of DM (Gerstein & 
Punthakee, 2010), although those with DM themselves have a four-fold risk of CVD and develop 
CVD approximately 15 years earlier than those without DM (Booth, Kapral, Fung, & Tu, 2006). 
Permanently living at HA confers a metabolic adaptation of high glucose uptake (Holden et al., 
1995). However, changing diets and lifestyle factors for residents at HA may result in increased 
mean blood glucose levels despite this metabolic adaptation (Sherpa et al., 2013). 
This section comprises a systematic review and meta-analysis of the relationship between blood 
glucose and residence at HA. Potential factors that influence blood glucose at HA and also blood 
glucose responses to short-term exposure to HA will be discussed. 
Methods 
A search was conducted in three major biomedical databases: PubMed, OvidSP (Medline & 
Embase) and Scopus. The MeSH terms ‘diabetes mellitus’ or ‘hyperglycemia’ with major 
subheading 'epidemiology' were combined with words ‘altitude’, or ‘mountain’ or ‘himalaya’ or 
‘highland’ or 'Tibetan' or 'Andean' in titles and/or abstracts. All relevant English language studies 
published until the end of May 2016 were scrutinized. Inclusion criteria were the studies with 
altitude level greater than or equal to 2400 m, sample size of greater than or equal to 100 and age 
of participants 18 years or over. Studies conducted on patients and not at population level, and 
among pregnant women were excluded.  
Random-effects meta-regression was used to assess the relationship between each of fasting 
plasma glucose (FPG) levels and DM prevalence by altitude. FPG was treated as a continuous 
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Gaussian variable and pooled estimate of mean FPG was estimated per 1000 m elevation. For 
meta-regression, a mixed linear model was used with reported mean FPG as a response variable 
that used the particular study as a random effect, and the inverse variance of the mean FPG as a 
weight. For the meta-regression of DM prevalence a pooled odds ratio for DM per 1000 m 
elevation in altitude was estimated using a similar random-effects model. If a study reported an 
altitude range rather than a specific level, the mean of the range was recorded. Sensitivity testing 
and sub-group analysis was also performed. Data at different levels of HA or from different 
ethnic populations in a particular study were treated as an independent study during the analysis 
if sample size was greater than or equal to 100, or otherwise excluded as per the eligibility 
criteria. Population samples of those of Tibetan and non-Tibetan origin were analysed separately 
because of the background of known differences in degree of adaptation and physiological 
response against environmental hypoxia, for these different ancestry groups. Tibetans and 
Andeans, the latter comprising the highest proportion among non-Tibetans, have the largest total 
populations living at HA at the present time (Moore et al., 1998). 
The measurement unit of blood glucose is mainly presented in mg/dL because the majority of the 
studies included in this review report FPG using this scale of measurement. The conversion 
factor from the International System of Unit (SI) is: 1 mmol/L=18 mg/dL. 
Results 
The search retrieved 262 papers; 84 from Scopus, 71 from PubMed, 61 from Medline and 46 
from Embase. A reference search was performed for 39 articles selected for full text review. A 
flow diagram for the selection of articles is presented in Figure 3.3. 
Eleven studies met eligibility criteria and were included in this review. Of these, seven were 
identified from a database search and four from a reference search. The selected studies were 
published between 2004 and 2016. Two studies were published each in 2008 and 2012. The total 
number of participants in included studies was 9884; five studies included fewer than 500 
participants, two studies had 500 to 1000 participants and four studies had more than 1000 
participants. Four studies were from China, three from Peru, and one each from Nepal, India, 
China and India combined, and seven from Latin American countries. The altitude level ranged 
from 2577 m to 4500 m. The risk of bias is presented in Table 3.3, which included consideration 
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of the sampling process, DM definitions, DM cut-point definitions, and the fasting state during 
blood glucose measurements. Briefly, participants were selected randomly in six studies and 
non-randomly in five studies. The vast majority of the studies considered FPG ≥126 mg/dL (≥7.0 

















Figure 3.3: Flow diagram for identification and selection of articles on blood glucose levels 







Titles / abstracts excluded 
       (n=223) 
- Not original research articles 
- Studies on patients 
- Sample size <100 
- Altitude level <2400 m 
- Studies on children 
 
 
Total articles retrieved 




Articles selected for full 
text review (n=39) 
 
Articles excluded  (n=27) 
- Altitude level not mentioned (6) 
- Duplicates across the databases 
(6) 
- Full text not available (5) 
- Altitude <2400 m (3)            
- Inadequate information (3) 
- Not relevant (3) 
- Sample size on high altitude         
<100 (2) 
 
Final articles included (n=11) 
Database search: 7 
Reference search from full text 
reviewed studies: 4 
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Age and gender 
Only two recent studies reported the age-related prevalence of DM at HA and both reported a 
positive relationship between the prevalence of DM and older age (Okumiya et al., 2016; S. Xu 
et al., 2015). Of three studies that reported prevalence of DM by gender, two reported a higher 
prevalence in men than in women (Gonzales & Tapia, 2013; S. Xu et al., 2015). A Latin 
American study showed higher prevalence in women in both HA samples (Schargrodsky et al., 
2008). Only one study reported mean FPG by gender, showing a higher mean FPG in women 
compared to men (Gonzales & Tapia, 2013). 
High and low altitude comparison 
Two studies compared populations from HA (≥2400 m) and LA (<2400 m) for each DM and 
FPG. Mean FPG was lower in HA samples than in LA samples in both studies (Lindgärde et al., 
2004; Sherpa et al., 2008). A Nepalese study found a higher prevalence of new DM cases in an 
HA population (Sherpa et al., 2008) whereas a Latin American study comprising data from two 
HA and five LA samples reported inconsistent results (Schargrodsky et al., 2008). 
Association of DM prevalence and mean FPG with altitude 
The prevalence of DM at HA was given in 16 population samples (from nine studies): nine with 
samples of Tibetan origin and seven with samples of non-Tibetan origin. Random-effects meta-
regression estimated odds ratio (95% CI) for DM prevalence in Tibetan origin population of 1.49 
(0.49 to 4.48) per 1000 m, P=0.49 (Figure 3.4). For non-Tibetan origin populations this 
association was 0.82 (0.22 to 3.0) per 1000 m, P=0.80 (Figure 3.5). These point estimates 
suggest the gradient for DM prevalence of 2.9% (2000 m), 3.8% (3000 m), and 6.5% (4000 m) 
for a Tibetan population; and 5.7% (2000 m), 4.8% (3000 m), and 3.8% (4000 m) for a non-
Tibetan population. Sensitivity analysis by excluding population samples with older populations 
(≥60 years) (Matsubayashi et al., 2009; Okumiya et al., 2010) yielded a similar result. There 
were no significant changes in effect size when the populations samples specifying an altitude 
range rather than an exact altitude were excluded (W. Chen et al., 2011; Okumiya et al., 2010; S. 
Xu et al., 2015); odds ratio (95% CI) was 1.35 (0.13 to 13.46), P=0.79 for Tibetan origin 
samples. 
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Random-effects meta-regression of FPG was performed in eight population samples, four each 
from Tibetan and non-Tibetan origin participants, from six studies. Consistent with the trends 
observed for DM, mean FPG increased by 5.2 mg/dL (-8.3 to 18.8) per 1000 m, P=0.45 in 
Tibetan populations but decreased by -7.9 mg/dL (-55 to 39.3) per 1000 m, P=0.74 in non-
Tibetans. Heterogeneity statistics examined by tau, I
2
, and the Q statistics showed a high 
heterogeneity across the studies. Hence the point estimates from the individual studies were not 
combined for either DM prevalence or FPG analysis. 




Definition DM Cut-point Fasting 
Lindgarde et al. 
2004 
Non-random Not relevant Not relevant Yes 
Lhamo et al.  
2008 
Random ADA 2008 
 






Non-random WHO  
(exact year not 
given) 
 
≥126 mg/dL or 2hpg ≥200 mg/dL Yes 
Okumiya et al. 
2010 
Non-random Not given ≥126 mg/dL or 2hpg ≥200 mg/dL Yes 
Chen et al. 2011 Random Not given Fasting ≥126 mg/dL or OGTT ≥200 
mmol/L or self- report of treatment 
Yes 
Negi et al. 2012 Random Not given Fasting >126 mg/dL  Yes 
Gonzalez & Tapia 
2012 
Random Not given Fasting >126 mg/dL Yes 
Xu et al. 2015 Random Chinese 
guidelines 
Fasting ≥126 mg/dL or OGTT ≥200 
mg/dL or self-report of diabetes or on 
medication 
Yes 
Okumiya et al. 
2016 
Non-random WHO 2006 Fasting ≥126 mg/dL  Yes 
Schargrodsky et al. 
2008 
Random Not given Fasting ≥126 mg/dL or self-report Yes 
Ojeda et al. 2014 Non-random Not given Fasting >125 mg/dL or on treatment Yes 
DM, Diabetes Mellitus; ADA, American Diabetes Association; WHO, World Health Organization; 2hpg, 2 hour 
plasma glucose; OGTT, Oral Glucose Tolerance Test. 126 mg/dL=7.0 mmol/L; 200 mg/dL=11.1 mmol/L. Few 
studies define DM cut-point in mmol/L.  
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Table 3.4: Key features of included studies on blood glucose levels and diabetes at high altitude 
Author Location Altitude (m) Sample size DM (%) Mean FPG (SD) 
Lindgarde  
et al. 2004 
Peru 3800 m (Cuzco), 
150 m (Lima) 
3800 m: 105 
150 m: 105 
(≥35 years) (W) 
Not reported (mmol/L) 
3800 m: 3.8 (1.1) 
150 m: 4.6 (0.7) 
Lhamo et al. 
2008 
Nepal 2900 m (Everest 
region), 1200 m 
(Kathmandu) 
 
2900 m: 119 
1200 m: 121 
(30-70 years) 
2900 m: 3.6 
1200 m: 2.4 
(New DM only) 
(mg/dL) 
2900 m: 97 (14.8) 
1200 m: 100.4 (12.3) 





Chile (seven Latin 
American countries) 
High altitude 
2600 m (Bogota), 
2850 m (Quito) 
Moderate or low 
altitude 
566 m 
(Barquisimeto), 25 m 
(Buenos Aires), 1550 
m (Lima), 2250 m 
(Mexico City), 520 m 
(Santiago) 
High altitude 
2600 m: 738 (M), 815 
(W), 2850 m: 813 
(M), 825 (W) 
Moderate or low 
altitude 
566 m: 713 (M), 1135 
(W), 25 m: 734 (M), 
748 (W), 1550 m: 769 
(M), 883 (W), 2250 
m: 833 (M), 889 (W), 




2600 m: 8.1 
(M:7.4, W:8.7), 
2850 m: 5.9 (M: 
4.6, W:7.3) 
Moderate or low 
altitude 
566 m: 6 (M: 5.6, 
W: 6.3), 25 m: 6.2 
(M:7.9, W:4.8), 
1550 m: 4.4 (M: 
4.3, W:4.6), 2250 
m: 8.9 (M:8.0, 
W:9.7), 520 m: 7.2 
(M:6.8, W:7.6) 
Not reported 
Matsubayashi et al. 
2009 











Tibetan: 91 (30.9) 
Mongolian: 84.4 (17.6) 
Han: 87.1 (33.4) 
 




3000-3200 m: 97 
3700 m: 209 
3000-3200 m: 7 
3700 m: 13 
2900-3800 m: 8 
(mg/dL) 
3000-3200 m: 90 (29) 





2900-3800 m: 117 
(≥60 years) 
2900-3800 m: 104 (21) 
Chen et al. 2011 China 3658 m-4200 m 
(Tibet) 
1289 (≥18 years) 2.9 
(M: 3.1, W: 2.5) 
 
Not reported 
Negi et al. 2012 India 3100 m, 3900 m 
(Himachal Pradesh) 
3100 m: 171 
3900 m: 242 
(>20 years) 
3100 m: 4.1 
3900 m: 0.4 
(mg/dL) 
3100 m: 102.6 (9.9) 
3900 m: 100.3 (10.6) 
Gonzales & Tapia 
2012 









M: 92.1 (16.3) 
W: 95.1 (25.9) 









Xu et al. 2015 China 3200-4500 m 
(Tibet) 
 
3200-3500 m: 444 
(M), 463 (W) 




3200-3500 m: 7.3 
(M:8.5, W:6.4) 




Okumiya et al. 2016 China 2900-4800 m 
(Tibet) 
2900-3499 m: 240 
(M), 334 (W) 
3500-4499 m: 210 
(M), 317 (W) 
≥4500 m: 91 (M), 66 
(W) 
(40-87 yrs) 
2900-3499 m: 3.1 
3500-4499 m: 9.5 
≥4500 m: 8.9 
Not reported 
m, metre; M, men; W, women; DM, diabetes mellitus; FPG, fasting plasma glucose; SD, standard deviation. The units of FPG (mg/dL or mmol/L) 





Figure 3.4: Meta-regression of logit event rate of diabetes on altitude for Tibetan 
origin populations 
 
Figure 3.5: Meta-regression of logit event rate of diabetes on altitude for non-Tibetan 
origin populations 
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This systematic review and meta-analysis showed no evidence of statistically significant 
associations between FPG, DM prevalence, and altitude in adult HA populations living at 
an altitude of 2400 m or higher. However, the point estimates for FPG and DM prevalence 
increased with increasing altitude in Tibetans but decreased with increasing altitude in non-
Tibetan origin populations. A difference between the different populations, should one in 
fact exist, may be due to genetic differences in pathways affecting glucose metabolism in 
these ethnic groups (Xing et al., 2008). An important point is that the systematic review-
based estimates of the point prevalence of DM at different levels of HA were usually lower 
than the global estimate of DM in general the adult population (8.5%) (NCD Risk Factor 
Collaboration, 2016). It is difficult to draw conclusions about the influence of age and 
gender on DM and FPG at HA because very few studies presented these data. 
With regard to the studies reporting a high prevalence of DM, a recent study in Tibet 
reported the prevalence of 9.5% at 4000 m and 8.9% at 4500 m (Okumiya et al., 2016). A 
strong association between polycythemia and glucose intolerance was observed in this 
study. A Peruvian study involving a sample of older adults (≥60 years) at HA also reported 
the odds ratio (95% CI) for being diabetic or having impaired glucose tolerance as 3.0 (1.2 
to 7.8) in those with polycythemia compared to non-polycythemic participants (Okumiya 
et al., 2011). Polycythemia may be associated with glucose intolerance because poor 
adaptation to hypoxia or polycythemia may be a compensatory response to insufficient 
oxygen supply during glucose metabolism (Okumiya et al., 2011). The evidence for this 
hypothesis is inconsistent. No association between hemoglobin concentration and blood 
glucose was found in another Peruvian study, although there was an association between 
DBP and hemoglobin concentration (Gonzales & Tapia, 2013).  
A Tibetan study reported fasting hyperglycemia (>100 mg/dL) (>5.5 mmol/L) in 57.5% of 
692 HA farmers and herdsmen (Sherpa et al., 2013). This has important health implications 
because people with pre-diabetes have an almost five-fold higher risk of future diabetes 
(Gerstein et al., 2007). Increasing availability and consumption of sugary carbonated 
drinks, processed foods and instant noodles at HA may be responsible for this high rate of 
fasting hyperglycemia. A study in Taiwan found the prevalence of DM was highest in a 
75 
 
mountainous region compared with the other regions surveyed (Pan, Yeh, Chang, Hwu, & 
Ho, 2003). A Saudi Arabian study conducted in the Asir region at an altitude of 3150 m 
showed that diabetes was one of the most common risk factors among 124 patients 
admitted for diagnosed acute MI (Ashouri et al., 1993). A Swiss study of those under the 
age of 20 years found twice as many diabetics in the mountain region compared to two 
other geographical regions (Zuppinger, Teuscher, & Lüscher, 1975).  
There are many potential reasons for lower DM and FPG in non-Tibetan (particularly 
Andean) populations at HA. A sub-analysis of 29,806 Peruvian people living at greater 
than or equal to 3000 m found that an inverse association between altitude and diabetes 
was not statistically significant after adjusting for a number of potential confounding 
variables: wealth index, age and sex. This suggests that lower socio-economic status may 
be relevant to lower rates of diabetes at HA (Mori, Seclén, Rosas, & Arias, 2015). Several 
types of glucose tolerance tests have also shown that HA residents had a more rapid 
decline in glucose levels compared to LA residents for both an intravenous glucose 
tolerance test (Picón-Reátegui, 1963) and an oral glucose tolerance test (Srivastava, 
Kumria, Grover, Sridharan, & Malhotra, 1975). HA residents were also found to have 
higher insulin sensitivity compared to LA residents (Lindgärde et al., 2004). Lower hepatic 
glucagon sensitivity (Sutton & Garmendia, 1976) and higher glucose disposal in the 
skeletal muscle (Woolcott, Ader, & Bergman, 2015) might also contribute to lower glucose 
levels in HA dwellers. Colder ambient temperatures at HA may affect glucose metabolism 
because carbohydrates are a key thermogenic fuel during shivering (Haman et al., 2005). 
There is a broad consensus in the literature that acclimatization to HA results in an 
increased preference for the use of glucose as a metabolic substrate. This is because using 
glucose as a metabolic substrate has high oxygen efficiency. Glucose derives more 
adenosine triphosphate (ATP) per unit of oxygen consumed compared with lipids when 
oxidized (Braun, 2008; Roberts et al., 1996). A study in two aboriginal HA dwellers, 
Andean Quechuas and Nepalese Sherpas, found that the preference for glucose as a 
substrate in the heart correlated positively in these populations but negatively among LA 
residents (Holden et al., 1995). Furthermore, that study reported that glucose metabolism in 
myocardium was 25% to 50% more oxygen efficient than free fatty acids. There is also 
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evidence that intermittent hypoxia reduces hepatic glucose output by 50% in rats 
(Freminet, Megas, & Puceat, 1990). Similar phenomena are plausible among human HA 
residents.  
Plants and crops produced and consumed in HA regions may possess anti-diabetic 
properties. Some traditional plants are recommended by traditional healers as an integral 
part of folk medicine practices. One study identified three plants found in the Eastern 
Himalayan belt that have hypoglycemic properties (Mosihuzzaman et al., 1993). Some of 
the 46 plants used by local people to treat diabetes in the Himalayan region of India also 
had anti-diabetic effects in rodent models (Tag, Kalita, Dwivedi, Das, & Namsa, 2012). A 
Chinese study showed that a bean (Vigna angularis) when grown at HA may have both 
antioxidant and anti-diabetic properties (Yao, Cheng, Wang, Wang, & Ren, 2012). Another 
Chinese study conducted at HA areas found hypoglycemic effects in a tea (Kucha), which 
may be due to a reduction in disaccharidase activity (Xie et al., 2009). An Indian study in a 
Himalayan region of Sikkim and Darjeeling reported that out of 37 species being used as 
an anti-diabetic agent, 19% were included as hypoglycemic agents in the dictionary of 
Indian Folk Medicine and Ethnobotany (D. Chhetri, Parajuli, & Subba, 2005). Serviceberry 
plant, which has been used by the Blackfeet Indian tribe of the Rocky Mountains in 
Montana, United States of America (USA), reduced post-prandial glycemic response (A. J. 
Zhang, Rimando, Fish, Mentreddy, & Mathews, 2012). Buckwheat, one of the major crops 
at HA, (Stevens, 1996), was shown to lower blood glucose levels in a hospital-based 
experimental study in China (C. J. Lu, 1993). This benefit is mainly attributed to the 
unique protein structure and amino acid composition of buckwheat (S.-Q. Li & Zhang, 
2001). 
Environmental and physiological factors are likely to be more important than genetic 
factors in explaining blood glucose levels at HA. For instance, studies of Peruvian 
(Lindgärde et al., 2004) and Nepalese (Sherpa et al., 2008) participants report comparisons 
between populations of similar genetic background but residing at different altitudes. In 
both studies, participants living at lower altitudes had a higher prevalence of increased 
blood glucose levels. Related examples are findings from studies of genetically similar 
American and Mexican Pima Indians with groups living at HA, in a Sonora mountain area, 
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who had lower fasting insulin levels compared to those of similar ethnicity living in a 
lowland area of the USA, even after adjusting for age, sex, and obesity (Esparza-Romero et 
al., 2010). Another study of migrants carried out in the Republic of Dagestan found that 
when highlanders migrated to lower altitudes the prevalence of DM increased from its 
original lower rate to the higher rate of the lowlander population (Abusuev, Khachurov, & 
Akhmedkhanov, 1992). 
In studies that also reported on obesity there was an expected increased prevalence of high 
blood glucose levels at HA (Málaga, Zevallos-Palacios, Lazo, & Huayanay, 2010; Pan et 
al., 2003). In a Nepalese HA study, waist circumference (WC) was a significant predictor 
for impaired fasting glucose (IFG) (Sherpa et al., 2008). In common with international 
recommendations (Mozaffarian, 2016), these findings suggest that nutritional interventions 
of HA dwellers should target both obesity and diabetes.  
Evidence for the effect of short-term exposure to HA on glucose metabolism 
Many people are exposed to HA for short periods for work or recreational purposes. A 
number of studies on short-term residents at HA, including both healthy people and those 
with illness, report lower glucose concentrations with short-term exposure to HA.  
A report of fasting blood glucose levels in seven Indian male lowlanders during their stay 
at 4000 m found an initial increase in blood glucose that decreased gradually after 10 
months and increased again on return to sea level (Srivastava et al., 1975). A Taiwanese 
study found even a stay of only three days at HA (4000 m) improved glucose tolerance 
(W.-C. Lee et al., 2003). The authors suggested that HA living conditions and activities 
may serve as a potential natural remedy for diabetes.  
Blood glucose levels tend to become lower among diabetic patients during short-term stays 
at HA. A Saudi Arabian study found that HA living at 2400 m, but not at extreme altitude, 
improved glycemic control in type II diabetic patients (Hessien, 2013). Some studies even 
highlight the risk of hypoglycemia among type I diabetics under treatment during short-
term exposure to HA (Brubaker, 2005). Exposure to very HA (5000 m) may also affect 
glycemic control in both type I and type II diabetic patients (de Mol et al., 2011). 
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Not all studies report a positive effect on glucose metabolism with increasing altitude 
during HA sojourn. An Indian study of 25 men found no changes in glucose tolerance 
during measurements at sea level, repeated tests after 10, 30, and 300 days at HA (3500 
m), and again 14 days after a return to sea level (Brahmachari, Malhotra, Joseph, & 
Krishnan, 1973). Some studies report that blood glucose concentrations increase rapidly on 
arrival at HA and later gradually decrease toward sea level values (Sawhney, Malhotra, & 
Singh, 1991; Williams, 1975). This could be due to the protective effects of HA on blood 
glucose being overwhelmed by increased hepatic glycogenolysis and glucose release due to 
the activation of the sympatho-adrenomedullary and adrenocortical system, or alternatively 
due to the increment in the rate-limiting enzymes (pyruvate kinase and pyruvate 
phosphotransferase) in glucose metabolism (Hance et al., 1980). 
Conclusion 
The evidence presented in this section suggests that long-term residence at HA usually has 
a beneficial effect on glucose metabolism although this may vary by ethnicity. Although 
the point estimates from meta-analysis were consistent with a positive association between 
DM prevalence and FPG and HA in Tibetan origin populations, and with the opposite 
association in non-Tibetan origin populations (mainly Andeans), the estimates of 
association had wide confidence limits and were not statistically significant. These findings 
should be interpreted with the following caveats: first, only studies published in the 
English language were included. Thus, there may be a publication bias for papers 
published in the local language of HA countries, mainly Chinese language papers from 
China and Spanish language papers from Andean countries. Second, because of small 
sample sizes included studies often had limited statistical power to detect important effects.  
Environmental and physiological factors are likely to be more important than genetic 
factors for maintaining normoglycemia at HA. However, as HA populations are changing 
from traditional lifestyle and diet to other lifestyle habits a higher risk of elevated blood 





3.3 Lipid profile at high altitude 
Dyslipidemia is a very powerful predictive factor for ischemic heart disease (IHD) 
(Simons, 1986). HA living may alter lipid concentrations due to hypoxia (Garmendia, 
Arroyo, & Muro, 1970; Roberts et al., 1996). This section will briefly outline the 
relationship between individual components of lipid profile and CVD, and then review the 
effects of HA living on lipid profile.  
There is a positive association between IHD mortality and increasing total cholesterol (TC) 
levels (Prospective Studies Collaboration, 2007). There is also a very strong association 
between the risk of IHD and higher TC levels with no apparent lower threshold of risk (M. 
Law, 2010). Among different components of the lipid profile an elevated level of low-
density lipo-protein (LDL) is particularly associated with increased IHD risk. The carrier 
protein (apolipoprotein B) of LDL is highly atherogenic (Superko, 1996). There is an 
inverse association between IHD risk and high-density lipo-protein (HDL) (Prospective 
Studies Collaboration, 2007). The association between triglyceride (TG) and IHD is 
uncertain. TG levels may be a conditional risk factor for IHD in those with low HDL, 
central obesity or DM (Foody, 2006; Padwal & Sharma, 2010). Large studies have not 
confirmed a strong positive association between lipid components and stroke mortality 
(Prospective Studies Collaboration, 2007) and incident ischemic stroke (Willey et al., 
2009). However, strong positive relationships were found between incident cardiovascular 
morbidity and mortality, and the TC to HDL ratio after adjustment for other risk factors 
(Kappelle, Gansevoort, Hillege, Wolffenbuttel, & Dullaart, 2011). 
Hypoxic and hypobaric conditions of HA alter the use of energy producing metabolic fuels 
(Gonzales, 2001), which may secondarily affect lipid profiles. As discussed in the previous 
section (3.2), hypoxia causes a preference for glucose utilization and decreases uptake of 
free fatty acids because of oxygen-efficient adaptation (Holden et al., 1995; Roberts et al., 
1996). There could also be a physiological phenomenon of energy compensation in the 
form of increased concentrations of lipids in hypoxemia (Garmendia et al., 1970). Hypoxia 
alters hepatic lipid oxidation and can increase the levels of TG (Muratsubaki, Enomoto, 
Ichijoh, & Yamamoto, 2003) and HDL (Meerson, Tverdokhlib, Nikonorov, Filippov, & 
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Frolov, 1988). This section comprises systematic review only because there are not enough 

















Figure 3.6 : Flow diagram for identification and selection of articles on lipid profiles 
at high altitude. 
Methods 
In order to identify relevant literature about lipids at HA, a search was conducted in three 
major biomedical databases: PubMed, OvidSP (Medline & Embase) and Scopus (Figure 
3.6). The search terms ‘lipid profile’, ‘lipids’, ‘metabolic syndrome’ and individual 
components of lipid profiles; ‘TC’, ‘LDL’, ‘HDL’ and ‘TG’ (both words and 
abbreviations) were combined with the words ‘altitude’, or ‘mountain’, or ‘himalaya’, or 
‘highland’ in titles and/or abstracts. Inclusion criteria were studies published in any 
language with at least the abstract available electronically in English, participants aged 18 
Titles / abstracts excluded 
       (n=372) 
- Not original research articles 
- Studies on patients 
- Sample size <100 
- Altitude level <2400 m 
- Age <18 years 
- Duplicate across the databases 
 
 
Total articles retrieved 




Articles selected for full 
text review (n=37) 
 
Articles excluded  (n=28) 
- Full text not available (14) 
- Not permanent residents (4) 
- Altitude <2400 m (4) 
- Altitude level not mentioned (3) 
- Inadequate information (3) 
 
Final articles included (n=9) 
Database search: 7 
Reference search from full text 




years or older, and availability of data on prevalence or mean values of lipid components at 
HA. Studies conducted on patients rather than at population level, and those not denoting 
specific altitude levels were excluded. All relevant studies published until the end of 
January 2014 were scrutinized.  
The measurement units for lipid components are presented in mg/dL because the majority 
of the included studies report it this way. The conversion factor from the SI unit is: 1 
mmol/L=38.67 mg/dL for TC, LDL, and HDL; and 1 mmol/L=88.57 mg/dL for TG. 
Results 
A total of nine studies met the selection criteria. The key features of the selected studies are 
summarized in Table 3.5. Five studies are from Peru, two from China (Tibet), and one each 
is from Venezuela and Central Asia. Most studies are relatively small, less than 500 
participants, and so have limited statistical power to examine confounding variables 
influencing lipid profiles. Three of the studies had a sample size of less than 100, between 
100 and 500, and between 500 and 700 respectively. The levels of altitude ranged from 
3200 m to 4100 m. Three studies compared lipid levels between HA (≥2400 m) and LA 
(<2400 m). Six studies provided data on prevalence and used the cut-points as per Adult 
Treatment Panel III (ATP III) criteria (Grundy et al., 2002). However, one study used the 
HDL cut-point of less than 40 mg/dL (<1.0 mmol/L) for both sexes (Gonzales & Tapia, 
2013), and two used greater than or equal to 160 mg/dL (≥4.1 mmol/L) as a LDL cut-point 
(Gonzales & Tapia, 2013; Sherpa et al., 2011). 
The studies identified by the literature search variably identify higher (Baracco, Mohanna, 
& Seclén, 2007; Gonzales & Tapia, 2013; Málaga et al., 2010; Mohanna et al., 2006; 
Sherpa et al., 2011) and lower lipid levels in association with HA (Caceres Pilares, Rojas 
Bravo, Caceres Espinoza, & Ortiz Martinez, 2004; De Mendoza et al., 1978; Fiori et al., 
2000; Sherpa et al., 2013). The studies reporting dyslipidemia in HA also had many 
participants who were overweight or obese, or had central adiposity (Gonzales & Tapia, 
2013; Málaga et al., 2010; Mohanna et al., 2006; Sherpa et al., 2011). It may be that in 
these studies lifestyle and dietary patterns affected the lipid profile of HA residents.  
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Some studies report exceptionally high levels of some of the lipid components. A Peruvian 
study of 74 adult permanent residents living at 3600 m reported low levels of HDL in 
93.5% of women and 50% of men, and elevated level of TC in 40.6% including both sexes 
(Málaga et al., 2010). Another Peruvian study of 506 participants aged between 35 and 75 
years living at 4100 m altitude reported a high prevalence of TG: men 60.4% and women 
66.8%; and low levels of HDL, men 66.9% and women 63.2% (Gonzales & Tapia, 2013). 
This study also reported an association between higher hemoglobin levels and higher levels 
of TC, LDL, TG and non-HDL levels. Other studies reported different and usually lower 
levels of lipid profile components; however, levels of TG were elevated (Caceres Pilares et 
al., 2004). 
Six studies reported the prevalence of 'abnormal levels' or mean values of lipid components 
by sex. The trend was observed for high mean values or prevalence of high TG and LDL in 
men and low HDL values in women. An equal number of studies reported high and low 
values of TC. Only three studies compared lipid values at low and high altitude. Distinctive 
patterns of lipid components varying by altitude of residence were not seen, other than high 





Table 3.5: Key features of included studies on lipid profile at high altitude 









et al. 1979 
Venezuela 1000,  
3500 
1000 m:  
136 




- 1000 m 
TC, M: 190 (38), W: 
192 (37); TG, M: 130 
(53), W:125 (52); HDL, 
M: 41 (10), W:44(10); 
LDL, M:122 (35), 
W:122(37) 
3500m 
TC, M:172(38),W: 164 
(35); TG, M: 141(49), 
W:149(50); HDL, M: 
36 (10), W:37(8); LDL, 
M:108(37),W:97(35) 













- 600 m 










Peru 3400 120 
(30-39 
years) 
- TC: 191, TG: 158, 
HDL: 46.8, LDL:113 
Mohanna et 
al. 2006 
Peru 4100 102 
(≥30 years) 
High TC: 34.3 














High TG: 29.7 





High TG: 56.6 








TG: 134.6 (53.1) 
HDL: 54.3 (10.3) 
4100 m 






HA living, with either short-term or long-term exposure, has been reported to be associated 
with increased TG levels (Brito et al., 2007; Siqués et al., 2007). A Taiwanese national 
survey found that TG levels were highest in mountainous parts of all regions surveyed 
(Chang, Yeh, Chang, Tsai, & Pan, 2002). Dietary factors may confound this relationship. 
HA residents often drink large amounts of alcohol and consume large amounts of 
carbohydrate (Baracco et al., 2007; Sherpa et al., 2013; Sherpa et al., 2010). High uptake of 
 
 
Malaga et al. 
2010 
Peru 3600 74 
(>18 
years) 
High TC: 46.3 
(M), 38.3(W) 
High TG: 50 
(M), 47.8 (W) 
Low HDL: 50 
(M), 93.5 (W) 
- 
Sherpa et al. 
2011 
China 3660 537 
(30-70 
years) 
High TC: 31 
(M:30.8, W: 
32.3) 











Peru 4100 506 
(35-75 
years) 
High TC: 25.3 
(M), 27.2 (W) 
High TG: 60.4 
(M), 66.8 (W) 
Low HDL: 
66.9 (M), 63.2 
(W) 
High LDL: 9.1 
(M), 8.8 (W) 
TC, M: 168.8 (45.7), 
W: 170.8 (56.5); TG, 
M:183.8 (90), W: 182.1 
(104); HDL, M: 
36.2(10), W:36.8 
(12.8); LDL, M:100.9 
(35), W: 103.4 (40.8) 
Sherpa et al. 
2013 
China  3700 692 
(30-80 
years) 
Low HDL: 3.9 
(M: 0.6, W: 6) 
High TG: 7.6 
(M:9.8, W:5.8) 
- 
Abbreviations: m, metre; M, men; W, Women; SD, standard deviation; TC, total cholesterol; TG, 
triglycerides; LDL, low-density lipoprotein cholesterol; HDL, high-density lipoprotein cholesterol 
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alcohol raises TG levels because of the increased secretion of its carrier protein (very low-
density lipoprotein (VLDL)), impaired lipolysis, and increased free fatty acid from adipose 
tissue (Klop, do Rego, & Cabezas, 2013). Studies in France and Northern Ireland 
(Ruidavets et al., 2010), and in Switzerland (Foerster et al., 2009) show an increase in TG 
levels even in light drinkers, and the highest increment in heavy drinkers. Another study 
reported that a high consumption of fat and alcohol synergistically raises plasma TG 
(Barson et al., 2009). Alcohol intake increased the risk of hyperlipidemia by 2.4 fold in a 
Chinese study among 1425 people living at a moderate altitude of 1500 m to 2500 m 
(Deng, Luo, Huang, Shen, & Ma, 2012). Nonetheless, raised levels of TG were also 
reported in 29% of 330 Argentinean children living at an altitude of 3750 m who were 
unlikely to consume a significant amount of alcohol (Maccallini et al., 2012). TG levels 
may also rise when dietary carbohydrate accounts for more than 55% of the total energy 
(Parks, 2001). Carbohydrate-laden foods such as potatoes, barley and buckwheat are the 
mainstay of HA dietary patterns (Baracco et al., 2007; Sinnett & Whyte, 1973; Stevens, 
1996).  
Ambient cold temperature may also confound the lipid profile relationship with HA. Cold 
temperature is associated with catabolism of TG in both muscle and adipose tissue, 
although it is not certain whether this affects plasma TG (Vallerand & Jacobs, 1990). The 
concentration of HDL was lowest in the coldest months in a Wales study of 2036 men – 
the Caerphilly prospective study (Eldwood et al., 1993).  
No clear relationship between ethnicity and lipid profile at HA has been identified, unlike 
the evidence identified for BP. In studies of Tibetans living at HA, high lipid values were 
observed in urban Tibetans of Lhasa (Sherpa et al., 2011), compared to low values among 
Tibetan farmers and herdsmen (Sherpa et al., 2013). In Peru, an older study among HA 
residents reported a low prevalence of dyslipidemia (Caceres Pilares et al., 2004). Recent 
studies from Peru consistently show high levels of lipids (Gonzales & Tapia, 2013; Luis 
Enrique Macias Bustes, Cabrera Valentin, & Blas Posada, 2011; Málaga et al., 2010). 
These examples suggest that acculturation with modernity and associated behavioural and 
lifestyle factors could be more important than ethnicity in affecting lipid status in HA 
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people. Nevertheless, there is some evidence to show some role of ethnicity and genetic 
variation on lipid profiles during short exposure to HA (Vats et al., 2013). 
Lipid values at intermediate altitude and after short-term exposure to HA  
In short-term exposure to HA, studies have used exposure times of between three weeks 
and four years. No consistent patterns of changes to lipid profile in association with 
altitude have been reported. Some studies report a decrease in TC and LDL values, and an 
increase HDL values (Ferezou, Richalet, Coste, & Rathat, 1988; Tin'kov & Aksenov, 
2002). Some studies report increased TC levels (S. K. Jha et al., 2002), and marked 
increases in TG (Brito et al., 2007; Siqués et al., 2007). One study of nearly 20,000 young 
male soldiers found no increase in TC with short-term living at HA (Ruhli et al., 2008). 
In studies of the effects of intermediate altitude, between 1500 m and 2400 m, there is no 
particular relationship between HA and lipid profiles. In a Chinese study conducted among 
1415 participants at an altitude of 1500 m to 2500 m, hyperlipidemia was found in 49.3%, 
hypercholesterolemia in 23.3% and hypertriglyceridemia in 34.1% (Deng et al., 2012). In 
the Aymara adults of Northern Chile, who live at an altitude of greater than 2000 m, the 
prevalence of serum hypercholesterolemia in men was 36.8% and in women 37.4%; low 
HDL, men 26.3% and women 24.4%; and TC/HDL ratio greater than or equal to 5, men 
28.2% and women 30.5%) (Santos, Pérez-Bravo, Carrasco, Calvillán, & Albala, 2001). A 
study of 779 participants from Papua New Guinea living at altitudes of between 1828 and 
2590 m, reported low mean TC values; however, hypertriglyceridemia was frequent in 
both genders (Sinnett & Whyte, 1973). 
Conclusion 
There is insufficient robust literature to draw robust conclusions about the association 
between lipid profiles and living at HA. Lifestyle factors rather than ethnicity or genetic 
factors seem likely to be the main influences on lipid components. The most consistent 






The study was a cross-sectional sample survey. This chapter discusses the geographical 
area where the study was performed, the target population, sampling design, data collection 
procedures, instruments, data processing and analysis, ethical considerations, and the 
candidate’s role in this study. 
4.1 Geographical study area  
Nepal has 75 districts, 16 of which are part of a mountainous ecological region. Two 
mountainous districts, Mustang and Humla, were sampled using a priori information on 
their geography, altitude, population ethnicity, and feasibility of administering the study 
procedures. Particular areas of these districts were selected primarily for altitude levels, 
population density, and logistical support such as transportation and availability of 
electricity. The selected study areas were Jomsom, 2800 metre (m), which is an urban 
setting;  Jharkot (3270 m), a rural setting; Muktinath (3620 m), another urban setting of the 
Mustang district (Figure 4.1); and Simikot (2890 m) which is a rural setting of the Humla 
district (Figure 4.2). Climate is 'cold temperate' at 2800 m in Mustang and at 2890 m in 
Humla, and 'alpine' at 3270 m and 3620 m in Mustang. Life expectancy at birth is 64.15 
years in Mustang and 65.04 years in Humla, both lower than the national figure of 68.8 
years (Government of Nepal & United Nations Development Programme, 2014). Tourism 
and its natural resources mean that Mustang people are relatively wealthy and the dominant 
Thakali ethnic group has the highest human development index (HDI) score in Nepal 
(Government of Nepal & United Nations Development Programme, 2014). In contrast, 
Humla is a district with the lowest HDI score (Government of Nepal & United Nations 
Development Programme, 2014) and it is the only district of Nepal without any road 
access. Both districts border China and the Tibetan culture is influential in these districts. 
The district health office records for 2013/2014 report that gastritis and urinary tract 
infection (UTI) were the main health problems in both districts. Among cardiovascular 
disease (CVD) related risk factors hypertension (HT) ranked eighth as a leading cause for 
hospital visits in the Mustang district but no CVD risk factors were in the top 10 leading 














Figure 4.1: Map of Mustang district indicating study areas Jomsom and Muktinath (Source: 
google image) 




4.2 Study population 
A description of the study’s target populations for all four study areas are presented in 
Table 4.1. All of these figures describe permanent residents. All study target populations 
were from two ethnicities – Tibetan and Khas-Arya. As a group, Tibetans migrated to the 
high mountains of Nepal some 500 years ago. Tibeto-Burman is their native language and 
they practise Buddhism (Rambal, 2012). Thakali, Tibetan Gurung, and Lama of the study's 
population belong to this category. Khas-Arya migrated to Nepal some 2000 years ago, 
speak the Nepalese language, and the majority of them are Hindu (Eagle, 2000). Brahmins, 
Chettris, and Dalits are mainly categorized as Khas-Arya (Gellner, 2016).While in New 
Zealand ethnicity is assigned by self-report, which may not strongly reflect ancestry, 
Tibetans and Khas-Aryas are distinctive in appearance, language, and name. In this thesis, 
the terms 'ethnicity' and 'ancestry' are used interchangeably to describe associations with 
being Tibetan or Khas-Arya.  
Table 4.1: Household number and population in study areas 
Study 
area 






Mustang  3354 13452 6767 
Jomsom 2800 m 145 775 502 
Jharkot 3270 m 57 385 228 
Muktinath 3620 m 37 255 169 
Humla  9479 50858 17577 
Simikot 2890 m 215 1161 688 
Total  454 2576 1587 
Source : Profile of Jomsom, Muktinath and Simikot village development committees 2011 and 
consultation with local people  
4.2.1 Inclusion and exclusion criteria 
Inclusion criteria 
- Age 30 years and above 
- Speak and understand Nepalese language 




- Unable or unwilling to provide written or verbal consent 
- Impairments in hearing and speaking 
- Pregnant 
Inclusion and exclusion criteria were determined through participants’ self-reported 
responses. The pregnancy status of female participants was queried only when pregnancy 
was suspected, consistent with culturally appropriate questioning in this study group. 
Female research assistants were assigned to confirm whether women were pregnant. Six 
female participants were withdrawn from the study during data collection when it became 
apparent that they were pregnant. 
4.3 Sample design 
4.3.1 Sample size calculation 
The desired sample size within each group was around 250 individuals. This gives a 
margin of error for a proportion based on anticipated prevalence of HT of around 25% (K. 
K. Aryal et al., 2014) of plus or minus 5% after adjusting for the design effect and an 
expected non-response rate of 10%.  
4.3.2 Sampling technique 
Sampling was carried out in two stages. In the first stage, three areas of Mustang and one 
area of Humla were purposively sampled on the basis of altitude levels, population density 
and availability of logistical support to undertake the study. In the second stage, a list of 
households was developed, and a unique number was assigned to each of them. We 
estimated that 25% of the households in each study area would need to be sampled to 
achieve the planned sample size. Household numbers were randomly selected with the help 
of a computer-based randomization technique. All eligible family members of the 
randomly selected households were considered. Where none of the household members 




This sampling technique is a cluster sampling scheme by household; however, the analysis 
treats the data as being from a simple random sampling scheme. This is because of the 
absence of a robust sampling frame, low population size and very low population density 
of the study areas. 
4.4 Instruments 
This study employed three main instruments to address the research questions: 
i) World Health Organization (WHO) STEPS questionnaire for non-communicable disease 
(NCD) risk factors 
ii) Questionnaire for verifying stroke-free status (QVSFS) 
iii) Electrocardiogram (ECG) 
4.4.1 World Health Organization non-communicable disease risk factors  
STEPS interview questionnaire 
Cardiovascular risk-related sections of the WHO NCD risk factors STEPS questionnaire 
version 2.2 were used. The Nepal Health Research Council (NHRC) has already translated 
it into Nepalese language, validated through a pilot study in a community, and approved by 
expert meetings (K. K. Aryal et al., 2014). This questionnaire has three sections. The first 
section has questions on socio-demographic and lifestyle factors, a second section consists 
of blood pressure and anthropometric (height, weight, waist, hip) measurements, and the 
third section contains measurements of blood glucose and lipids.  
Demographic and socio-economic information 
This initial section included questions related to age, sex, ethnicity, education, occupation, 
household income, and marital status. The ethnicity question further asked whether 
participants were from Tibetan ancestry. Altitude-related questions (origin of birth, 





Questions on both smoking and non-smoking forms of tobacco use were included. 
Questions were related to current (in the last 30 days) and past tobacco use. Duration of 
smoking was also noted among current smokers by asking what age they started smoking.  
In Nepal, the most common types of smoked tobacco are manufactured cigarettes, bidis 
(unprocessed tobacco wrapped in leaves), and pipes (locally called hookah, tamakhu). 
Among non-smoked types, commercially or non-commercially manufactured chewing 
items from tobacco leaves locally known as khaini, surti, gutkha, zarda, paan are the most 
popular. Nose-snuffing of ground tobacco leaf (locally called Nas) is also common in 
mountain areas of Nepal, and especially among those from Tibetan culture. 
Alcohol consumption 
Alcohol consumption-related questions were about current, past and ‘ever drinking’ status, 
frequency of drinking, and the number of standard drink units (SDU) consumed in the past 
30 days. Current drinkers were defined as those drinking alcohol in the past 30 days. A 
hazardous drinker was defined as weekly consumption of ≥21 and ≥14 SDUs of alcohol for 
men and women respectively (Piccinelli et al., 1997). 
SDU of alcohol was calculated by the formula: 
Amount of drink (litre)(l) × percent of volume of alcohol (%) × density of ethanol at room 
temperature (0.789) (Health Promotion Agency New Zealand, 2015). 
A glass with 90 millilitre (mL) volume was a popular size in the study areas. The few 
participants who consumed alcohol in different-sized glasses were asked to estimate the 
volume with reference to a 90 mL glass. Traditionally home-made and locally brewed 
alcoholic beverages were popular in the study areas, mainly jaad (made of rice), chang 
(also made of rice but using a different method), and raksi (made of rice, millet or barley). 
The percentage of volume of alcohol was determined as 12% for jaad and chang, 25% for 




Fruit and vegetables, salt and oil consumption 
Participants were asked to estimate how many days they consumed fruit or vegetables in a 
typical week and the mean consumption of fruit or vegetables portions on those days. One 
portion of fruit and vegetables was defined as 80 gram (g) as per the WHO 
recommendation (World Health Organization : Joint WHO/FAO expert consultation, 2003) 
– for example, an apple, a banana, 10 grapes, or one panyu (tablespoon) of vegetables. 
The amount of salt and oil consumption was determined by asking how much participants 
estimated their household consumed in a month, and this amount was divided by the 
number of family members currently sharing the kitchen for the main meal. Salt was 
usually available in one kilogram (kg) packets and oil in a 500 mL packet. 
Physical activity 
Physical activity was classified into vigorous and moderate levels. Vigorous physical 
activity was defined as any activity, such as carrying heavy loads, lifting heavy weights, 
digging or ploughing fields etc., causing a significant rise in breathing and heart rate for at 
least 10 minutes. Moderate physical activity was defined as continuous involvement in an 
activity for at least 30 minutes that caused a slight increment in breathing or heart rate, 
such as brisk walking, cleaning, washing clothes by hand, gardening, and any domestic 
chores. Participants were asked on average time they spent in vigorous and moderate 
physical activity per day in a typical week. Participants who were involved in a vigorous 
physical activity only at particular times in a year, such as during crop harvesting or other 
agriculture-related work were also considered. 
The physical activity-related questions also included mean walking and sedentary time per 
day. Sedentary time was defined as behaviours such as reading a book, watching 
television, or sitting with friends. 
History of CVD, HT, diabetes and high cholesterol 
Information on personal and family history of CVD was collected. A family member was 
defined as being first-degree blood relations (parents, siblings, or children). Participants 
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were also asked if they currently or previously had HT, diabetes and high cholesterol, or if 
they were currently on treatment for these. 
Anthropometric measurements 
Among anthropometric components, height, weight, waist and hip were measured. Weight 
was measured by a portable digital weighing scale (Seca, Germany) placed on a hard, flat 
surface. Weight was measured without shoes, heavy clothing and mobile phone, and 
participants were asked to empty their pockets. Participants were asked to stand steadily on 
the machine with their head facing forward and weight evenly distributed between both 
feet. Weight was recorded to the nearest 0.5 kg in accordance with the Frankfurt Plane 
technique (Cogill, 2003).  
Height was measured by a portable standard stature scale. Participants were asked to take 
off their shoes, head caps and head ornaments. They were asked to stand with head looking 
forward, legs straight and heels together, arms to the side and shoulders relaxed. The 
research team members ensured that heels, buttocks, scapulae and the back of the head 
were against the wall. The participants and the research team member faced each other 
while measuring the participants’ height. The participants were asked to inhale deeply and 
hold their breath while standing in an erect position. A ruler was lowered to the 
participant’s highest point with enough pressure for the participant to feel their hair 
compressed and height was noted to the nearest 0.5 centimeter (cm) as per the Frankfurt 
Plane technique (Cogill, 2003). The classification of body mass index (BMI) was based on 
WHO established guidelines (World Health Organization, 1995); ≥30 kg/m
2
: obese, ≥25 
kg/m
2
: overweight, 18.5 to 24.9 kg/m
2
: normal, <18.5 kg/m
2
: underweight. 
Waist and hip were measured with soft fabric tapes as per WHO recommendation (World 
Health Organization, 1995). A room was partitioned off with a curtain to ensure privacy. 
Waist circumference was measured at the end of normal expiration at a level of midway 
between the lowest rib and the superior border of the iliac crest. Participants were asked to 
roll up their inner garments above the waist, loosen tight garments around the waist, 
including belts, and empty their pockets. Hip circumference was measured at the level of 
95 
 
most protrusion. Participants were asked to roll down their lower garments, except for 
underwear.  
Both waist and hip circumferences were measured with the participants' feet fairly close 
together, around 12 cm to 15 cm apart. Two members of the study team were assigned; one 
person measured the tape at eye level with one finger between tape and participant’s body 
and the second person checked that the tape was horizontal around the body with no folds 
anywhere. For cultural reasons only female research assistants measured the waists and 
hips of female participants.  
High waist circumference (WC) was defined as >90 cm (men) and >80 cm (women) using 
International Diabetes Federation (IDF) criteria for South Asian populations (Alberti, 
Zimmet, & Shaw, 2006). High waist to hip ratio (WHR) was defined as ≥0.90 (men) and 
≥0.85 (women) according to the WHO recommendation (World Health Organization, 
2008). 
Blood pressure 
BP was measured by oscillometric method using an automatic blood pressure measuring 
device (Omron HEM-7221). The recommended operating ambient pressure conditions of 
this machine are from 700 to 1060 hectopascals. This is the atmospheric pressure at around 
3000 m, which was further verified with the manufacturer (Rudi Fernandez, personal 
communication, JA Davey Pty Ltd, 3rd October, 2016). Moreover, Omron BP monitoring 
machines have also passed the validation criteria at 3650 m as proposed by the European 
Society of Hypertension International Protocol Revision 2010 (ESH-IP2) (Cho, Tian, Lan, 
Zhao, & Yan, 2013). Three readings were recorded from left arm of each participant in 
sitting position with at least 10 minutes elapsing in between. The first measurement was 
taken a minimum of 10 minutes after the questionnaire was administered. If the readings 
differed by more than 10 units, a fourth measurement was taken and the lowest three were 
considered for mean calculation. 
BP (systolic/diastolic) was classified as normal (<120/80 mmHg), pre-HT (120–39/80–89 
mmHg), HT (≥140/90 mmHg), Stage I HT (140–159/90–99 mmHg), and Stage II HT 
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(≥160/100 mmHg) according to the seventh report of the Joint National Committee on 
prevention, detection, evaluation, and treatment of high BP (Chobanian et al., 2003). 
Blood glucose and lipids 
Glycated hemoglobin (HbA1c) and lipid profiles were measured using a Cobas b 101 
device (Roche Diagnostics). Cobas b 101 uses immunoassay method for HbA1c and 
enzymatic method for lipid profile measurements (Cobas b 101 system : operator's manual 
software version 1.0). This device is validated for use at up to 3200 m and thus participants 
at 3620 m were requested to come down to the measurement facility set up at 3270 m. A 
small amount of capillary whole blood was taken by single finger-prick and processed by 
the device, which provided results for both HbA1c and lipids within 15 minutes. Single use 
only disposable lancets (Accu-Chek safe-T-Pro-Plus, Roche Diagnostics) were used for 
finger-prick. This lancet has 1.3 mm, 1.8 mm and 2.3 mm depth settings. Third or fourth 
finger of the non-dominant hand was selected for finger-prick. Firstly, the selected finger 
was massaged from the base to the tip to ennsure good blood flow. The lancing area (top 
side of the finger) was cleaned with an alcohol swab and dried with a tissue. The first drop 
of blood was wiped away and the finger was again massaged gently until a second large 
drop of blood formed. 
A quality control check of this device was performed after every 100 participants, using the 
manufacturer’s operating guidelines. 
HbA1c was classified as diabetes (≥48 mmol/mol) and pre-diabetes (≥39 to 47 mmol/mol) 
according to the guidelines of the American Diabetes Association (American Diabetes 
Association, 2016). The National Cholesterol Education Program (NCEP), Adult 
Treatment Panel III (ATP III) guidelines were used to classify lipid profile; high total 
cholesterol (TC) (≥5.2 mmol/L), high triglyceride (TG) (≥1.7 mmol/L), high low-density 
lipoprotein-cholesterol (LDL) (≥3.4 mmol/L), low high-density lipoprotein-cholesterol 
(HDL) (<1.3 mmol/L for women, <1.0 mmol/L for men), and high non-HDL (≥4.1 




CVD risk prediction 
Estimated 10-year risks of fatal or non-fatal cardiovascular events (myocardial infarction 
(MI) or stroke) were calculated using the validated risk prediction chart designed by WHO 
and the International Society of Hypertension (ISH) for the WHO region of South-East 
Asia, sub-region D (Mendis et al., 2007). The risk categories were defined as low (less than 
10%), moderate (equal to or greater than 10% and lower than 20%), high (equal to or 
greater than 20% and lower than 30%), and very high (equal to or greater than 30%) 
(World Health Organization, 2007a). This risk prediction chart follows the total 
cardiovascular risk assessment approach and requires six components: presence or absence 
of diabetes, gender, smoker or non-smoker, age, systolic blood pressure (SBP), and TC. 
4.4.2 Questionnaire for Verifying Stroke-Free Status 
The QVSFS was administered to estimate prevalence of cerebrovascular disease – stroke 
or transient ischemic attack (TIA) (Jones, Williams, & Meschia, 2001). This questionnaire 
was chosen because it has high face validity and was developed by the American Heart 
Association. Efforts are also underway to use it in low-and middle-income countries where 
people have a low literacy level and very limited knowledge of stroke and its symptoms 
(Sarfo et al., 2016). The questionnaire consists of eight structured questions related to the 
history of stroke or TIA as confirmed by a medical doctor, and positive symptoms of 
stroke (sudden weakness and numbness on one side of the body, sudden loss in one or both 
eyes or one-half vision, sudden loss of ability to understand and express verbally or in 
writing). 
Questions were modified for the local context and culture. Content validity was assessed 
by discussion with clinical members of Shahid Gangalal National Heart Hospital, Nepal. 
The accuracy of the English–Nepalese translation was checked by back-translation. Face 
validity was tested by piloting the questionnaire during the training session for the local 
research assistants. 
4.4.3 Electrocardiography recordings 
The 12-lead ECG was recorded using a portable Edan SE-600 instrument. Participants 
were asked to remove clothing from the chest area, lie flat with face up, arms at sides and 
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legs uncrossed. Oily, sweaty, or clammy skin was wiped with alcohol swabs. Electrodes 
were placed on the chest in accordance with standard practice and connected with colour-
coded leads. Artefacts due to alternating current (AC) interference was a particular 
problem, which was solved by using only the battery back up of the instrument. Qualified 
female nurses recorded the ECG results and other team members assisted when required. 
The prevalence of coronary heart disease (CHD) was defined as the presence of 
pathological Q waves in the ECG or self-report of personal history of CHD (previous event 
of MI or chest pain from heart disease (angina)). Left ventricular hypertrophy (LVH) was 
assessed using the commonly used Sokolow-Lyon (Sokolow & Lyon, 1949) and the 
stricter definition of Romhilt and Estes (Romhilt & Estes, 1968). After review by a 
cardiologist using standard widely accepted criteria, ECG recordings were categorized as 
definitely abnormal, for example showing evidence of previous MI; borderline, non-
specific T-wave flattening/inversion or one or more features suggesting possible LVH that 
did not fully meet accepted criteria defined by the published definitions we used; or 
normal. If there was a consistent QRS vector in the bipolar leads (I, II, III, aVR, aVL, aVF) 
then axis could be assessed. QRS axis was otherwise determined using the conventional 




positive axes the following in a clockwise direction and negative values anticlockwise. Left 
axis deviation was determined if the QRS axis was lower than -30° and right axis deviation 
was determined if the QRS axis was greater than +90°. 
4.5 Data collection procedures 
4.5.1 Training and standardization of research personnel 
The Student Investigator (SI) and Research Assistants (RAs) were trained and standardized 
regarding data collection measurements. RAs were public health graduates, nurses with 
previous research experience, and local community health workers.  
Training sessions were organized for three days with three hours of sessions each day. On 
the first day, the SI provided orientation on the aims and protocol of the study, contents of 
the questionnaires, and ethical considerations. RAs practiced the full-length questionnaire. 
On the second day, they were provided with blood pressure and anthropometric 
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measurement training. Finally, they were oriented on the operation of the Cobas b 101 
instrument for HbA1c and lipid profile, and ECG. 
The SI was earlier provided training on the use of the Cobas b 101 instrument by 
manufacturer staff members (Roche Diagnostics NZ). He also got ECG-related training 
from a cardiac physiologist and a biomedical technician at Wellington Regional Hospital, 
New Zealand.  
4.5.2 Data collection techniques 
The research team held a consultation meeting with local community leaders and apprised 
them of the aims of the study. The community leaders were asked to disseminate 
information about the study through their channels. Local RAs also informed the 
communities about the study. Administering the questionnaires and BP measurements were 
carried out at the selected participants’ homes. Practically, it was not feasible to undertake 
blood sample testing, ECG recordings and bio-physical measurements in individual houses 
so a local community hall was used as the measurement facility. Participants were asked to 
come for these measurements at a time suitable for them. 
Blood samples were processed separately in a disc for blood lipids and HbA1c. After use 
all discs and ECG electrodes were stored in a closed container and deposited in the clinical 
waste bins of the local health facility. Finally, they were disposed of according to the 
current Safe Operational Procedure (SOP) for blood disposal in the clinical setting of 
Nepal. 
Data was collected from June to August (summer) 2014 in the Mustang district and March 
to May (spring) 2015 in the Humla district. The ambient temperature was between 25 and 
31 degrees Celsius in Mustang and around 15 degrees Celsius in Humla on most of the 
study days. 
The non-response rate was 18/521 (3.4%). The most common reason for non-participation 




4.6 Data processing and statistical methods 
The data from questionnaires, and the bio-physical and bio-chemical measurements were 
captured on a single form. Data was entered into a spreadsheet programme after the field 
level data was collected. The SI double-checked the accuracy of the data and then exported 
it into the statistical package.  
Data was analyzed in three stages. In the first stage, descriptive statistics were generated 
using mean, standard deviation, frequency and percentages. The Clopper-Pearson method 
was used to estimate an exact confidence interval for a single proportion. All results are 
presented for each level of altitude. In the second stage, analysis of variance (ANOVA) 
and analysis of covariance (ANCOVA) models for the relationship between SBP, diastolic 
blood pressure (DBP) and altitude are shown. In the third stage, logistic regression was 
used to estimate the association between an abnormal (or borderline abnormal) ECG and 
altitude in univariate and multivariate models. Relevant parametric and non-parametric 
tests of quantitative and categorical data, and the odds ratios (OR) for the comparisons of 
the groups are shown as appropriate. Altitude was treated as a continuous variable in the 
multivariate models. The strength of the associations is described as strong, moderate, and 
weak at the significance level of P <0.01, P=0.01 to 0.05, and P=0.06 to 0.10 respectively. 
Assumptions for the statistical analysis of ANOVA and ANCOVA models were examined. 
Normality assumptions were examined by inspecting standardized residual plots. Linearity 
and homoscedasticity assumptions were examined by inspecting studentized residuals 
versus predicted value plots. Outliers were reviewed by inspection of leverage versus 
residuals squared plots. Particular data points were reviewed carefully if more than 5% of 
the cases had a standardized residual value of greater than 2. Sensitivity analysis tests were 
also performed by examining changes in regression parameters with or without outliers. 
For logistic regression models, assumption of linearity between logarithm of odds of 
abnormal (or borderline abnormal) ECG and explanatory variables were examined by 
LOWESS plot. 
STATA version 12 was used for statistical analysis. 
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4.7 Ethical considerations 
This study was approved by the ethical review board of the Nepal Health Research Council 
(NHRC) and the University of Otago Human Ethics Committee. Information sheets and 
consent forms were provided in Nepalese language. The participants were informed that 
they could ask questions at any stage, had the right to withdraw at any point without giving 
any reason, and their decision on whether or not to participate would not have any 
consequences whatsoever. A written consent was sought where possible. In cases where 
participants were not literate, witnessed oral consent was given.  
There was no significant risk involved with this research, although the finger-prick blood 
taking process can be painful for some people. Participants were informed of this risk. 
Privacy of information was maintained. Temporarily stored paper or electronic data was 
partially de-identified with reference to participants by using a numerical code known only 
to the SI and kept securely in the University of Otago, Wellington, New Zealand. 
The preliminary findings of the study were presented at the District Health Office of 
Mustang district and among local community health workers in the Humla district.  
4.8 Candidate’s role in the study 
The candidate was involved in the design, development of the proposal, the ethical 
approval process, field level data collection, data entry, statistical analysis and report 





This chapter is divided into three sections. The first section presents descriptive results for 
(i) socio-economic and demographic characteristics (ii) lifestyle-related characteristics 
(smoking and alcohol consumption patterns, physical activity, dietary habits) (iii) 
anthropometric measures (height, weight, waist and hip measurements) (iv) bio-chemical 
measures (lipid profile and glycated hemoglobin (HbA1c)) (v) stroke and cardiovascular 
disease (CVD) risk prediction. In the second and third sections descriptive, univariate and 
multivariate models are presented for blood pressure (BP) and electrocardiogram (ECG) 
recordings respectively. Results have been presented for each level of altitude and 
compared with the national prevalence where possible.  
5.1 Descriptive statistics 
5.1.1 Socio-economic and demographic characteristics 
Table 5.1: Sample size and age distribution of the participants 
 Humla  Mustang  
Altitude 2890 m 2800 m 3270 m 3620 m 
 (Rural) (Urban) (Rural) (Urban) 




30–39 105 (41.8) 46 (27.9) 6 (9.8) 16 (36.4) 
40–49 71 (28.3) 40 (24.2) 16 (26.2) 10 (22.7) 
50–59 50 (19.9) 36 (21.8) 15 (24.6) 6 (13.6) 
60 +  25 (10.0) 43 (26.1) 24 (39.3) 12 (27.3) 
Age Mean (SD) 42.9 (11.0) 50.3 (13.7) 55.4 (13.2) 48.3 (12.5) 
 
Table 5.1 shows the distribution of study sample and age at each altitude level. Participants 
were sampled from four altitude levels; 2800 metre (m), 2890 m, 3270 m, and 3620 m in 
the two districts of Mustang and Humla. The sample sizes were lower at 3270 m and 3620 
m due to the low population size at those altitudes.  
More than a quarter of the study participants at the altitudes of 2800 m, 3270 m and 3620 
m were aged 60 years or older. Age differed by altitude levels: Kruskal-Wallis test Chi-
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square (3 df) 59.1, P <0.01. Women comprised a greater proportion than men at all levels 
of altitude (Figure 5.1) but this difference was not statistically significant, Chi-square (3 df) 
2.5, P=0.47.  
Women and older participants were more likely to be sampled partly because the sampling 
of the households was irrespective of age and sex, and because women and older adults 
were more likely to be at home. 
 





























Table 5.2: Educational status of the study participants at each altitude level 
 Humla  Mustang  
Altitude 2890 m 2800 m 3270 m 3620 m 
 (Rural) (Urban) (Rural) (Urban) 
Education attainment N (%) 
No formal education/illiterate 168 (66.9) 67 (40.6) 41 (67.2) 29 (65.9) 
Less than primary level 18 (7.2) 45 (27.3) 19 (31.1) 6 (13.6) 
Primary level completed 20 (8.0) 25 (15.1) 0 (0) 4 (9.1) 
Secondary level or higher completed  45 (17.9) 28 (17.0) 1 (1.6) 5 (11.4) 
 
Table 5.2 describes the educational status of the study participants at each level of altitude. 
Participants at an altitude of 2800 m were more literate and a higher proportion had 
completed at least primary school level of education compared with the participants at 
other altitude levels. More than two-thirds of the study participants at an altitude level of 
2890 m, 3270 m, and 3620 m were illiterate or had no formal education.  
Table 5.3: Occupation and household income of the study participants at each 
altitude level 
 Humla  Mustang  
Altitude 2890 m 2800 m 3270 m 3620 m 
 (Rural) (Urban) (Rural) (Urban) 
Occupation types N (%) 
Govt or non-govt employee 39 (15.5) 25 (15.1) 1 (1.6) 7 (15.9) 
Self-employed 21 (8.4) 86 (52.1) 6 (9.8) 14 (31.8) 
Agriculture/daily        waged 
labour 
135 (53.8) 41 (24.8) 39 (63.9) 21 (47.7) 
Unemployed/retired/ 
homemaker 
56 (22.3) 13 (7.9) 15 (24.6) 2 (4.5) 
Household income 
(per year) 
    
NRS <200,000 136 (54.2) 37 (22.4) 22 (36.1) 6 (13.6) 
NRS 200,000 to 400,000 58 (23.1) 43 (26.1) 23 (37.7) 17 (38.6) 
NRS >400,000 57 (22.7) 85 (51.5) 16 (26.2) 21 (47.7) 
1 NZ $ = NRS 77 (as of 6
th
 December 2016) 
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As shown in Table 5.3, participants at all altitude levels were usually more involved in 
agriculture or daily waged labour work. Altitudes of 2800 m and 3620 m are tourist areas, 
so a significant proportion of the participants from these altitudes were self-employed in 
hotels, lodges, shops and other tourist-related businesses. Correspondingly, a higher 
proportion of the participants from these two altitudes also self-reported having the highest 
annual household income, greater than 400,000 Nepalese Rupees (NRS). Although there 
was no obvious trend of household income by level of altitude, the differences in 
proportions in the different income bands across altitude levels were statistically 
significant: Chi-square (6 df) 67.9, P <0.01. 
 
Figure 5.2: Marital status of the study participants by altitude level 

























2800 m 2890 m 3270 m 3620 m
Currently married Unmarried  /separated / widowed
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Table 5.4: Birthplace and duration of high altitude residence of study participants by 
altitude level 
 Humla  Mustang  
Altitude 2890 m 2800 m 3270 m 3620 m 
 (Rural) (Urban) (Rural) (Urban) 
Birth place N (%) 
Same district as current 
residence 
246 (98.0) 148 (89.7) 59 (96.7) 38 (86.4) 
District elsewhere 5 (2.0) 17 (10.3) 2 (3.3) 6 (13.6) 
Duration at high altitude (≥ 2800 m) 
For lifetime 246 (98.0) 148 (89.7) 59 (96.7) 38 (86.4) 
>10 years 2 (0.8) 17 (10.3) 2 (3.3) 6 (13.6) 
5 to 10 years 3 (1.2) 0 (0) 0 (0) 0 (0) 
 
Table 5.4 shows the birthplace of study participants and duration of residence at high 
altitude (HA) at each altitude level. The vast majority of the study participants were both 
born in the district of their current residence and had been living there most of their life. Of 
the participants who were born elsewhere, most of them had been living at their current 
residence for more than 10 years.  
Table 5.5: Ethnicity of the study participants by altitude level 
 Humla  Mustang  
Altitude 2890 m 2800 m 3270 m 3620 m 
 (Rural) (Urban) (Rural) (Urban) 
Ethnicity N (%) 
Tibetan 82 (32.7) 132 (80.0) 58 (95.1) 37 (84.1) 
Khas-Arya 169 (67.3) 33 (20.0) 3 (4.9) 7 (15.9) 
 
The majority of participants were Tibetan at all three altitude levels of the Mustang district 
and participants were mostly Khas-Arya at 2890 m in the Humla district (Table 5.5). 
Particular ethnic groups amongst Tibetans were Thakali, Tibetan Gurung and Lama; and 




5.1.2 Lifestyle-related characteristics 
Table 5.6: Smoking-related characteristics of the study participants by altitude level 
 Humla  Mustang  
Altitude 2890 m 2800 m 3270 m 3620 m 
 (Rural) (Urban) (Rural) (Urban) 
Variables N/N (%) 
Current smoker 97/251 (38.6) 17/165 (10.3) 2/61 (3.3) 4/44 (9.1) 
Current smokeless      
tobacco user 
27/251 (10.8) 49/165 (29.7) 19/61 (31.1) 11/44 (25.0) 
Past smoker 29/154 (18.8) 23/148 (15.5) 11/59 (18.6) 11/40 (27.5) 
Past smokeless tobacco 
user 
6/224 (2.7) 12/116 (10.3) 14/42 (33.3) 4/33 (12.1) 
 Mean (SD) 











Table 5.6 shows that fewer participants at an altitude level of 2800 m, 3270 m and 3620 m 
in Mustang reported currently smoking compared to more than one-third (38.6%) at 2890 
m in Humla. This trend was opposite for the consumption of smokeless tobacco: it was 
greater at all three altitude levels in Mustang and lower at 2890 m in Humla. Of the 
smokers in Humla, 87.3% self-reported smoking tobacco daily. None of the women 
participants at 3270 m and 3620 m were current smokers, whereas 2.3% women at 2800 m 
and 31.1% at 2890 reported being current smokers. Nose snuffing of tobacco was a popular 
cultural practice at all altitude levels and particularly at 2800 m (21.2%). Of the non-
smoking groups, at least 15% were past smokers at each altitude level.  
Rural participants were significantly more likely to self-report being current smokers than 
the urban participants, rural 31.7% and urban 10.05%, the proportion difference of 21.6% 
(95% confidence interval (CI) 15 to 28.6), P <0.001; whereas urban participants were 
significantly more likely to self-report being current smokeless tobacco users, urban 28.7% 
and rural 14.7%, the proportion difference of 14% (95% CI 6.7 to 21.3), P <0.001. 
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For those in Nepal aged over 30 years, the national prevalence of current smokers is 24.7% 
and users of smokeless tobacco is 23.2% (K. K. Aryal et al., 2014).  
Table 5.7: Self-reported alcohol intake characteristics of the study participants at 
every altitude level 
 Humla  Mustang  
Altitude 2890 m 2800 m 3270 m 3620 m 
 (Rural) (Urban) (Rural) (Urban) 
Variables N/N (%) 
Current drinker 123/251 (49.0) 84/165 (50.9) 39/61 (63.9) 20/44 (45.4) 
Past drinker 74/251 (29.5) 57/165 (34.5) 19/61 (31.1) 20/44 (45.4) 
Never a drinker 54/251 (21.5) 24/165 (14.5) 3/61 (4.9) 4/44 (9.1) 
Daily drinker 43/123 (34.9) 44/84 (52.4) 30/39 (76.9) 11/20 (55.0) 
Hazardous drinker 24/123 (19.5) 26/84 (30.9) 22/39 (56.4) 8/20 (40.0) 
Current drinker: participants who drank alcohol in the past 30 days Hazardous drinker: 
participants drinking ≥21 (males) or ≥14 (females) standard drink units of alcohol per week 
In Table 5.7, self-reported alcohol intake by altitude level is shown. Approximately half of 
the participants at all altitude levels self-reported being current drinkers, which is greater 
than the national prevalence of 21.5% for the Nepalese population aged older than 30 years 
(K. K. Aryal et al., 2014). In general, participants in older age groups at all altitude levels 
were most likely to report being current drinkers. The exception was that the proportion of 
current drinkers at 2800 m was highest in the age group 40 to 49 years. A similar 
proportion of rural (51.9%) and urban (49.8%) participants self-reported being current 
drinkers, the proportion difference of 2.2% (95% CI -6.7 to 10.7), P=0.63. 
Figure 5.3 shows the box plots of average daily consumption of alcohol in standard drink 
units (SDU) and bar charts of proportions of current drinkers by sex. A higher proportion 
of men were current drinkers compared to women at every altitude level. Participants at an 
altitude of 3270 m self-reported drinking more than four average SDU of alcohol daily, 
nearly twice that reported by current drinkers at other altitudes. Self-reported alcohol 




Figure 5.3: Average consumption of alcohol per day and the proportions of current 
drinker by sex at each altitude level 
Table 5.8: Self-reported physical activity-related characteristics at each altitude level 
 Humla Mustang 
Altitude 2890 m 2800 m 3270 m 3620 m 
 (Rural) (Urban) (Rural) (Urban) 
Variables Mean (SD) 
Vigorous physical  









Moderate physical  





























Vigorous physical activity: activity (such as carrying heavy loads, digging) causing large increases in 
breathing or heart rate for at least 10 minute continuously  Moderate physical activity: activity (such as brisk 
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As shown in Table 5.8, vigorous physical activity decreased and sedentary hours increased 
with increasing levels of altitude. Men were more likely to be sedentary than women at all 
altitude levels except at 3270 m. Three-quarters of participants at each altitude level self-
reported that they walked mean duration of at least 30 minutes per day. Urban participants 
self-reported having significantly higher sedentary hours per day than the rural particpants, 
urban 3.7 hours and rural 3.0 hours, the proportion difference of 0.7 hour (95% CI 0.3 to 
1.1), P <0.001. Urban participants were also significantly less likely to have recommended 
levels of walk (minimum 30 minutes per day) than the rural participants, urban 77% and 
rural 89.7%, the proportion difference of -12.7% (95% CI -5.3 to -18.7), P <0.01. 
Table 5.9: Self-reported fruit, vegetable and salt intake by altitude level 
 Humla Mustang 
Altitude 2890 m 2800 m 3270 m 3620 m 
 (Rural) (Urban) (Rural) (Urban) 
Variables N/N (%) 
<5 fruit & vege 









>5 gram of salt 









 Mean (SD) 
Fruit & vege 





















Table 5.9 shows that the vast majority of the participants at every altitude level self-
reported consuming fewer portions of fruit and vegetables and higher amounts of salt per 
day than internationally recommended levels (see Chapter 4, section 4.4.1). For every 
altitude level, the mean consumption of salt was at least two times greater than the 
recommended level of 5 grams (g) per day. Rural participants were significantly more 
likely to consume recommended level of fruit and vegetables (five portions per day) than 
the urban participants, rural 37.2% and urban 23.4%, the proportion difference of 13.8% 
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(95% CI 6.2 to 21.8), P <0.01; and rural participants were also more likely to consume 
more than the recommended level of salt per day, rural 95.9% and urban 91%, the 
proportion difference of 4.9% (95% CI 0.2 to 9.8), P=0.03.  
5.1.3 Anthropometric measurements 
Table 5.10 shows a summary of anthropometric measures among the participants at each 
altitude level. In general, participants at 2800 m and 3620 m had a greater proportion of 
values above the obesity and overweight cut-points for all of the measured anthropometric 
variables, compared to participants at other altitude levels. A large proportion of the 
participants in the youngest age group of 30 to 39 years from these two altitude levels were 
overweight or obese – 60% at 2800 m and 43.7% at 3620 m. At 2890 m, despite having the 
lowest proportion of participants who were overweight, obese, or with a high waist 
circumference (WC), more than three-quarters of the participants at this altitude had a high 
waist to hip ratio (WHR), related to a low hip circumference. Urban participants had 
significantly higher mean body mass index (BMI) compared with the rural participants, 
urban 25.5 kg/m
2
 and rural 22.5 kg/m
2
, mean difference of 3.0 kg/m
2
 (95% CI 2.3 to 3.7), 
P <0.001. 
The proportion of participants who were overweight or obese was higher at 2800 m and 
3620 m but lower at 2890 m and 3270 m when compared with Nepal’s national prevalence 
for those aged over 30 years (28.3%) (K. K. Aryal et al., 2014). Figure 5.4 shows the box 
plots of BMI by sex at each altitude level. Women comprised a greater proportion of those 
with a higher BMI than men for every altitude level; however, this difference was 
statistically significant only at 2800 m – mean difference (95% CI) 2.2 kg/m
2
 (1.00 to 




Table 5.10: Proportions of anthropometric variables at each altitude level 
 Humla Mustang 
Altitude 2890 m 2800 m 3270 m 3620 m 
 (Rural) (Urban) (Rural) (Urban) 
Variables N/N (%) 
Overweight or obese 52/251 (20.7) 81/143 (56.6) 16/60 (26.7) 21/44 (47.7) 
High waist circumference 43/251 (17.1) 88/142 (62.0) 16/60 (26.7) 17/44 (38.6) 
High waist–hip ratio 190/251 (75.7) 94/142 (66.2) 39/60 (65.0) 19/44 (43.2) 
Overweight or obese: BMI ≥25 kg/m
2
, high waist circumference: >90 cm for men and >80 cm 
for women, high waist–hip ratio: ≥0.90 for men and ≥0.85 for women 
 
 
Figure 5.4: Body mass index by sex at each altitude level 
5.1.4 Bio-chemical measurements 
Table 5.11 shows lipid profiles of the study participants at each altitude level. No clear 
trend in lipid components by altitude level is present. Residents at 2800 m and 3620 m had 
higher total cholesterol (TC) and triglyceride (TG), and those at 2890 m had a lower high-
density lipoprotein-cholesterol (HDL). Based on cut-points (see Chapter 4, section 4.4.1), a 




































TC, TG, low-density lipoprotein-cholesterol (LDL) and non-HDL cholesterol. The 
proportions of participants with high TC and low HDL were lower at all altitude levels 
compared with Nepal’s national prevalence of 29.8% and 74.5% respectively in those aged 
30 years or older. The proportion of participants with high TG was higher than the national 
prevalence (33.4%) at all altitude levels except 2890 m (K. K. Aryal et al., 2014). 
Table 5.11: Lipid profiles of the participants at each altitude level 
 Humla Mustang 
Altitude 2890 m 2800 m 3270 m 3620 m 
 (Rural) (Urban) (Rural) (Urban) 
Variables Mean (SD) 






















































 N/N (%) 
High TC 23/168 (13.7) 34/142 (23.9) 7/56 (12.5) 6/38 (15.8) 
High TG 62/168 (36.9) 74/142 (52.1) 17/56 (30.4) 22/38 (57.9) 
Low HDL 120/168(71.4) 91/142 (64.1) 22/56 (39.3) 21/38 (55.3) 
High non-HDL 23/167 (13.8) 23/140 (16.4) 4/55 (7.3) 7/37 (18.9) 
High TC: ≥5.2 mmol/L, high TG: ≥1.7 mmol/L, high LDL: ≥3.4 mmol/L, low HDL: <1.3 mmol/L 




Figure 5.5: Proportions of high total cholesterol to high-density lipoprotein-
cholesterol (TC/HDL) ratio by sex at each altitude level 
Overall more than one-third (35.3%) of participants had abnormal results, based on cut-
points (see Chapter 4, section 4.4.1), for at least two lipid variables. Only four (0.8%) 
participants were being treated with cholesterol lowering drugs.  
As shown in Figure 5.5, more than one-quarter of the participants had a TC to HDL ratio 
higher than the cut-point of 5.0 at all altitude levels except at 3270 m. A higher proportion 
of men had a high TC to HDL ratio at all altitude levels; however, the difference in 
proportions compared to women was statistically significant at 2800 m only: proportion 
difference (95% CI), 16% (2 to 30), P=0.03. Compared to rural participants, urban 
participants had significantly higher proportion of high TC (urban 22.2% and rural 13.4%) 
and high TG ( urban 53.3% and rural 35.3%). The proportion differences were 2.2% (95% 
CI 1.5 to 16.5), P=0.02 for high TC; and 18% (95% CI 8.4 to 27.6) , P <0.01 for high TG. 
Although the proportions of high LDL and high TC to HDL ratio were also higher in urban 
participants and the proportion of low HDL was higher in rural participants, these 
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An instrument failure at 2890 m meant that lipid components were available from 168/251 
(67%) participants at this altitude level. 
Table 5.12: Glycated hemoglobin and diabetes related characteristics at each altitude 
level 
 Humla Mustang 
Altitude 2890 m 2800 m 3270 m 3620 m 
 (Rural) (Urban) (Rural) (Urban) 
Variables N/N (%) 
Diabetes or medication 6/172 (3.5) 15/142 (10.6) 2/61 (3.3) 6/44 (13.6) 
Diabetes 5/171 (2.9) 13/141 (9.2) 2/61 (3.3) 5/44 (11.4) 
Impaired glucose tolerance 63/171 (36.8) 31/141 (22.1) 24/61 (39.3) 11/44 (25.0) 
Diabetes newly diagnosed 1/171 (0.6) 5/141 (3.5) 2/61 (3.3) 3/44 (6.8) 
 Mean (SD) 








Impaired glucose tolerance: HbA1c ≥39 to 47 mmol/mol, Diabetes: HbA1c ≥48 mmol/mol, 
Diabetes or medication : HbA1c ≥48 mmol/mol or on anti-diabetic medication 
HbA1c and diabetes-related characteristics are presented in Table 5.12. There was no 
significant trend in diabetes-related characteristics by altitude level. The proportion of 
participants with diabetes was higher at 2800 m and 3620 m compared to all other altitude 
levels and compared to national prevalence in those aged over 30 years (5.9%) (K. K. 
Aryal et al., 2014). However, mean HbA1c were similar at all altitude levels. Men were 
more likely to be diabetic or on treatment than women at every altitude level, but the 
differences in proportions between men and women were not significantly different at any 
level. Three-quarters (74.5%) of the participants had never had a blood sugar test before 
and 2.7% were currently on anti-diabetic treatment. Urban participants were significantly 
more likely to be diabetic or on treatment than the rural counterparts, urban 11.3% and 
rural 3.4%, the proportion difference of 7.9% (95% CI 2.5 to 12.7), P=0.002.  
Technical measurement problems at 2890 m meant that HbA1c levels were measured from 
171/251 (68%) participants at this altitude level. 
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5.1.5 Stroke and cardiovascular disease risk prediction 
Table 5.13 shows that 6.7% (35/521) participants had self-reported "yes" for at least one of 
the eight questions in the Questionnaire for Verifying Stroke Free Status (QVSFS) and 
higher proportions of participants who were residents at altitude of 2800 m and 3270 m 
reported a positive answer consistent with cerebrovascular disease. Eleven of 521 (2.1%) 
participants reported having a stroke history confirmed by a doctor. No obvious patterns 
were observed by altitude level. A higher proportion of men (8.2%) reported a positive 
stroke symptoms or history for at least one question than women (5.5%) but this difference 
was not statistically significant: Chi-square (1 df) 1.5, P=0.22.  
Table 5.13: Stroke-related symptoms according to the questionnaire for verifying 
stroke free status for every altitude level 
 Humla Mustang 
Altitude 2890 m 2800 m 3270 m 3620 m 
 (Rural) (Urban) (Rural) (Urban) 
Variables N/N (%) 
At least one symptom 7/251 (2.8) 17/165 (10.3) 9/61 (14.7) 2/44 (4.5) 
Symptoms     
Told by physicians having 
stroke 
0/251 (0) 3/165 (1.8) 6/61 (9.8) 2/44 (4.5) 
Told by physicians having mini- 
stroke or transient ischemic 
attack 
0/251 (0) 0/165 (0) 0/61 (0) 0/44 (0) 
Sudden painless weakness on 
one side of the body 
4/251 (1.6) 7/165 (4.2) 7/61 (11.5) 2/44 (4.5) 
Sudden numbness on one side 
of the body 
4/251 (1.6) 8/165 (4.8) 7/61 (11.5) 1/44 (2.3) 
Sudden painless loss of vision in 
one or both eyes 
5/251 (2.1) 5/165 (3.0) 5/61 (8.2) 1/44 (2.3) 
Suddenly lost one half of the 
vision 
4/251 (1.6) 8/165 (4.8) 3/61 (4.9) 1/44 (2.3) 




Suddenly lost ability to express 
verbally or in writing 
3/251 (1.2) 7/165 (4.2) 6/61 (9.8) 1/44 (2.3) 
 
Table 5.14 shows the proportions of participants with World Health Organization (WHO) / 
International Society of Hypertension (ISH) 10-year risk of future fatal or non-fatal major 
cardiovascular events (myocardial infarction (MI) or stroke) in different risk categories, 
based on the assessment for the WHO South East Asia sub-region D (SEAR D). This 
assessment incorporates age, sex, BP, TC, smoking status and presence or absence of 
diabetes. Overall, 3.9% (16/408) of the participants had a high or very high risk (equal to 
or greater than 20%) of a fatal or non-fatal major cardiovascular event within the next 10 
years but this risk was not consistent by level of altitude. Although residents living in 
urban areas (2800 m and 3620 m) were more likely to develop this risk than those living in 
rural areas (2890 m and 3270 m) – urban 5.6% and rural 2.2% – the difference in 
proportion by residential areas was not statistically significant: Chi-square (1 df) 3.04, 
P=0.08. 
Table 5.14: Proportions of World Health Organization / International Society of 
Hypertension (WHO/ISH)-10 year risk of a fatal or non-fatal major cardiovascular  
events by altitude level 
                       
In summary, no strong relationships were found between the presence of CVD risk factors 
and altitude. Higher proportions of participants with CVD risk factors were found at 
altitudes of 2800 m and 3620 m, particularly for anthropometric, lipid and diabetes-related 
 Humla  Mustang  
Altitude 2890 m 2800 m 3270 m 3620 m 
 (Rural) (Urban) (Rural) (Urban) 
Sample size 173 141 56 38 
WHO/ISH risk categories N (%) 
Low (<10%) 164 (94.8) 125 (88.6) 49 (87.5) 31 (81.6) 
Moderate (≥10% to <20%) 4 (2.3) 10 (7.1) 6 (10.7) 3 (7.9) 
High (≥20% to <30%) 4 (2.3) 2 (1.4) 0 (0) 1 (2.6) 
Very high (≥30%) 1 (0.6) 4 (2.8) 1 (1.8) 3 (7.9) 
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characteristics. Men were more likely to have CVD-related risk factors than women. 
Alcohol drinking was very common at all levels of altitude and more than twice as high as 




5.2 Blood Pressure 
This section is divided into two parts. In the first part, BP and hypertension (HT) are 
described in relation to altitude, socio-demographic, lifestyle and clinical characteristics. In 
the second part, analysis of variance (ANOVA) and analysis of covariance (ANCOVA) 
models for the relationship between systolic blood pressure (SBP) and diastolic blood 
pressure (DBP) and altitude are shown.  
Table 5.15 describes SBP and DBP at each altitude level. The mean SBP and DBP were 
highest at the highest altitude of 3620 m but did not consistently increase with increasing 
altitude. There was strong evidence that SBP and DBP were different across the altitude 
levels. The F-statistics from the ANOVA with SBP as the response variable and altitude as 
a categorical predictor variable was 12.6 (3 df,517), P<0.01; and for DBP, 3.64 (3 df,517), 
P=0.01. For a comparison between similar altitude levels, 2800 m and 2890 m, the mean 
differences (95% CI) were for SBP 9.6 (5.8 to 13.3) mmHg, t 5.1, P<0.01; and for DBP, 
2.9 (0.5 to 5.3) mmHg, t 2.4, P=0.02. Figure 5.6 shows boxplots of SBP and DBP by the 
levels of altitude.  
Table 5.15: Systolic and diastolic blood pressure by the level of altitude 
 
 Humla Mustang 
Variable 2890 m 2800 m 3270 m 3620 m Total (Mustang) 
 (Rural) (Urban) (Rural) (Urban)  




























 Figure 5.6 : Boxplot of mean systolic and diastolic blood pressure values by altitude 
level 
Summaries of HT-related characteristics at different altitude levels are shown in Table 
5.16. Residents at 3620 m had higher proportions of participants with HT and related 
characteristics than those at lower altitude. When altitude was treated as a continuous 
variable the age and sex adjusted odds ratio (95% CI) for being hypertensive or on anti-
hypertensive medication was 1.54 (0.72 to 3.29), P=0.26 for every 1000 m increment in 
altitude. Residents at 2800 m had higher odds for HT or for being on anti-hypertensive 
medication compared to residents at 2890 m with age and sex adjusted odds ratio (95% CI) 
of 1.49 (0.96 to 2.33), P=0.07.  
Altitudes of 2800 m and 3620 m are tourist areas and people have a modern lifestyle, 
whereas 2890 m and 3270 m are rural areas. For residents with modern lifestyle compared 
to those with a rural lifestyle the age and sex adjusted odds ratio (95% CI) for HT (or being 
on anti-hypertensive medication) was 1.68 (1.15 to 2.47), P=0.008.  
The national prevalence of HT (or being on anti-hypertensive medication) for those aged 
30 years or older living in Nepal is 36.8% (K. K. Aryal et al., 2014) and so the prevalence 
of HT at 2800 m, 3270 m and 3620 m in Mustang were higher than this, and lower at 2890 
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were diagnosed with HT, based on the measurements done for this study, for the first time. 
Overall, only 17/521 (3.3%) participants were on anti-hypertensive medication. 
Table 5.16: Blood pressure and hypertension related characteristics by altitude level 
 Humla Mustang 
Altitude 2890 m 2800 m 3270 m 3620 m 
 (Rural) (Urban) (Rural) (Urban) 
 N=251 N=165 N=61 N=44 
Variables N (%) 
HT or on medication 73 (29.1) 76 (46.1) 25 (40.9) 24 (54.5) 
HT 73 (29.1) 66 (40.0) 20 (32.8) 22 (50) 
HT stage I 46 (18.3) 41 (24.8) 10 (16.4) 13 (29.5) 
HT stage II 27 (10.8) 25 (15.1) 9 (14.7) 9 (20.4) 
Pre-HT 69 (27.5) 59 (35.8) 21 (34.4) 10 (22.7) 
HT new 63 (25.1) 30 (18.2) 13 (21.3) 18 (40.9) 
HT ever 21 (17.2) 51 (34.0) 17 (29.8) 7 (16.7) 
BP measured ever 123 (49.0) 150 (90.9) 57 (93.4) 42 (95.4) 
HT or on medication: SBP ≥140 or DBP ≥90 mmHg or on anti-hypertensive medication;  
HT stage I: SBP 140-159 or DBP 90-99 mmHg; HT stage II: SBP ≥160 or DBP ≥100 mmHg; 
pre-HT: SBP 120-139 or DBP 80-90 mmHg. 
 
Table 5.17 shows the proportion of HT (or those on anti-hypertensive medication) by 
socio-economic and demographic characteristics at each altitude level. Participants who 
were men, in older age groups, with formal school education, higher self-reported annual 
household income and currently married were more likely to have HT (or be on anti-
hypertensive medication). The trend was inconsistent for different types of occupation. 
Men had almost two-fold higher odds than women for being hypertensive or on anti-
hypertensive medication: age adjusted odds ratio (95% CI) of 1.96 (1.34 to 2.86), P<0.01. 
For every decade, older age was associated with sex adjusted odds ratio (95% CI) of 1.67 
(1.44 to 1.94), P<0.01 for HT (or on anti-hypertensive medication). When compared with 
participants with a self-reported annual household income of less than NRS 200,000, the 
age and sex adjusted odds ratio (95% CI) for HT or being on anti-hypertensive medication 
was 1.25 (0.77 to 2.02), P=0.36 for those with annual household income of between NRS 
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200,000 to 400,000, and 1.79 (1.14 to 2.81), P=0.01 for those with greater than NRS 
400,000.  
Table 5.17: The proportion of hypertension (or those on anti-hypertensive 
medication) by socio-economic and demographic characteristics at each altitude level 
 Humla Mustang 
Altitude 2890 m 2800 m 3270 m 3620 m 
 (Rural) (Urban) (Rural) (Urban) 
HT or on medication N=73 N=76 N=25 N=24 
Variables N/N (%) 
Age group (years)     
30–39 18/105 (17.1) 12/46 (26.1) 0/6 (0) 5/16 (31.2) 
40–49 22/71 (30.9) 16/40 (40.0) 7/16 (43.7) 6/10 (60.0) 
50–59 23/50 (46.0) 18/36 (50.0) 6/15 (40.0) 4/6 (66.7) 
≥60  10/25 (40.0) 30/43 (69.8) 12/24 (50.0) 9/12 (75.0) 
Sex     
Male 42/103 (40.8) 41/80 (51.2) 14/29 (48.3) 11/19 (57.9) 
Female 31/148 (20.9) 35/85 (41.2) 11/32 (34.4) 13/25 (52.0) 
Education     
No formal education / 
illiterate 
49/168 (29.2) 27/67 (40.3) 17/41 (41.5) 15/29 (51.7) 
Less than primary level 3/18 (16.7) 18/45 (40.0) 8/19 (42.1) 2/6 (33.3) 
Primary level completed 8/20 (40.0) 16/25 (64.0) 0/0 (0) 4/4 (100.0) 
Secondary level 
completed or more 
13/45 (28.9) 15/28 (53.6) 0/1 (0) 3/5 (60.0) 
Occupation     
Govt or non-govt 
employee 
16/39 (41.0) 15/25 (60.0) 0/1 (0) 6/7 (85.7) 
Self-employed 8/21 (38.1) 37/86 (43.0) 4/6 (66.7) 6/14 (42.9) 
Agriculture/daily waged 
labour 
39/135 (28.9) 19/41 (46.3) 14/39 (35.9) 10/21 (47.6) 
Unemployed/retired/ 
homemaker 
10/56 (17.9) 5/13 (38.5) 7/15 (46.7) 2/2 (100.0) 
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Household income (per year) 
<NRS 200,000 37/136 (27.2) 15/37 (40.5) 9/22 (40.9) 2/6 (33.3) 
NRS 200,000 to 400,000 18/58 (31.0) 15/43 (34.9) 10/23 (43.5) 11/17 (64.7) 
NRS >400,000 18/57 (31.6) 46/85 (54.1) 6/16 (37.5) 11/21 (52.4) 
Marital Status     
Unmarried/divorced/ 
widowed 
3/9 (33.3) 7/21 (33.3) 4/10 (40.0) 3/7 (42.9) 
Currently married 70/242 (28.9) 69/144 (47.9) 21/51 (41.2) 21/37 (56.8) 
1 NZ $ = NRS 77 (as of 6
th
 December 2016) 
 
The relationship between HT (or being on anti-hypertensive medication) and ethnicity by 
altitude level is shown in Table 5.18. Participants from Tibetan ethnicity were predominant 
at all three altitude levels in Mustang. Khas-Aryas were the majority ethnic group of those 
living in Humla. Overall, participants with Tibetan ethnicity had a higher proportion of HT 
(or being on anti-hypertensive medication) compared to Khas-Aryas; however, when 
adjusted for age and sex the odds ratio (95% CI) for HT (or being on anti-hypertensive 
medication) among participants with Tibetan compared to Khas-Arya ethnicity was 0.86 
(0.58 to 1.29), P=0.49. 
Table 5.18: Hypertension (or on anti-hypertensive medication) by ethnicity at each 
altitude level 
 Humla Mustang Total 
Altitude 2890 m 2800 m 3270 m 3620 m  
 (Rural) (Urban) (Rural) (Urban)  





















 Tibetan = Thakali and Tibetan Gurung in Mustang and Lama in Humla, Khas-Arya = Dalit, 
Brahmin and Chhetri in both Mustang and Humla. 
The proportion of participants with HT (or on anti-hypertensive medication) in relation to 
self-reported smoking and alcohol-related characteristics for each altitude level is 
described in Table 5.19. At least a quarter of the current drinkers and current smokers were 
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hypertensive or on anti-hypertensive medication at all altitude levels. HT residents at 3270 
m self-reported consuming markedly higher mean SDUs of alcohol than participants at all 
other altitudes. Overall, the age and sex adjusted odds ratio (95% CI) for HT or being on 
anti-hypertensive medication was 0.87 (0.54 to 1.37), P=0.54 for current smokers 
compared to non-smokers, and 0.82 (0.55 to 1.22), P=0.34 for current drinkers compared 
to non-drinkers. 
Table 5.19: Hypertension (or on anti-hypertensive medication) by self-reported 
tobacco and alcohol-related characteristics and standard drink units of alcohol at 
each altitude level 
 Humla Mustang 
Altitude 2890 m 2800 m 3270 m 3620 m 
 (Rural) (Urban) (Rural) (Urban) 
Variables N/N (%) 
Smoking status     
Current smoker 32/97 (32.9) 7/17 (41.2) 1/2 (50.0) 1/4 (25.0) 
Past smoker 6/29 (20.7) 10/23 (43.5) 5/11 (45.4) 4/7 (57.1) 
Current smokeless 
tobacco user 
10/27 (37.0) 25/49 (51.0) 6/19 (31.6) 5/11 (45.4) 
Past smokeless  
tobacco user 
5/6 (83.3) 6/12 (50.0) 8/14 (57.1) 1/4 (25.0) 
Alcohol status     
Current drinker 35/123 (28.5) 38/84 (45.2) 17/39 (43.6) 14/20 (70.0) 
Ever a drinker 58/197 (29.4) 65/141(46.1) 23/58 (39.7) 24/40 (60.0) 
Hazardous drinker 8/24 (33.3) 13/26 (50.0) 12/22 (54.5) 6/8 (75.0) 
 Mean (SD) 
Standard drink units of 









Current drinker: participants who drank alcohol in the past 30 days Hazardous drinker: 
participants drinking ≥21 (males) or ≥14 (females) standard drink units of alcohol per week 
Table 5.20 describes physical activity-related variables in those with HT (or on anti-
hypertensive medication) at each altitude level. Among those with HT there was no 
consistent trend in reports of sedentary behaviour by altitude levels, except that the 
125 
 
participants at higher altitudes of 3270 m and 3620 m reported having more sedentary 
hours per day than the participants from 2800 m and 2890 m. Generally, those with HT (or 
on anti-hypertensive medication) were physically less active and sedentary at all altitude 
levels (data not shown). 
Table 5.20: Physical activity-related variables in hypertensive (or on anti-
hypertensive medication) participants by altitude level 
 Humla Mustang 
Altitude 2890 m 2800 m 3270 m 3620 m 
 (Rural) (Urban) (Rural) (Urban) 
Variables Mean (SD) 
Vigorous physical  









Moderate physical  





























Vigorous physical activity: activity (like carrying heavy loads, digging) causing large increases in 
breathing or heart rate for at least 10 minutes continuously  Moderate physical activity: activity 
(such as brisk walking, cleaning, washing clothes by hand) causing small increases in breathing or 
heart rate 
Table 5.21 shows the self-reported fruit and vegetable consumption and salt intake of those 
with HT (or on anti-hypertensive medication) by altitude level. Hypertensive residents at 
all altitude levels usually reported that they consumed less fruit and vegetables than the 
recommended five portions per day, and more salt than the recommended 5 g per day. 
Consumption of fruit and vegetables was lower in those with HT (or on anti-hypertensive 
medication) compared to non-hypertensives at all altitude levels, but this trend was not 
observed for salt consumption (data not shown). 
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Table 5.21: Self-reported fruit, vegetable and salt intake among hypertensive (or on 
anti-hypertensive medication) participants by altitude level 
 Humla Mustang 
Altitude 2890 m 2800 m 3270 m 3620 m 
 (Rural) (Urban) (Rural) (Urban) 
Variables N/N (%) 
<5 fruit & vege 









>5 gram of salt 









 Mean (SD) 
Fruit & vege 




















BMI among those with HT (or on anti-hypertensive medication) at different altitude levels 
is shown in Table 5.22. BMI was higher at 2800 m compared to other altitude levels but 
there was no obvious trend by altitude. At least half of the participants who were 
overweight or obese (BMI ≥25 kg/m
2
) had HT (or were on anti-hypertensive medication) 
at all altitude levels (Figure 5.7). Overall, overweight or obese participants had nearly 
three-fold higher odds for presence of HT (or being on anti-hypertensive medication) 
compared to the participants with normal BMI (<25 kg/m
2
), age and sex adjusted odds 
ratio (95% CI) of 2.97 (1.95 to 4.52), P<0.01. 
Table 5.22: Body mass index in hypertensive participants at each altitude level 
 Humla Mustang 
Altitude 2890 m 2800 m 3270 m 3620 m 
 (Rural) (Urban) (Rural) (Urban) 
Variables Mean(SD) 
















Figure 5.7: The proportion of hypertensive (or on anti-hypertensive 
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5.2.1 Blood pressure and altitude 
Analysis of variance (ANOVA) and analysis of covariance (ANCOVA) models were used 
to estimate the nature and strength of associations between SBP and DBP and altitude. In a 
univariate ANOVA model four altitude levels were considered as explanatory variables 
and treated as categorical variables with 2800 m nominated as the reference level and 
compared to altitude levels 2890 m, 3270 m and 3620 m.  
In the ANCOVA models predicting BP age, sex, weight, self-reported salt intake, and self-
reported alcohol intake (standard drinks in the past 30 days) were used as possible 
confounding variables and altitude was treated as a continuous variable. There were four 
values of altitude (2800 m, 2890 m, 3270 m, and 3620 m). Overall normality and other 
statistical assumptions for ANOVA and ANCOVA were reasonably well met. 
In a univariate model there was strong evidence of a relationship between SBP and 
altitude: F (3,517) 12.6, P<0.001, with root mean square of error (RMSE) 19.4 and an R-
squared of 6.8% (adjusted R-squared 6.3%). However, the relationship was only moderate 
between DBP and altitude: F (3,517) 3.6, P=0.01, with a RMSE of 12.5 and R-squared 
2.1% (adjusted R-squared 1.5%). Table 5.23 shows the estimates of the difference in mean 
BP for each altitude level compared to 2800 m in a univariate model. 
Table 5.23: Estimates of the difference in mean systolic and diastolic blood pressure 
by altitude level in a univariate ANOVA model 
Variables Comparison Estimate (95% CI) P value 
Systolic BP Altitude 2890 m versus 2800 m -9.6 (-13.4 to -5.7) <0.001 
 Altitude 3270 m versus 2800 m -1.4 (-7.1 to 4.3) 0.62 
 Altitude 3620 m versus 2800 m 5.0 (-1.5 to 11.5) 0.13 
Diastolic BP Altitude 2890 m versus 2800 m -2.9 (-5.4 to -0.5) 0.02 
 Altitude 3270 m versus 2800 m -2.9 (-6.6 to 0.7) 0.12 
 Altitude 3620 m versus 2800 m 2.5 (-1.7 to 6.7) 0.24 
 
In a multivariate model adjusting for potential confounders there was moderate evidence of 
a relationship between SBP and altitude (Table 5.24). Mean SBP (95% CI) increased by 
11.3 mmHg (-0.1 to 22.7), P=0.05 for every 1000 m elevation. For the ANCOVA model as 
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a whole, as anticipated, the potential confounding variables were associated with SBP, 
overall F (6,222) 10.3, P<0.001 with a RMSE of 17.9 and R-squared of 21.8% (adjusted R-
squared of 19.7%). Older age and self-reported units of standard drinks of alcohol in the 
past 30 days were associated with higher mean SBP. Unexpectedly, higher self-reported 
salt intake was moderately associated with a lower mean SBP.  
Table 5.24: Estimates of the mean systolic blood pressure for altitude in a multi–
variate ANCOVA and associations for confounding variables 
Variable and Comparison Estimate (95% CI) P value 
Altitude (per 1000 m higher) 11.3 (-0.1 to 22.7) 0.05 
Weight (per kg higher) 0.2 (-0.03 to 0.5) 0.08 
Salt intake (per gram higher) -0.4 (-0.8 to -0.1) 0.02 
Age (per decade older) 5.0 (3.2 to 6.8) <0.001 
Sex (male compared to female) 2.6 (-2.7 to 7.9) 0.33 
Alcohol intake (per standard 
drink higher) 
0.03 (0.003 to 0.05) 0.005 
 
For the data used in the adjusted model, data were missing for 76 participants for the 
confounding variables weight and self-reported salt intake. The mean SBP was higher in 
missing data points for confounding variable weight (129.2 mmHg compared to 121.8 
mmHg) with a mean difference (95% CI) of 7.3 mmHg (-1.0 to 15.8), t -1.7, P=0.08. It was 
also higher in missing data points for self-reported salt intake (123.6 mmHg compared to 
122.0 mmHg) with a mean difference (95% CI) of 1.6 mmHg (-4.1 to 7.4), t -0.5, P=0.57 
when compared with fully observed data points. 
Table 5.25 shows the estimates of the associations between DBP and altitude and other 
covariates. In the multivariate model adjusting for the potential confounders, the 
relationship between DBP and altitude was positive, albeit with wider confidence intervals. 
Mean (95% CI) DBP increased by 5.4 mmHg (-1.7 to 12.6) per 1000 m higher altitude. 
The ANCOVA model as a whole has F (6, 222) 4.85, P<0.001 with R-squared 11.6% 
(adjusted R-squared 9.2%) and a RMSE 11.2.  
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Interaction analyses in multivariate models adjusting for potential confounding variables 
showed that the differences in SBP and DBP between urban and rural participants per 1000 
m elevation of altitude were statistically not significant; the difference was 19.6 mmHg 
(95% CI -4.4 to 43.7), P=0.11 for SBP; and 1.0 mmHg (95% CI -0.1 to 2.2), P=0.08 for 
DBP.  
Table 5.25: Estimates of mean diastolic blood pressure for altitude in a multivariate 
ANCOVA and associations for confounding variables 
Variable and Comparison Estimate (95% CI) P value 
Altitude (per 1000 m higher) 5.4 (-1.7 to 12.6) 0.14 
Weight (per kg higher) 0.2 (0.06 to 0.4) 0.007 
Salt intake (per gram higher) -0.1 (-0.4 to 0.1) 0.21 
Age (per decade older) 1.3 (0.2 to 2.4) 0.02 
Sex (male compared to female) 0.4 (-2.9 to 3.8) 0.79 
Alcohol intake (per standard drink higher) 0.02 (0.002 to 0.03) 0.02 
 
In the multivariate analysis, a greater number of standard drinks of alcohol in the past 30 
days, older age, and higher body weight were associated with higher DBP. As for SBP, 
there were 76 participants missing full data for the multivariate ANCOVA analysis, 
particularly for confounding variables such as weight and self-reported salt intake. The 
mean DBP was higher in missing data points for confounding variable weight (88.6 mmHg 
compared to 85.0 mmHg) with a mean difference (95% CI) of 3.6 mmHg (-1.6 to 8.9),        
t -1.3, P=0.18. It was also higher in missing data points for self-reported salt intake (86.7 
mmHg compared to 84.9 mmHg) with a mean difference of 1.8 mmHg (-1.9 to 5.3), t -0.9, 
P=0.35 when compared with fully observed data points.  
In summary, multivariate ANCOVA models suggested moderate evidence of a relationship 
between SBP and altitude, and no evidence of a relationship between DBP and altitude, 
after adjustment for potential confounding variables. Variables associated with mean SBP 
were age and self-reported alcohol intake; and age, self-reported alcohol intake and body 
weight for mean DBP. Surprisingly, salt intake was associated with decreased mean SBP. 
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Nearly one-quarter of the study participants and two-thirds of hypertensives were 
diagnosed with HT for the first time. 
The prevalence of HT (or being on anti-hypertensive medication) was higher at each 
altitude level, except at 2890 m, when compared with the national prevalence in Nepal. 
Overall, HA residents who were men, older, with high household income, living a modern 
lifestyle, and who were overweight or obese were significantly more likely to be 
hypertensive after adjusting for the potential confounders. Ethnicity categorised as Tibetan 




5.3 Electrocardiography recordings 
This section describes ECG recordings taken at each level of altitude. As described in 
detail in the methods section (Chapter 4, section 4.4.3), ECG recordings were reviewed by 
a cardiologist and categorized as abnormal, borderline or normal. ECG reports are 
described in these categories in relation to socio-demographic, lifestyle, and clinical 
characteristics. Logistic regression was used to estimate the association between an 
abnormal (or borderline abnormal) ECG and altitude in univariate and multivariate models. 
5.3.1 Electrocardiographic analysis 
Arrhythmias: Three participants had isolated ectopic beats on their 12-lead ECGs: one 
atrial, one junctional and one ventricular. Four participants had clear evidence of pre-
excitation of the ventricles (Wolff-Parkinson-White syndrome). Four participants showed 
prolonged AV (atrioventricular) nodal conduction (first degree AV block) with PR 
intervals varying between 205 msec and 286 msec (normal up to 200 msec). One 
participant had left bundle branch block (LBBB) and six had right bundle branch block 
(RBBB) (three each complete and incomplete). Two participants, a man and a woman, had 
prolonged QT intervals: 470 msec and 490 msec. 
Morphological abnormalities: Two participants had tall peaked P waves, suggesting right 
atrial hypertrophy. Three participants showed extreme axis deviation (arm lead electrode 





possible congenital abnormalities and/or pulmonary hypertension. Twenty-six other 





which two had right ventricular hypertrophy (RVH). Four others had left axis deviation 




. No participant had Q waves to suggest past 
Q-wave MI. Thirteen had inverted T waves outside the accepted normal leads (III, aVR, 
V1); nine of these were of doubtful significance as they were in the antero-septal 
precordial leads V1to V4. Two had inverted T waves in inferior leads (II, III and aVF) and 
two in aVL alone. Seventeen participants met Sokolow-Lyon criteria for left ventricular 
hypertrophy (LVH), with the largest S in V1 or V2 plus the largest R in V5 or V6 greater 
than 3.5mV, but only one of these met the stricter definition of Romhilt and Estes (six 
points); three others were borderline (four points). Two additional participants had down-
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sloping ST segments with no other cause but suggestive of hypertrophy, one with four 
points on the Romhilt-Estes scoring system but negative using Sokolow-Lyon criteria.  
The key findings of ECG recordings are presented in Table 5.26. 
Table 5.26: Key findings of electrocardiographic recordings 






Arrhythmias    
Ectopics 0 3 3 
Wolff-Parkinson-White 2 2 4 
Atrioventricular block 4 0 4 
Left bundle branch block 0 1 1 
Right bundle branch block 5 1 6 
Long QT 2 0 2 
Morphological abnormalities    
Right atrial hypertrophy 0 2 2 
Right ventricular hypertrophy 0 2 2 
Extreme axis deviation 3 0 3 
Right axis deviation 







Inverted T wave 7 6 13 
Left ventricular hypertrophy 13 4 17 
*Participants could have more than one abnormalities 
 
None of the participants showed a definite electrocardiographic evidence of CHD. Overall 
27/485, 5.6% (95% CI 3.7 to 8.0), of the participants gave a self-report of a history of CHD 
confirmed by a medical doctor. The prevalence of CHD by sex was 17/212 (8.0%) in men 
and 10/273 (3.7%) in women, Chi-square (1 df) 4.3, P=0.04. Altogether 95/485, 19.6% 
(95% CI 16.1 to 23.4), of the participants had an abnormal (or borderline abnormal) ECG. 
The main categories of abnormality were: RAD in 26/485, 5.4% (95% CI 3.5 to 7.7); and 
LVH by voltage criteria in 17/485, 3.5% (95% CI 2 to 5.5). Of the 26 participants with 
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RAD, 16 (61.5%) were men and 13 (50%) were from the age group 30 to 39 years. Among 
17 participants with LVH, 11 (64.7%) were women, 12 (70.6%) were aged 50 years or 
over, and 11 (70.6%) were hypertensive or on anti-hypertensive treatment. 
Participants living in the Mustang district at altitudes of 2800 m, 3270 m and 3620 m 
mostly had abnormalities on the left side of the heart. Humla participants at 2890 m mostly 
had abnormalities on the right side of the heart. However, the differences in proportions 
were not statistically significant. For example, Mustang participants had 15/243 (6.2%) 
ECG findings of LVH, LAD, or LBBB compared to 7/242 (2.9%) Humla participants: 
proportion difference (95% CI), 3.3% (-0.39 to 6.9), P=0.08. In Humla, 21/242 (8.7%) 
ECG reports had RAD, RBBB, or right atrial hypertrophy compared to 13/243 (5.3%) in 
the Mustang participants: proportion difference (95% CI), 3.4% (-1.1 to 7.9), P=0.14. 
Table 5.27 shows the proportion of abnormal (or borderline abnormal) ECGs by altitude 
level. More than a quarter of the participants at 3270 m and 3620 m had an abnormal (or 
borderline abnormal) ECG, almost twice as high as those living at 2800 m and 2890 m. 
The proportion of abnormal (or borderline abnormal) ECGs was similar for similar level 
altitudes: 2800 m and 2890 m. After adjustment for age and sex, the odds ratio (95% CI) 
for abnormal (or borderline abnormal) ECG at 2890 m compared to 2800 m was 1.38 (0.73 
to 2.43), P=0.34. There was no association between the participants' lifestyle (urban versus 
rural) and probability for abnormal (or borderline abnormal) ECG, with an estimate of the 
age and sex adjusted odds ratio (95% CI) of 0.85 (0.52 to 1.34), P=0.49.  
Table 5.27: Abnormal or borderline abnormal electrocardiogram by altitude 
 
 Humla Mustang 
Altitude 2890 m 2800 m 3270 m 3620 m 
 (Rural) (Urban) (Rural) (Urban) 
Variable N/N (%) 
Abnormal or 
borderline ECG 




Figure 5.8: The line graph of abnormal or borderline abnormal electrocardiogram by 
altitude level 
Figure 5.8 shows the line graph of the proportion of abnormal or borderline abnormal 
ECGs by altitude level. The proportions of abnormal (or borderline abnormal) ECGs by 
socio-economic and demographic characteristics at each altitude level are shown in Table 
5.28. Participants in older age groups, men, and those with high self-reported household 
income, were more likely to have abnormal (or borderline abnormal) ECGs at all altitude 
levels. Among those with abnormal (or borderline abnormal) ECGs, there was no distinct 
pattern in self-reported types of occupation and completed levels of education by altitude 
levels. The sex adjusted odds ratio (95% CI) for abnormal or borderline abnormal ECG 
was 1.21 (1.02 to 1.44), P=0.02 per decade older age. Men had more than two-fold higher 
odds for presence of abnormal (or borderline) ECGs compared to women, age adjusted 
odds ratio (95% CI) of 2.10 (1.33 to 3.34), P=0.001. When compared with participants 
with self-reported annual household income of less than NRS 200,000, the age and sex 
adjusted odds ratio (95% CI) for abnormal (or borderline abnormal) ECGs was 0.78 (0.43 
to 1.42), P=0.42 for those with annual household income of between NRS 200,000 and 










































Table 5.28: The proportion of abnormal or borderline abnormal electrocardiogram 
by socio-economic and demographic characteristics at each altitude level 
 Humla Mustang 
Altitude 2890 m 2800 m 3270 m 3620 m 
 (Rural) (Urban) (Rural) (Urban) 
Abnormal ECG N=42 N=22 N=18 N=13 
Variables N/N (%) 
Age group (years)     
30–39 16/100 (16.0) 3/40 (7.5) 1/6 (16.7) 6/16 (37.5) 
40–49 11/68 (16.2) 4/33 (12.1) 5/16 (31.2) 2/10 (20.0) 
50–59 12/49 (24.5) 7/29 (24.1) 3/14 (21.4) 2/6 (33.3) 
≥60  3/25 (12.0) 8/22 (21.6) 9/24 (37.5) 3/12 (25.0) 
Sex     
Male 25/99 (25.2) 11/65 (16.9) 10/29 (34.5) 10/19 (52.6) 
Female 17/143 (11.9) 11/74 (14.9) 8/31 (25.8) 3/25 (12.0) 
Education     
No formal education /  
illiterate 
26/162 (16.0) 12/56 (21.4) 10/41 (24.4) 8/29 (27.6) 
Less than primary level 1/18 (5.6) 5/39 (12.8) 8/18 (44.4) 1/6(16.7) 
Primary level completed 3/19 (15.8) 1/21 (4.8) 0/0 (0) 2/4 (50.0) 
Secondary level  
completed or more 
12/43 (27.9) 4/23 (17.4) 0/1 (0) 2/5 (40.0) 
Occupation     
Govt or non-govt 
employee 
9/39 (23.1) 3/22 (13.6) 0/1 (0) 4/7 (57.1) 
Self-employed 7/21 (33.3) 11/75 (14.7) 2/5 (40.0) 5/14 (35.7) 
Agriculture/daily waged 
labour 
20/129 (15.5) 5/30 (16.7) 10/39 (25.6) 3/21 (14.3) 
Unemployed/retired/ 
homemaker 
6/53 (11.3) 3/12 (25.0) 6/15 (40.0) 1/2 (50.0) 
Household income (per year) 
<NRS 200,000 23/131 (17.6) 6/32 (18.7) 6/22 (27.3) 2/6 (33.3) 
NRS 200,000 to 400,000 5/55 (9.1) 7/34 (20.6) 6/22 (27.3) 4/17 (23.5) 
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NRS >400,000 14/56 (25.0) 9/73 (12.3) 6/16 (37.5) 7/21 (33.3) 
Marital Status     
Unmarried/divorced/  
widowed 
1/8 (12.5) 4/16 (25.0) 1/9 (11.1) 0/7 (0) 
Currently married 41/234 (17.5) 18/123 (14.6) 17/51 (33.3) 13/37 (35.1) 
 1 NZ $ = NRS 77 (as of 6
th
 December 2016)  
Table 5.29 shows the proportion of abnormal (or borderline abnormal) ECGs by ethnicity 
at each altitude level. Tibetan participants had a lower prevalence of abnormal (or 
borderline) ECGs at each level of altitude compared to Khas-Aryas. The age and sex 
adjusted odds ratio (95% CI) for abnormal (or borderline abnormal) ECG was 0.66 (0.40 to 
1.08), P=0.10 for participants with Tibetan ethnicity compared to Khas-Aryas. 
Table 5.29: The proportion of abnormal or borderline abnormal electrocardiogram 
by ethnicity at each altitude level 
 Humla Mustang Total 
Altitude 2890 m 2800 m 3270 m 3620 m  
 (Rural) (Urban) (Rural) (Urban)  
Abnormal 
ECG 
N=42 N=22 N=18 N=13 N=95 
Variables N/N (%) 
Tibetan 11/79 (13.9) 16/115 (13.9) 16/57 (28.1) 9/37 (24.3) 52/288 (18.1) 
Khas-Arya 31/163 (19.0) 6/24 (25.0) 2/3 (66.7) 4/7 (57.1) 43/197 (21.8) 
 Tibetan = Thakali and Tibetan Gurung in Mustang and Lama in Humla, Khas-Arya= Dalit, 
Brahmin and Chhetri in both Mustang and Humla. 
As shown in Table 5.30, the proportions of abnormal (or borderline abnormal) ECGs were 
higher at 3270 m and 3620 m for most of the smoking and tobacco-related variables. Those 
reporting a habit of tobacco use or higher alcohol consumption in the past 30 days had a 
higher prevalence of abnormal (or borderline abnormal) ECGs.  
Overall, the odds ratio adjusted for age and sex (95% CI) for abnormal (or borderline 
abnormal) ECG was 0.75 (0.43 to 1.34), P=0.34 for current smokers compared to non-
smokers, and 0.77 (0.48 to 1.24), P=0.29 for current drinkers compared to non-drinkers. 
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Table 5.30: Abnormal or borderline abnormal electrocardiogram by self-reported 
tobacco and alcohol related characteristics at each altitude level 
 Humla Mustang 
Altitude 2890 m 2800 m 3270 m 3620 m 
 (Rural) (Urban) (Rural) (Urban) 
Variables N/N (%) 
Smoking status     
Current smoker 14/96 (14.6) 3/13 (23.1) 1/2 (50.0) 2/4 (50.0) 
Past smoker 10/29 (34.5) 3/20 (15.0) 5/11 (45.4) 3/7 (42.9) 
Current smokeless 
tobacco user 
4/27 (14.8) 9/39 (23.1) 6/19 (31.6) 5/11 (45.4) 
Past smokeless  
tobacco user 
2/6 (33.3) 1/11 (9.1) 6/14 (42.9) 2/4 (50.0) 
Alcohol status     
Current drinker 17/117 (14.5) 10/72 (13.9) 13/39 (33.3) 9/20 (45.0) 
Ever a drinker 32/190 (16.8) 19/120 (15.8) 18/58 (31.0) 13/40 (32.5) 
Hazardous drinker 4/22 (18.2) 4/21 (19.0) 10/22 (45.4) 6/8 (75.0) 
 Mean (SD) 
Standard drink unit of 









Current drinker: participants who drank alcohol in the past 30 days Hazardous drinker: 
participants drinking ≥21 (males) or ≥14 (females) standard drink units of alcohol per week 
Participants with an abnormal (or borderline abnormal) ECG were physically less active 
and more sedentary than those with normal findings (data not shown). Table 5.31 describes 
self-reported physical activity among the participants with abnormal (or borderline 
abnormal) ECGs. There was no consistent trend by altitude level for vigorous and 
moderate physical activity and walk time, but participants with abnormal (or borderline 
abnormal) ECGs were more sedentary with increasing levels of altitude.   
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Table 5.31: Self-reported physical activity related characteristics among participants 
with abnormal (or borderline abnormal) electrocardiogram at each altitude level 
 Humla Mustang 
Altitude 2890 m 2800 m 3270 m 3620 m 
 (Rural) (Urban) (Rural) (Urban) 
Variables Mean (SD) 








































Vigorous physical activity: activity (like carrying heavy loads, digging) causing large increases in 
breathing or heart rate for at least 10 minutes continuously  Moderate physical activity: activity 
(such as brisk walking, cleaning, washing clothes by hand) causing small increases in breathing or 
heart rate 
 
As shown in Figure 5.9, the proportion of abnormal or borderline abnormal ECGs 
consistently increased with increasing levels of altitude in overweight or obese participants 
and those with central obesity. The age and sex adjusted odds ratio (95% CI) for abnormal 
(or borderline abnormal) ECG was 3.08 (0.83 to 11.35), P=0.09, per 1000 m elevation 
among overweight or obese participants, and 4.3 (1.1 to 16.6), P=0.04 among centrally 
obese participants. 
Figure 5.10 compares the proportions of HT, high TC/HDL ratio and diabetes among those 
with abnormal (or borderline abnormal) ECGs by altitude level. Among those with 
abnormal (or borderline abnormal) ECGs, the proportion of participants with HT or on 





Figure 5.9: The proportions of abnormal or borderline abnormal 
electrocardiogram among the participants with overweight or obesity 
and central obesity  
 
Figure 5.10: Comparison of hypertension, high TC/HDL ratio, and 
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BP, lipids and blood sugar levels among the participants with abnormal (or borderline 
abnormal) and normal ECGs are given in Table 5.32. Mean TC, TG, and HbA1c were 
higher and HDL levels lower among participants with abnormal (or borderline) ECGs 
compared to those with normal ECGs at every altitude level, with the exception of TC at 
3270 m and TG at 2890 m.  
Among those with an abnormal (or borderline abnormal) ECG there was no distinct ECG 
pattern by the levels of altitude. However, most of the abnormal values were measured at 
the highest altitude of 3620 m. Mean HDL cholesterol was lower than the abnormal cut-
point of <1.3 mmol/L mostly for women. Women with low HDL had nearly three-fold 
higher odds for presence of abnormal or borderline abnormal ECG compared to women 
with normal HDL: age adjusted odds ratio (95% CI) of 2.83 (1.07 to 7.49), P=0.04.  
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Table 5.32: Blood pressure, lipids and blood sugar-related characteristics in participants with an abnormal (or 
borderline abnormal) and normal electrocardiogram by altitude level 
 Humla Mustang 
Altitude 2890 m 2800 m 3270 m 3620 m 
 (Rural) (Urban) (Rural) (Urban) 
ECG status Abnormal Normal Abnormal Normal Abnormal Normal Abnormal Normal 
Variables Mean (SD) 


















































































































5.3.2 Electrocardiographic abnormalities and altitude  
Logistic regression models were used to estimate associations between the probability of 
an abnormal ECG and altitude. For these models altitude is treated as a continuous 
variable. There were four values of altitude (2800 m, 2890 m, 3270 m, and 3620 m). Both 
univariate and multivariate logistic regression models were used, firstly for the univariate 
association between ECG recordings and altitude, and secondly for the multivariate 
association adjusting for potential confounding variables. Systolic blood pressure, TC to 
HDL ratio, HbA1c, current smoking status, age and sex were considered potential 
confounders. The assumption of linearity between logarithm of the odds of abnormal (or 
borderline abnormal) ECG and explanatory variables were satisfactorily met. 
In the univariate model there was a strong evidence of relationship between the probability 
of an abnormal (or borderline) ECGs and altitude: likelihood ratio (LR) Chi-square (1 df) 
7.20, P=0.007. Table 5.33 shows the estimates of the odds ratio for an abnormal (or 
borderline abnormal) ECG by altitude. 
Table 5.33: Estimates of the odds ratio for an abnormal or borderline abnormal 
electrocardiogram by altitude in a univariate logistic model 
Variable Odds ratio (95% CI) P value 
Altitude  
(per 1000 m higher) 
3.16 (1.39 to 7.18) 0.006 
 
There was also a moderate association between the probability of abnormal (or borderline 
abnormal) ECG and altitude when adjusted for potential confounding variables in a 
multivariate logistic model (Table 5.34). The odds ratio (95% CI) was 2.83 (1.07 to 7.45), 
P=0.03 per 1000 m elevation of altitude. The multivariate logistic model as a whole had 
LR Chi-square (7 df) 34.7, P<0.01. Among the confounding variables higher SBP was 
strongly associated with abnormal (or borderline abnormal) ECG.   
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Table 5.34: Estimates of the odds ratio for abnormal or borderline abnormal 
electrocardiogram by altitude in a multivariate logistic model and associations for 
confounding variables 
Variables and Comparison Odds ratio (95% CI) P value 
Altitude (per 1000 m higher) 2.83 (1.07 to 7.45) 0.03 
Systolic blood pressure 
(per 10 mmHg higher) 
1.25 (1.08 to 1.44) 0.002 
TC to HDL ratio (per unit ratio higher) 0.93 (0.75 to 1.15) 0.49 
HbA1c (per mmol/mol higher) 1.02 (0.99 to 1.05) 0.49 
Smoke tobacco (yes compared to no) 1.69 (0.97 to 2.94) 0.06 
Age (per decade older) 1.14 (0.91 to 1.43) 0.24 
Sex (men compared to women) 1.69 (0.97 to 2.94) 0.06 
 
The multivariate models had 99 missing data points for the confounding variables TC to 
HDL ratio and HbA1c. There were no statistically significant differences between ECG 
reports (abnormal or normal) and data status (missing or not missing): TC to HDL ratio, 
LR Chi-square (1 df) 1.05, P=0.31; HbA1c, LR Chi-square (1 df) 0.02, P=0.88. 
A separate multivariate logistic model including the interaction term for the effect of sex 
on the association between altitude and the presence of abnormal (or borderline abnormal) 
ECG, adjusting for the potential confounding variables, showed a moderate evidence of 
effect modification by sex (P=0.04). The odds ratio (95% CI) was 7.92 (1.97 to 31.88), 
P=0.004 for men and 1.02 (0.24 to 4.29), P=0.98 for women for the presence of abnormal 
(or borderline) ECG, per 1000 m higher altitude. Another interaction analysis to examine 
the effect of residential settings (urban or rural) on the association between altitude and the 
probability of having abnormal ECG (or borderline abnormal) showed no significant 
association, the difference in odds ratio between urban and rural participants was 0.4 (95% 
CI -0.03 to 5.9) per 1000 m elevation of altitude, P=0.51.   
In summary, none of the participants showed definite electrocardiographic evidence of 
CHD. However, logistic regression models suggest moderate evidence of an association 
between the probability of participants having an abnormal (or borderline abnormal) ECG 
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and altitude. This association was particularly strong for men. Higher SBP was 
significantly associated with the presence of abnormal or borderline abnormal ECG.  
The proportion of abnormal (or borderline abnormal) ECGs was almost twice as high at 
altitudes of 3270 m and 3620 m compared to 2800 m and 2890 m. RAD and LVH were the 
most common types of ECG abnormality. The proportion of participants with an abnormal 
(or borderline abnormal) ECG increased with increasing altitudes for participants who 
were overweight, obese, or had central obesity. Participants with an abnormal (or 
borderline abnormal) ECG were significantly more likely to be sedentary with increasing 
altitudes. 
There was no statistically significant relationship between the types of lifestyle (urban or 
rural) and ethnicity (Tibetan or Khas-Arya) and the probability of having an abnormal (or 
borderline abnormal) ECG. Low HDL was associated with an abnormal (or borderline 





This chapter first discusses the limitations of the present study and then concentrates on 
three key topic areas of this thesis i) cardiovascular disease (CVD) ii) blood pressure (BP), 
and iii) other CVD risk factors (lipid profile, diabetes and tobacco use). Where possible the 
results within these topic areas are compared with similar data from other high altitude 
(HA) areas of Nepal and other HA areas of the world, and with low altitude (LA) areas of 
Nepal and South Asia. Each section describes the main results in context, new findings, 
strengths and weaknesses, and areas for future research. Finally, overall conclusions are 
presented. 
6.1 General limitations 
A number of limitations relevant to the interpretation of the results are common across the 
three topic areas. These are: confounding and effect modification, lack of robust local 
administrative health datasets, the sampling process, reliance on self-report in an area of 
poor health literacy, that other literature uses cut-points for estimation of prevalence and 
incidence, and the cross-sectional design.  
An important aspect of this thesis is whether there is a relationship between CVD, BP, 
and/or or other CVD risk factors, and increasing altitude of usual residence. Multiple 
potential confounding and effect modification factors could explain an apparent 
relationship between the three topic areas and altitude. These include ancestry, cultural-
related lifestyle practices, socio-economic status, and residential settings (rural versus 
urban). As discussed in the literature review section, there are known differences in 
physiological responses to HA hypoxia and lifestyle practices (mainly the intake of dietary 
salt and alcohol, and use of tobacco) between those HA populations with Tibetan ancestry 
and other populations with a shorter history of living at HA, for example Khas-Aryas. The 
socio-economic status of the participants varied between different sampled areas included 
in the present study. Participants living in urban areas (2800 metre (m) and 3620 m) were 
relatively well off, but those in rural areas (2890 m and 3270 m) were poor. These 
differences are accounted for where relevant data were available, but clearly the potential 
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inter-relationships between altitude of residence, ethnicity, socio-economic, and cultural 
factors are complex. 
A lack of robust local administrative data sets means that key data that are usually 
available in more developed and wealthier countries, such as robust death certification, 
health surveys, accessible electronic or paper-based clinical records, and academic 
publications on important health conditions are not available for remote regions of Nepal. 
Therefore, it is difficult to triangulate the findings from the data gathered from this current 
study's pragmatic cross-sectional survey design with other forms of information. This 
means that any biases resulting from personal recollections of those surveyed, that is, recall 
bias, and the results of simple physical examination and testing, are difficult to assess. 
The sampling process for this study had to be adapted to suit the available sampling frames 
and the logistical challenges of administering the research procedures in rural Nepal. As 
described in the methodology section, the sampling technique used was convenience-based 
cluster sampling. Although this technique meant that some observations may have been 
correlated within sampling units it was not feasible to weight this appropriately because of 
an absence of detailed knowledge of sampling frame factors such as socio-economic status, 
combined with the problem of sparsely populated areas. Furthermore, the study areas 
comprised both urban and rural settings, diverse ethnic populations and varying lifestyle 
practices, making it difficulties to use proper conventional weighting schemes in the 
analysis phase. The analysis strategy chosen assumed a simple random sample and this 
meant that the precision of estimates of associations might be too narrow. Due to the 
moderate sample size, there might be the possibility of type II error meaning that not 
rejecting the null associations when it should be. 
The present study relied on participants 'self-report' to gather information about personal 
and family history of CVD and its risk factors, current and past medication, socio-
demography, and lifestyle practices. The population surveyed had generally low health 
literacy based on a low level of overall education. At least 40% of participants at all 
altitude levels were illiterate or had no formal education. In addition, the self-reporting 
process could have led to various manifestations of information bias such as recall bias and 
social-desirability bias. This implies that there may be systematic discrepancies between 
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self-report and actual behaviour, particularly for lifestyle practices such as smoking and 
alcohol intake due to under-reporting, which might also confound or bias the identified 
associations. 
The literature review showed one limitation of the existing literature: that most 
publications defined CVD risk factors using dichotomous cut-off values, despite many 
CVD risk factors having a graded continuous relationship with actual risk. In order to 
compare the results of the current study with existing literature, these specific thresholds 
needed to be used, meaning an inevitable risk of loss of information, especially where 
values are closer to thresholds, and there are some discrepancies in threshold values 
between studies. 
The cross-sectional design of the study also has other limitations with reference to 
inference about causality. One of these limitations is the uncertainty, already alluded to 
above with respect to recall bias, about when things occurred in relation to current reports. 
Odds ratios in the cross-sectional studies could be biased away from true measure of effect 
if prevalence is high. This could be relevant to the hypertension (HT) related odds ratios in 
this thesis. Another limitation is that individuals who could potentially have been part of 
the sampling frame may have moved away from the area or died after developing the 
conditions that were of interest, meaning that the sampling frame may only have contacted 
healthy individuals. This poses the risk of 'healthy survivor bias' or 'healthy individual 
effect' because, in the absence of quality health care, people with CVD, myocardial 
infarction (MI), or stroke might have moved to LA for treatment or died, so reported 
prevalence might not reflect true incidence. On the other hand, it is also likely that healthy 
young populations of study areas may have internally migrated to city areas or emigrated 
to other countries for job, education or for other reasons. Thus, this 'migration effect' could 




6.2 Cardiovascular disease 
Main results in context 
In the present study, none of the participants showed definite electrocardiographic 
evidence of coronary heart disease (CHD) as indicated by pathological Q wave infarction. 
However, 5.6% of the participants self-reported a personal history of CHD. Although few 
population-based studies have been done on CHD in HA populations living at 2500 m or 
more worldwide, the majority of available reports suggest a low incidence of MI in people 
living at HA (Ashouri et al., 1993; Alberto Hurtado, 1960; Ramos et al., 1967). These were 
all hospital-based studies, carried out and published a few decades ago. Nonetheless, this 
finding is consistent with a recent systematic analysis of the burden of disease in Chinese 
provinces reporting that the age-standardized mortality rate from CHD in men in Tibet, 
mean altitude of 4500 m above sea level, was significantly lower compared with those 
living at lower altitudes, although this difference was not seen in women (Zhou et al., 
2016). Various biological (Cai et al., 2003; Ding et al., 2005; Essop, 2007; Sasaki et al., 
2002; Semenza, 2006) and environmental-related (J. D. Anderson & Honigman, 2011; 
Burtscher, 2014) plausible explanations have been suggested for potential cardio-
protection from living at HA.  
The finding of a low prevalence of CHD in the present study, defined by the presence of 
pathological Q waves or self-report of a medical history of CHD, is similar to reports of 
CHD based on electrocardiogram (ECG) recordings or documented personal history at LA 
in Nepal of 5.7% (Vaidya et al., 2009). A systematic review of global studies of CHD 
prevalence (ECG recordings or documented personal history) in adults estimated the 
prevalence of CHD in Asia was 5.8%, between 5.6% and 5.9% in rural China, between 
1.4% to 4.6% in rural areas of India, 3.4% in rural areas of Bangladesh, and 5.1% in urban 
Pakistan (Zhu, Wang, Zhu, Zhou, & Wang, 2015).  
Caution should be taken when considering the CHD prevalence of the present study 
because it is based on self-report of personal history alone, as no participants had any 
objective evidence of CHD such as pathological Q waves on an ECG. Validity of the self-
report of a medical history is questionable in both developed (Kehoe, Wu, Leske, & 
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Chylack, 1994) and developing (Vellakkal et al., 2013) countries. One study reported that 
for CHD the sensitivity of the self-report was low at 57% (Kehoe et al., 1994). In the 
context of the present study, there is an additional risk of inaccurate recall of personal 
history of CHD due to the poor literacy of the participants. 
6.2.1 Major electrocardiographic abnormalities and patterns 
In the present study, right axis deviation (RAD) was the most common ECG abnormality. 
This is a possible early indication of pulmonary HT or right ventricular hypertrophy 
(RVH). A large body of evidence also suggests RAD is the most common feature of HA 
residents, particularly among Andeans. A review reports that RAD could be up to four 
times higher in HA residents compared to sea-level residents (Windsor, Rodway, & 
Montgomery, 2010). A number of studies have reported a positive association between 
RAD and pulmonary artery pressure (Raynaud et al., 1981; Windsor et al., 2010). In the 
present study, pulmonary artery pressure was not measured; however, the prevalence of 
RAD was significantly higher in Humla participants (Khas-Aryas) compared to Mustang 
participants (Tibetan ancestry). Other studies also report higher prevalence of RAD in 
Andeans compared to Tibetan population samples (Jackson, 1975). Tibetan HA residents 
are known to be genetically adapted to the hypoxic pulmonary vasoconstriction (M. Gupta 
et al., 1992). In addition, morphological differences between these populations may be 
relevant to this difference, for example, the shorter stature of Tibetans compared to Khas-
Aryas. 
The present study identified that abnormal (or borderline abnormal) ECG recordings 
occurred on the left side of the heart amongst Tibetan-dominant areas (Mustang district), 
and on the right side among the Khas-Arya dominant area (Humla district). The ECG 
abnormalities suggesting right heart abnormalities may reflect increased pulmonary 
vascular resistance. Right-sided ECG abnormalities have previously been reported to occur 
more frequently among HA residents where the populations are likely to be less well 
adapted to hypoxia, such as Andeans or North Americans (Pryor et al., 1965; Rotta & 
Lopez, 1959), but with a lower prevalence in those with a high degree of adaptation, such 
as Tibetans (Groves et al., 1993). This phenomenon could apply to the findings of the 
present study. As discussed in the introduction chapter, contrasting cardiopulmonary 
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responses to HA exposure have been reported among the largest HA populations: Tibetans, 
Andeans and Aymaras (Abdias Hurtado et al., 2012).  
The prevalence of some ECG abnormalities in the present study was lower than in other 
studies of HA natives. For example, HA studies with ECG recordings frequently report a 
high prevalence of RVH and right bundle branch block (RBBB) in both Tibetan (Halperin 
et al., 1998) and Andean (Rotta & Lopez, 1959) HA populations. These occurred 
infrequently in the present study, with a prevalence of 0.4% for RVH and 1.2% for RBBB. 
However, this is similar to the findings of an Indian study of Tibetan-related participants 
(Kaushal et al., 1995). Studies reporting higher prevalence of RVH and RBBB were 
carried out at higher altitude levels than the present study. These higher altitudes may 
cause a greater decline in inspired oxygen level, leading to significant rise in pulmonary 
vascular resistance and resulting in greater strain on the right side of the heart.  
A review of the English language literature in this thesis (Chapter 2, section 2.5) about the 
prevalence of ECG abnormalities identified no studies reporting an association of ECG 
abnormalities with altitude at different levels above 2500 m. Thus, it is difficult to compare 
the present study's finding of a moderate association between abnormal (or borderline 
abnormal) ECG and altitude with other studies. One study comparing RAD at different 
levels of HA in participants with a variety of ethnic backgrounds reported increasing 
deviation of frontal plane QRS with increasing levels of altitude (Raynaud et al., 1981). 
6.2.2 Predictors of an abnormal (or borderline abnormal) 
electrocardiogram 
In the present study, higher systolic blood pressure (SBP) was strongly associated with an 
increased probability of an abnormal (or borderline abnormal) ECG. There is a well-
documented association between SBP and CVD (Banach et al., 2014; Lim et al., 2012; 
Prospective Studies Collaboration, 2002) so this association is unsurprising in the present 
study. High BP can also lead to left ventricular hypertrophy (LVH), which produces 
changes in the ECG that overlap with those caused by CHD. Among those with an 
abnormal (or borderline abnormal) ECG in the present study at least 50% at three altitude 
levels had HT or were on treatment for HT.  
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In the present study, there was a strong evidence of an association between altitude and the 
probability of having an abnormal (or borderline) ECG in men but not in women after 
controlling for confounding factors such as SBP, smoking tobacco, total cholesterol (TC) 
to high-density lipoprotein-cholesterol (HDL) ratio, glycated hemoglobin (HbA1c), and 
age. HA men may also have more of some other confounding factors that were not 
measured in the present study. 
6.2.3 Other important observations 
Consistent with well-established evidence of the association between obesity and CVD 
(Hubert et al., 1983; Kramer et al., 2013), in the present study obese and centrally obese 
participants were significantly more likely to have an abnormal (or borderline abnormal) 
ECG compared to those whose body mass index (BMI) and waist circumference (WC) 
were in the normal range. Furthermore, the proportion of abnormal (or borderline 
abnormal) ECGs in obese and centrally obese participants consistently increased with 
increasing altitude levels. Living at HA may exacerbate lifestyle-related risk such as high 
alcohol intake and sedentary behaviour due to cold temperatures and physical hardship 
(Littman, 1970; Schinder & Ruder, 1989).  
6.2.4 Cerebrovascular disease 
The present study found a positive stroke history, or stroke symptoms by positive self-
report for at least one criterion of the Questionnaire for Verifying Stroke Free Status 
(QVSFS), among 6.7% of the participants. The QVSFS was chosen to investigate stroke-
related risk because it is a widely accepted validated tool and is appropriate in settings like 
the present study where neuroimaging facilities are not available. In the present study 2.1% 
of participants self-reported that a physician had previously diagnosed them as having had 
a stroke. This is significantly higher than reported in most other studies carried out in LA 
residents using QVSFS (Fitzpatrick et al., 2012) or other prevalence estimates in South 
Asia (Dhamija & Dhamija, 1998). No previous studies carried out in HA populations have 
reported using the QVSFS. However, the high prevalence of self-reported stroke is 
consistent with past studies in Tibetans that have identified a disproportionately higher 
prevalence of HT and stroke compared to LA residents (G. Xu et al., 2013; Zhou et al., 
2016). A significant proportion of the present study's participants had Tibetan ancestry 
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and/or follow similar lifestyle and cultural practices as Tibetans. The apparently high 
prevalence of self-reported history of stroke may be related to the high prevalence of HT, 
which is a potent risk factor for all types of stroke (O'Donnell et al., 2010). 
Accuracy of self-reported medical history of stroke is contestable even in developed 
countries (Cristina, Williams, Parkinson, Sibbritt, & Byles, 2016). With the poor literacy 
rate of the participants in the present study and possible lack of capability to understand the 
complex nature of stroke, misclassification and recall biases are possible.  
Although a positive history of stroke was relatively high in the present study compared to 
most available studies at LA, the prevalence of positive stroke symptoms was lower than in 
LA studies using QVSFS (Farah et al., 2015; Fitzpatrick et al., 2012; V. J. Howard et al., 
2006) or another stroke questionnaire (Toole et al., 1996). One possible reason may be the 
lower minimum age for participation in the present study (30 years or over), which in other 
studies was usually 40 years or over. 
6.2.5 New findings 
This is the first study to report the prevalence of CHD (based on ECG or self-report) and 
history of stroke or suggestive symptoms in HA residents of Nepal. While the prevalence 
of CHD in the present study was comparable to that of LA residents in Nepal, South Asia 
or China, the prevalence of a stroke history was higher than in most of the available studies 
in LA populations. 
6.2.6 Strengths and weaknesses 
The present study estimates prevalence of CHD (based on ECG or self-report) and a 
history of stroke and stroke symptoms in HA areas of Nepal where ECG and neuroimaging 
facilities are not routinely available. The use of ECG is a well-validated method of 
assessing the prevalence of CHD at a population level because of the strong prognostic 
value of major ECG findings on CVD and CHD mortality (De Bacquer, De Backer, 
Kornitzer, & Blackburn, 1998). This is also the first study in Nepal that administered the 
QVSFS. This may encourage other researchers to use that instrument for population-based 
screening and for clinicians working in rural settings to identify patients with the risk of 
stroke. Self-report of one or more positive symptoms from the QVSFS was significantly 
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associated with the hazard ratio of 1.36 (95% confidence interval (CI) 1.08 to 1.72) for 
future incidence of stroke (Kleindorfer et al., 2011).  
Very few population-based studies have been done on CVD prevalence in HA (≥2500 m) 
areas worldwide and in LA areas in Nepal in particular with which to compare data in the 
present study. We could not measure pulmonary artery pressure either directly or indirectly 
(e.g., by echocardiography) or hematocrit level, which could also explain the findings 
about the prevalence of CHD and stroke. All ECG reports were examined by one 
cardiologist, which may introduce bias, although interpretation was standard. Study 
participants were exposed to in-door air pollution to some extent, for example by using 
solid biomass fuels for cooking or heating purpose. Although improved cook-stoves 
(which significantly minimize in-door air pollution) is common in the study areas, they still 
use wood or coal inside the house for heating purpose. We could not assess the impact of 
in-door air pollution on CVD. In-door air pollution may increase the risk of pulmonary HT, 
right heart failure (Bloomfield et al., 2012) and can trigger CVD related mortality and non-
fatal events (Brook et al., 2010). Stroke-like symptoms may arise from other conditions, 
for example migraine, seizure, cataract, and further examinations to rule out any other 
possibilities were not possible. In addition, the QVSFS has been reported to have high 
sensitivity but a moderate level of specificity (Jones et al., 2001). One possible 
confounding factor of 'healthy individual effect' as discussed in the general limitations 
section above (6.1) may be underestimating the reported prevalence of CHD and history 
and symptoms of stroke.  
6.2.7 Areas for future research 
The findings of the present study indicate a relatively higher risk of stroke at HA but CHD 
prevalence appears comparable to that in LA areas. A greater risk of stroke and related 
morbidities at HA is reported in several studies, particularly in Tibetan-related populations 
(G. Xu et al., 2013; H.-T. Zhang et al., 2015). However, such evidence for HA residents of 
other ethnicities is sparse, for example in the Andeans of South America, Amharics of 
Ethiopia, and Khas-Aryas of Nepal. Although the majority of past published work has 
findings consistent with a protective effect on CHD from permanent living at HA, there are 
few studies on comparable populations living at HA and LA. More research on the 
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relationship between HA, ethnicity and CVD may clarify relationships and potential for 
interventions. 
6.3 Blood pressure 
Main results in context 
The present study found a moderate association between SBP and altitude. Although point 
estimate for the association between diastolic blood pressure (DBP) with increasing 
altitude levels was consistent with a positive association, confidence interval for the 
estimate of association was wide. This study did not identify any association between HT 
(or use of anti-hypertensive medication) and ethnicity; however, those with Tibetan 
ancestry had a higher prevalence than Khas-Aryas. In multivariate models older age, 
increased body weight, and increased self-reported alcohol intake amount were associated 
with increased SBP and DBP. This study found an unexpected and inverse association 
between self-reported salt intake and SBP after adjusting for potential confounding 
variables.  
A systematic review and meta-analysis developed from this thesis (Chapter 3, section 3.1) 
and published in a peer-reviewed journal reported a weak association between SBP, DBP 
and altitude in populations of Tibetan origin but in non-Tibetan populations both SBP and 
DBP tended to decrease with residence at higher altitude, although there were wide 
confidence intervals (N. Aryal, Weatherall, Bhatta, & Mann, 2016). Another systematic 
review including studies conducted in Tibet reported a 2% increment in the prevalence of 
HT for every 100 m increment in altitude (Mingji et al., 2015). These findings are 
consistent with findings in the present study where, although participants were from both 
Tibetan and Khas-Arya ethnicities, the geographical location of the study districts border 
on the Tibetan side of China and Khas-Aryas have consequently acquired Tibetan lifestyle 
practices, mainly drinking tea made with salty butter and high amounts of alcohol. This 
may well contribute to the association between SBP and altitude regardless of ethnicity. 
Nonetheless, the association between altitude and BP was found even after controlling for 
alcohol and salt intake, which may indicate that the HA environment itself is an additional 
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independent factor in determining the high prevalence of HT although there may also be an 
underlying genetic risk (Gesang et al., 2002; Kumar et al., 2003). 
Although the present study's finding of multivariate adjusted associations between BP and 
age, alcohol intake, and body weight is consistent with past research the inverse 
relationship between self-reported daily salt consumption and SBP is not (Elliott et al., 
1996; Rose et al., 1988). High consumption of salt as a traditional dietary habit has been 
identified as one of the key factors for high BP in HA Tibetan populations (Sehgal et al., 
1968; Sun, 1986). In addition, a randomized controlled trial of a low-sodium/high-
potassium salt substitute showed a dramatic decline in BP among Tibetan HA populations 
(X. Zhao et al., 2014). The method used in the present study of self-report to calculate salt 
consumption may not have been an accurate reflection of actual salt consumption. 
Participants were asked about the mean amount of salt consumed by their family in a 
month, which was then divided by the number of family members sharing the kitchen for 
the main meal to estimate individual salt intake. This could have systematically led to 
underestimation of salt intake in those with the highest salt intake. 
The prevalence of HT (or those on anti-hypertensive medication) in participants in the 
present study is higher than in other studies carried out in HA populations in Nepal using a 
similar definition (Koju et al., 2015; S. Shrestha et al., 2012; Smith, 1999). Two possible 
explanations for this difference are the different ages of the study samples and a cohort 
effect. The minimum age to participate in the present study was 30 years, whereas other 
studies usually included participants from the age of 18 years or over. HT may be 
increasing in prevalence with the passage of time for reasons other than ethnicity or 
altitude. However, in the present study, the prevalence of HT (or those on anti-
hypertensive medication) in the Mustang district (Tibetans), is close to that reported in HA 
studies carried out on Tibetans living in Tibet or in India (Tripathy & Gupta, 2007; X. 
Zhao et al., 2012; X. Zheng et al., 2012). In the present study the prevalence of HT (or 
being on anti-hypertensive medication) in Mustang was higher than the national prevalence 
for the population aged 30 years or over (36.8%) (K. K. Aryal et al., 2014), but was lower 
in the Humla district with its dominant Khas-Arya population. 
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In the present study the prevalence of raised BP was high, but actual diagnosis and 
treatment of HT was very poor. Nearly two-thirds of participants who had raised BP were 
diagnosed with HT for the first time during the study. This highlights a huge unmet need 
for HT identification and management in these study areas. Only 3.3% of the study 
participants were on anti-hypertensive medication. This is substantially fewer compared to 
other HA settings where the prevalence of treatment is reported to be between 24.3% (X. 
Zheng et al., 2012) and 59.1% (Sherpa et al., 2013) in other parts of Tibet. A combination 
of factors such as lack of education and awareness and poor access to health care services 
in HA settings may contribute to this situation of undiagnosed and untreated HT. 
6.3.1 New findings 
This is the first study to report the relationship between BP and altitude at four different 
altitude levels above or equal to 2500 m. The present study also found that the non-Tibetan 
HA population of study areas has acquired Tibetan lifestyle habits (mainly high 
consumption of salty butter tea and alcohol), which may increase the risk of HT in the 
future. 
6.3.2 Strengths and weaknesses 
The main strength of the present study for the relationship between BP and HA is that 
information was collected at different altitude levels and from ethnically diverse samples. 
In an attempt to minimise BP measurement bias, recordings were carried out three times 
for each participant, a minimum of 10 minutes apart and the mean was used as the final 
reported BP. Also, if readings differed by more than 10 units, a fourth reading was taken 
and the lowest three readings were considered as the final mean. An electronic aneroid 
sphygmomanometer (Omron HEM-7221) well validated to operate at HA was used.  
Weaknesses include that possible factors associated with BP were measured by self-report 
for alcohol intake, smoking status, salt intake, and current treatment for HT. Under-
reporting of alcohol use in population surveys is very common because of such factors as 
social-desirability bias (Davis, Thake, & Vilhena, 2010) and recall bias (Stockwell et al., 
2004). Similarly, there is good evidence that dietary salt intake by self-report is under-
estimated compared to when using more objective measures (De Keyzer et al., 2015). Also, 
158 
 
in the present study information on the amount of salt consumed during home cooking was 
requested and other sources such as salt included in processed foods was not taken into 
account. Although home cooking contributes to around two-thirds of total dietary salt in 
Asian settings (C. A. Anderson et al., 2010), the given estimates could be still under-
reported. As mentioned above (6.2.6), study participants were likely to get exposed with 
in-door pollution and there is increasing evidence that chronic exposure to in-door air 
pollution is associated with higher BP (M.-S. Lee et al., 2012; Painschab et al., 2013). The 
present study could not examine this relationship. 
6.3.3 Areas for future research 
There is very limited research about BP among the non-Tibetan HA populations in Nepal. 
More data and analysis of these populations will help to better understand the HA and BP 
relationship. Comparisons of HA populations with homogeneous counterparts who later 
migrated to LA may also provide important insights into this relationship. The established 
association between salt intake and BP in general and known evidence of high intake of 
salt by some HA populations warrants further investigation. In HA settings of Nepal, no 
studies have collected information on salt intake by measuring urinary sodium excretion 
levels, which would yield the most definitive data. Recent findings suggest that a single 
fasting urine test with some correction (using the Kawasaki formula) is a valid method of 
measuring sodium excretion at a population level (Han et al., 2015). This could be a simple 
and reliable method to adopt in HA settings. Also, low-sodium/high-potassium salt 
substitute intervention, which was proved to be effective in reducing BP in other HA 
settings (X. Zhao et al., 2014), could also be tested in HA populations of Nepal. Finally, 
more exploration is required into the reasons behind the extremely high proportion of 




6.4 Other cardiovascular disease risk factors 
This section discusses the results of three key Framingham risk factors for CVD: lipid 
profile, diabetes, and tobacco use; and risk prediction for major cardiovascular events. Of 
other Framingham risk factors, BP has been discussed above and age has been discussed 
throughout the chapter.  
6.4.1 Lipid Profile 
Main results in context 
In the present study, the prevalence of high TC and low HDL are lower, but the prevalence 
of raised triglyceride (TG) is higher when compared with the national prevalence in Nepal 
for the population aged greater than or equal to 30 years (K. K. Aryal et al., 2014). There 
were no consistent trends in lipid components in relation to altitude and ethnicity. In other 
studies of lipids in HA settings, TC and TG are usually lower than the present study, and 
HDL higher.  
In particular, other HA studies report markedly higher prevalence of high TC (≥200 mg/dL 
or ≥5.2 mmol/L) compared to the present study (Málaga et al., 2010; Mohanna et al., 2006; 
Sherpa et al., 2011). Only one study in Nepal reported TC in a HA setting and identified a 
prevalence of high TC of 14.1% in study participants aged 15 years or older living in 
mountainous areas (K. K. Aryal et al., 2015). This is consistent with the present study's 
overall prevalence of elevated TC of 17.3%. The expectation was that the prevalence of TC 
would be high in those with Tibetan ancestry because of traditional diets with large 
amounts of oil, butter and meat products (Stevens, 1996). There is strong evidence that 
plasma TC level is highly genetically dependent and heritability is estimated to be around 
40% to 60% (Y. Lu et al., 2010). This may partly explain the reason for the relatively low 
prevalence of a high TC in the present study compared to other most HA studies. 
The present study's high TC prevalence is slightly lower compared to the studies carried 
out in LA areas of other South Asian countries using similar definitions (Guptha et al., 
2014; Kinra et al., 2010). This may be because of the hypoxia and cold temperature-
induced increments in plasma catecholamines (Moncloa, Gómez, & Hurtado, 1965) and 
subsequent metabolic effects on lipolysis (Okuda, Yanagi, & Fujii, 1966). The present 
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study also identified a higher prevalence of a high TG level compared with other LA 
populations. This is likely to be related to high consumption of alcohol and carbohydrates 
(Klop et al., 2013; Parks, 2001). In addition, alteration in hepatic lipid oxidation in hypoxia 
induced by HA may also increase TG levels (Muratsubaki et al., 2003). 
In the present study more than half of the men and two-thirds of women had low HDL. 
This finding, despite being higher than the results from other HA settings (Baracco et al., 
2007; Mohanna et al., 2006; Sherpa et al., 2011; Sherpa et al., 2013), is lower than the 
national prevalence in Nepal for the population aged 30 years or over (K. K. Aryal et al., 
2014) and closer to the studies conducted in LA areas of South Asia (N. Aryal & Wasti). 
Nearly half of the participants in the present study were current drinkers of alcohol and 
studies report a positive association between alcohol intake and HDL (Sung, Kim, & 
Reaven, 2007; Wakabayashi & Araki, 2010). The apparently low HDL in the present study 
compared to that in Nepal may be confounded by alcohol intake. There is also strong 
evidence of low HDL in South Asians (Karthikeyan et al., 2009; L. Zhang et al., 2010). 
Factors such as a low level of physical activity, low consumption of fruit and vegetables, 
other dietary habits (Joshi et al., 2007), and genetic predisposition (Dodani, Dong, Zhu, & 
George, 2008) are possible contributory factors to the high prevalence of low HDL in 
South Asian populations.  
Although most of the South American HA studies report a slightly higher prevalence of 
high TG and lower prevalence of low HDL compared to the present study (Baracco et al., 
2007; Gonzales & Tapia, 2013; Málaga et al., 2010; Mohanna et al., 2006), Tibetan studies 
show a markedly lower prevalence of high TG and low HDL (Sherpa et al., 2011; Sherpa 
et al., 2013). The known ethnic differences in lipid components (Anand et al., 2000; 
Chandalia, Mohan, Adams-Huet, Deepa, & Abate, 2008) may be the reason for the 
differences seen in different HA populations. 
Urban dwellers (2800 m and 3620 m) have higher levels of TC and TG compared to rural 
dwellers (2890 m and 3270 m) even in similar ethnic populations. This suggests lifestyle 
practices are more important in determining lipid component levels than altitude and 
ethnicity. Previous studies in Tibet also indicate desirable patterns of plasma lipid 
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components in rural residents (Sherpa et al., 2013) compared to the urban population 
(Sherpa et al., 2011). 
6.4.1.1 New findings 
This is the first study to report the prevalence of abnormal lipid components of Nepalese 
people living at different levels of HA. Just one previous study reported TC levels in 
mountainous regions but without specifying particular altitudes (K. K. Aryal et al., 2015). 
The present study found a low prevalence of high TC at HA compared to other reports both 
at HA and in South Asian LA populations. 
6.4.1.2 Strengths and weaknesses 
The main strength of this study with respect to lipid profile measurement was the use of a 
robust measurement system at HA. Quality control testing, as per the manufacturing 
company’s instructions, was carried out. An instrument failure at 2890 m reduced the 
sample size and precision of mean measurements in this group. This survey used non-
fasting blood samples for determination of a lipid profile. Fasting is not routinely 
recommended for lipid profile test. However, evidence shows a minor increase in TG 
levels after habitual meal, although clinically not significant (Nordestgaard et al., 2016). 
The present study might have over-reported TG levels in some participants with lipid 
profile measurements after meal. 
6.4.1.3 Areas for future research 
A low prevalence of raised TC levels in the present study compared to other HA areas 
warrants further research in other HA populations in Nepal. More data are needed from 
diverse ethnic groups. The major HA populations of Nepal are of Tibetan ancestry with 
traditional dietary habits of consuming high amounts of oil, butter, cheese, and meat 
products and these may raise TC levels. Detail information on use of these dietary 
components may help to assess this relationship. This study has also corroborated previous 
reports of high TG levels in HA population. Further research could focus on effective 
intervention to reduce TG levels and concomitant metabolic risk in HA populations.  
Little research has been published on the specific impact of HA on lipid components. For 
example, an association has been reported between vitamin D levels and favourable lipid 
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profiles (Challoumas, 2014). HA populations have a high level of vitamin D because of 
high ultraviolet B (UVB) light exposure (J. D. Anderson & Honigman, 2011). Some 
studies also report a positive association between hemoglobin and lipid components at HA 
(Gonzales & Tapia, 2013) and LA (Kawamoto et al., 2011). Since some HA populations, 
particularly those with a short ancestral history of living at HA, have high hemoglobin 
levels, this relationship may be worth assessing further to explore whether hemoglobin 





Main results in context 
There was no consistent pattern of blood glucose levels or prevalence of diabetes in 
relation to altitude and ethnicity in the present study. However, the prevalence of diabetes 
was higher in urban areas (2800 m and 3620 m) than in rural areas (2890 m and 3270 m). 
The prevalence of pre-diabetes was high in rural areas. Diabetes was more likely in men 
than in women but this difference was not statistically significant at any altitude level. 
In the present study the prevalence of diabetes was 3.3% (3270 m) and 3.5% (2890 m) in 
rural settings, and 10.6% (2800 m) and 13.6% (3620 m) in urban settings. This is higher 
than past estimates for the Nepalese population, particularly those in rural areas (Gyawali 
et al., 2015; International Diabetes Federation, 2015), and also higher than that reported in 
mountainous regions of Nepal (K. K. Aryal et al., 2015). Although differences in 
definitions and the inclusion of only participants aged 30 years or over may partly explain 
the difference when compared with other estimates, the increasing risk of diabetes in HA 
populations in the present study was unsurprisingly accompanied by a higher rate of pre-
diabetes. The prevalence of pre-diabetes was higher than the national estimate of 10.3% 
(Gyawali et al., 2015) at all altitude levels in the present study, particularly so in rural 
settings (2890 m and 3270 m) where at least one-third of the participants were pre-
diabetics.  
There may be both physiological and environmental reasons for the high prevalence of 
diabetes and pre-diabetes in rural populations in the present study compared to the national 
estimates for rural populations in Nepal. While moderate drinking has been found to have 
protective effects on blood glucose levels, evidence is strong on the relationship between 
heavy drinking and the risk of diabetes (Baliunas et al., 2009; A. A. Howard, Arnsten, & 
Gourevitch, 2004). A significant proportion of rural dwellers in the present study were 
hazardous drinkers (men drinking ≥21 standard drinking unit (SDU) and women drinking 
≥14 SDU of alcohol per week); for example, 56.4% participants at 3270 m were hazardous 
drinkers. This may account for the very high prevalence of pre-diabetes in rural dwellers in 
the present study. 
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The present study's findings on diabetes prevalence in urban HA areas (2800 m and 3620 
m) is higher than the reports from other urban HA settings (W. Chen et al., 2011; López de 
Guimaraes, Chiriboga García, Gonzáles Crisóstomo, & Vega Mejía, 2007; Okumiya et al., 
2016; Schargrodsky et al., 2008). However, there is significant variability in the prevalence 
of diabetes in other rural HA settings (Málaga et al., 2010; Negi et al., 2012; Ojeda et al., 
2014; Okumiya et al., 2016). The higher prevalence of diabetes in the urban HA areas in 
the present study compared to other HA settings may be due to high economic status and 
obesity. Urban areas studied are popular tourist destinations, for both religious and 
adventure travelling, and local people are mostly self-employed, mainly in shops and 
hospitality-related jobs. Thakali is the particular dominant Tibetan-related ethnic group in 
these areas and this group has the highest human development index (HDI) in Nepal 
(Government of Nepal & United Nations Development Programme, 2014). A positive 
association between income level and risk of diabetes is well established in the South 
Asian setting (Deepa, Anjana, Manjula, Narayan, & Mohan, 2011). In the present study 
urban participants had a considerably higher prevalence of overweight or obesity, 56.6% at 
2800 m and 47.7% at 3620 m. Obesity is the most significant risk associated with type 2 
diabetes (Field et al., 2001), which is mediated by insulin resistance (Boden & Chen, 
1995). One study in Eastern Nepal reported higher BMI, urban residency, and high socio-
economic status as the risk factors for diabetes (Mehta et al., 2011), which seems to apply 
in the present study as well. 
The finding of a higher prevalence of diabetes in men compared to women is similar to 
most studies carried out in other HA settings (W. Chen et al., 2011; Gonzales & Tapia, 
2013; S. Xu et al., 2015). This trend is observed worldwide as well. According to a recent 
estimate, in 2014, the prevalence of diabetes in men was 9% compared to 7.9% in women 
(NCD Risk Factor Collaboration, 2016). Although the prominent risk factor of obesity is 
more prevalent in women than in men globally, differences in biology, culture, nutritional 
uptake, lifestyle habits and environmental factors are likely to contribute to the higher risk 
of diabetes in men (Kautzky-Willer, Harreiter, & Pacini, 2016). 
In the present study 44% of diabetics were newly diagnosed, which is close to the global 
rate of 46.5% for undiagnosed diabetes in adults (International Diabetes Federation, 2015). 
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However, this prevalence of undiagnosed diabetes is far lower than the International 
Diabetes Federation (IDF) estimates of 62.1% in both urban and rural areas of Nepal 
(International Diabetes Federation, 2015). This may be partly due to the easily available 
self-monitoring blood glucose testing devices and purchasing capacity of study 
participants, particularly those located in urban areas. 
6.4.2.1 New findings 
This is the first study in Nepal to report the prevalence of diabetes in HA areas of Nepal at 
specified levels of altitude. One previous study reported on diabetes prevalence in 
mountainous regions without mentioning the altitude levels (K. K. Aryal et al., 2015) and it 
is likely that it included study areas located at less than 2500 m. 
Although the existing literature from HA populations has usually reported a lower 
prevalence of diabetes compared to the general population, this study is one of the very 
few which has found a higher prevalence in HA urban populations.  
6.4.2.2 Strengths and weaknesses 
The present study measured HbA1c levels using technology that is validated to perform 
well at HA. Quality control guidelines were strictly followed to ensure accuracy. Lipid 
profiles and HbA1c were measured using the same instrument and as mentioned in the 
lipid profile section, the machine had technical problems at 2890 m, which may minimize 
the precision of estimates for this group because of the reduced sample size. 
6.4.2.3 Areas for future research 
More evidence on the risk of diabetes and its risk factors among different ethnic HA 
populations in Nepal and at different levels of altitude may lead to appropriate health 
interventions. Particularly, future research should prioritize the role of alcohol and other 
lifestyle habits play in diabetes risk in Nepalese HA populations. This is equally important 
in HA residents of other countries. Recently some evidence has emerged of a strong 
association between polycythemia and glucose intolerance (Okumiya et al., 2016). Some 
HA populations, particularly those who are ancestrally less adapted to HA environments, 
tend to have high levels of erythrocytes or hemoglobin (Beall, 2007). The present study did 
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not measure these and exploring these relationships may contribute to the current small 
amount of evidence on hemoglobin-blood glucose association in HA populations. 
6.4.3 Tobacco use 
The present study found that the patterns of tobacco use varied with ethnicity rather than 
with altitude and residential settings (urban or rural). Compared with the national 
prevalence, the Mustang district with predominantly Tibetan populations (2800 m, 3270 m, 
and 3620 m) had a significantly lower prevalence of current smokers. The prevalence was 
higher in the Humla district (2890 m) where the majority were of Khas-Arya ethnicity. 
This pattern was reversed for current smokeless tobacco users. Men were more likely to be 
both smokers and smokeless tobacco users. 
In the present study, between 3.3% and 10.3% of the participants self-reported being 
current smokers in three different altitudes of Tibetan-dominant Mustang but this rate was 
markedly higher (38.6%) in Khas-Aryas who dominated in the Humla district. A low 
prevalence of current smokers among Tibetan-related populations in the present study 
compared to nationally (K. K. Aryal et al., 2014) and South East Asia region (World 
Health Organization, 2014b) may be attributed to the influence of cultural norms and 
practices. Unlike alcohol use, the preference for smoking is lower in traditional Tibetan 
culture. This tendency has also been observed among residents of the Appalachian 
Mountains in the US (Meyer et al., 2008). Other studies carried out in Tibetan (Sherpa et 
al., 2013; Sherpa et al., 2010) and Andean HA populations (Gonzales & Tapia, 2013; 
Jaillard et al., 1995) also report a low prevalence of smoking.  
There was a much higher rate of current smoking among dominant Khas-Arya populations 
in Humla in both genders than nationally (K. K. Aryal et al., 2014) and regionally (World 
Health Organization, 2014b). In this population at 2890 m, 49.5% men and 31.1% women 
self-reported current smoking with the vast majority being daily smokers. The main reason 
for this high prevalence may be the familial and societal acceptance of tobacco smoking as 
most of them recalled being inspired to smoke by senior family members or peers. In 
addition, locally made and cheaply available bidis (unprocessed tobacco wrapped in 
leaves) are also popular in villages. A high rate of smoking has been reported in a few 
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other South Asian HA populations as well (Shah, Arif, et al., 2001). Lack of tobacco 
control initiatives and poor awareness levels of smoking related risks could also be reasons 
for higher rates of tobacco smoking in the Nepalese rural population. One recent study 
among women in a LA rural area of Nepal reported a 43.6% prevalence of being a current 
smoker (Khatri et al., 2015). 
Cultural influences on tobacco use are reflected in the prevalence of the use of smokeless 
tobacco as well. While smoked tobacco is not preferred behaviour in Tibetan culture, use 
of smokeless tobacco is very common. Nose-snuffing of ground tobacco leaves is the most 
popular form of smokeless tobacco use in traditional Tibetan practice. Other common 
forms of smokeless tobacco are commercially or non-commercially manufactured chewing 
tobacco. In the present study, between 25% and 31.1% of participants from the Tibetan-
dominant Mustang district self-reported being current smokeless tobacco users, whereas 
the rate was just 10.9% for Khas-Aryas who dominate in the Humla district. The 
prevalence of current users of smokeless tobacco in Mustang (Tibetans) was slightly higher 
than the national prevalence of 23.2% (men 39.1% and women 7.7%) for the age group 30 
years or over (K. K. Aryal et al., 2014).  
The present study found a high prevalence of current smoking or use of smokeless tobacco 
in men compared to women. Globally, smoking prevalence is at least five times higher in 
men (37%) than in women (7%) (World Health Organization, 2014b). However, in the 
present study this difference was much wider in the Tibetan-related populations of 
Mustang but smaller in Khas-Aryas in Humla. It is rare to find tobacco smoking among 
Tibetan women. However, Tibetan men, being more exposed to the outer world, show a 
greater tendency to smoke. Among Tibetan-related populations in the present study, none 
of the women at 3270 m and 3620 m self-reported current smoking and the rate was 2.3% 
at 2800 m. About one-third of female participants in Humla were current smokers. A very 
low prevalence of smoking in Tibetan women, as in the present study, has been reported in 
several other HA studies (Sherpa et al., 2013; X. Zhao et al., 2012). 
6.4.3.1 New findings 
This study reports that half of the men and one-third of the women in the Humla 
population at 2890 m were current smokers. This is the highest documented prevalence of 
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current smokers in HA populations. This study also found that tobacco use did not 
correlate with levels of HA. 
6.4.3.2 Strengths and weaknesses 
The main strength of this study regarding tobacco use is that other related information was 
collected from those who self-reported being a current smoker or used smokeless tobacco. 
For example, for current smokers, data was gathered on the age of starting smoking, years 
of smoking, number of cigarettes smoked per day, and any previous attempts to stop 
smoking. This helped to confirm self-reported smoking behaviour. However, it was 
difficult to confirm whether the past smokers and past smokeless tobacco users really had 
stopped using tobacco or whether use had recurred. This is important to note because a 
number of participants self-reported having recently quit using tobacco. A growing bias 
against the social desirability of smoking may have led to underestimates of current 
tobacco use. The prevalence of nose-snuffing of ground tobacco leaves in Tibetan-related 
participants should be interpreted cautiously because only a few participants reported using 
it daily. Most reported using it while suffering from the common cold or during social 
gatherings.  
6.4.3.3 Areas for future research 
The present study shows that while Tibetan-related HA populations have a cultural bias 
against smoking tobacco, other HA residents may have exceptionally high rates. More 
information is required on tobacco use of HA populations in Nepal, particularly in Khas-
Aryas. There is no reliable information on determinants or triggers of tobacco use in 
Nepal’s HA populations. It is important to examine this because HA populations are 
different from LA residents in many ways; for example, environmental and working 
conditions are different. The government of Nepal introduced a stringent Tobacco Control 
Act in 2011 but there is no evidence on how effective it is in remote HA settings. Future 
research on its impact in HA areas and barriers to successful enforcement may significantly 




6.4.4 Risk prediction for major cardiovascular events 
In the present study, 3.9% of the participants were estimated to have a high risk 
(probability equal to or greater than 20%) of fatal or non-fatal cardiovascular events (MI or 
stroke) within the next 10 years according to the World Health Organization (WHO) and 
International Society of Hypertension (ISH) risk prediction chart for South-East Asia sub-
region D. The reported prevalence of CHD in the present study is in line with this. This is 
also similar to the report from the WHO-led study in a LA area of Nepal using the same 
risk prediction chart, which estimated the probability of high risk of future major 




6.5 Overall conclusion 
The sample of HA residents in the present study had a similar prevalence of CHD and 
future risk of major CVD events but a higher prevalence of a history of stroke, compared to 
the LA populations. Men were more likely than women to have a raised risk of abnormal 
ECG and lipid components, HT, diabetes, and being a smoker. The only exception was the 
prevalence of low HDL, which was higher in women. 
Cardiovascular risk profiles of HA populations may depend on altitude, ethnicity, cultural 
lifestyle practices, and residential setting (urban or rural). Altitude per se could be an 
important additional risk factor because of the relationship between HA levels and higher 
SBP, and increased prevalence of an abnormal (or borderline abnormal) ECG. Differences 
in ECG abnormality patterns in Tibetan and Khas-Arya populations may reflect different 
ancestry-related physiological responses to the low oxygen environment and the varying 
patterns of CVD-related risk in HA populations. Other important findings are: HT 
particularly in Tibetan-related populations, high current smoking rates in Khas-Aryas, and 
a high prevalence of pre-diabetes in all study samples. This indicates that ethnicity 
associated lifestyle practices are likely to be an important determinant of CVD health for 
HA residents and that HA populations are passing through a phase of epidemiological 
transition from lower to higher risk for CVD.  
To conclude, despite having a similar risk of CHD as the LA populations, some CVD risk 
factors (particularly HT) and consequent risk of stroke may be higher in specific HA 
populations. The main factors that should be considered for assessment and management of 
cardiovascular risk in HA populations are altitude, ethnicity and associated cultural 
lifestyle practices (such as salt and alcohol intake, smoking habit), and residential settings 
(mainly differences in physical activity and fruit and vegetable consumption between urban 
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Appendix A: Modified WHO NCD STEPS Questionnaire 
WHO STEPS Instrument 









The WHO STEPwise approach to 






WHO STEPS Instrument 
 
 
for Noncommunicable Disease  
Risk Factor Surveillance 
 




Location and Date Response Code 





















Step 1   Demographic Information 
 
 
EXPANDED: Demographic Information 





[INSERT COUNTRY-SPECIFIC CATEGORIES] 
No formal schooling 1 
 
C5 
Less than primary  school 2 
Primary school completed 3 
Secondary school completed 4 
High school completed 5 
College/University completed 6 
Post graduate degree 7 
What is your [insert relevant ethnic group / racial group / 
cultural subgroup / others] background? 
Thakali 1    
Tibetan Gurung 2 
Dalit 3 




    
CORE: Demographic Information 
Question Response Code 




What is your date of birth?     
 
Don't Know 77 77 7777 
 
└─┴─┘ └─┴─┘ └─┴─┴─┴─┘ If known, Go to C4 
     dd              mm                year 
C2 




In total, how many years have you spent at school and in full-
















Which of the following best describes your main work 
status over the past 12 months? 
 
 




Government employee 1 
C8 






Unemployed (able to work) 8 
Unemployed (unable to work) 9 
Refused 88 
How many people older than 15 years, including yourself, 
live in your household? 





EXPANDED: Demographic Information, Continued 
Question Response Code 
If you don’t know the amount, can you give an estimate of 
the annual household income if I read some options to 
you? Is it  
[INSERT QUINTILE VALUES IN LOCAL CURRENCY] 
 
(READ OPTIONS)   
 
>1,00,000 NRS 1 
C10 
1,00,000 to  2,00,000 NRS 2 
2,00,000 to 4,00,000 NRS  3 










CORE:  Tobacco Use 
Now I am going to ask you some questions about tobacco use. 
Question Response Code 
Do you currently smoke any tobacco products, 




No 2      If No,  go to T8 




How old were you when you first started 
smoking? 
Age (years) 
└─┴─┘ If Known, go to T5a/T5aw 
T3 
Don’t know  77 
Do you remember how long ago it was? 
 
(RECORD ONLY 1, NOT ALL 3) 
 
Don’t know 77 
In Years 




OR       in Months 
└─┴─┘ If Known, go to T5a/T5aw 
T4b 
 
OR        in Weeks └─┴─┘ 
T4c 
On average, how many of the following products 
do you smoke each day/week? 
 







Question Response Code 
Where were you borned ? Mustang OR Humla 1 C11 
Elsewhere  2 
For how long haveyou  been living in Mustang OR 
Humla ? 
               For the life time 1  
>10 years 2 
5 to 10 years 3 
>5 years 4  
C12 
Step 1    Behavioural Measurements 
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(IF LESS THAN DAILY, RECORD WEEKLY) 
 
(RECORD FOR EACH TYPE, USE SHOWCARD) 
 










┘                                                          







During the past 12 months, have you tried to stop 
smoking?  
Yes 1  T6 
No 2       
During any visit to a doctor or other health worker 
in the past 12 months, were you advised to quit 
smoking tobacco? 
Yes 1     If T2=Yes, go to T12; if T2=No, go 
to T9 T7 No 2     If T2=Yes, go to T12; if T2=No, go 
to T9 No visit during the past 12 
months 
 
3    If T2=Yes, go to T12; if T2=No, go 
to T9    
             In the past, did you ever smoke any tobacco 
products?  (USE SHOWCARD) 
Yes 1 
T8 
No 2      If No,  go to T12 
In the past, did you ever smoke daily? Yes 1  If T1=Yes, go to T12, else go to T10 T9 
No 2  If T1=Yes, go to T12, else go 
to T10 
 
EXPANDED: Tobacco Use 
Question Response Code 
How old were you when you stopped smoking? 
Age (years) 
└─┴─┘ If Known, go to T12 
T10 
Don’t Know  77 
How long ago did you stop smoking? 
 
(RECORD ONLY 1, NOT ALL 3) 
 
Don’t Know  77 
Years ago 
└─┴─┘ If Known, go to T12 
T11a 
OR       Months ago 
└─┴─┘ If Known, go to T12 
T11b 
OR        Weeks ago 
└─┴─┘ 
T11c 
Do you currently use any smokeless tobacco 
products such as [snuff, chewing tobacco, betel]? 
(USE SHOWCARD) 
Yes 1 




Do you currently use smokeless tobacco products 
daily?  
    Yes 1  
T13 
No 2       If No, go to T14aw      
How frequently do you use snuff by nose ? 
1 = Daily, 
2= 1-2 times a week 
3=3-4 times a week, 
4= Once a week 
5= Rarely 
T14a 
Do you chew tobacco products daily ? Yes  = 1, No= 2 T14c 
In the past, did you ever use smokeless tobacco 
products such as [snuff, chewing tobacco, or betel]? 
   Yes 1   
T15 
No 2     If No, go to T17 
In the past, did you ever use smokeless tobacco 
products such as [snuff, chewing tobacco, or betel] 
daily? 
Yes 1   
T16 
No 2 
During the past 30 days, did someone smoke in 
your home? 
Yes 1   
T17 
No 2 
During the past 30 days, did someone smoke in 
closed areas in your workplace (in the building, in a 
work area or a specific office)? 
Yes 1   
T18 No 2 
Don't work in a closed area 3 
Total  home and work smoking exposure days in a  
week 
  T19 
 
CORE:  Alcohol Consumption 
The next questions ask about the consumption of alcohol. 
Question Response Code 
Have you ever consumed any alcohol such as beer, 
wine, spirits or [add other local examples]? 
(USE SHOWCARD OR SHOW EXAMPLES) 
Yes 1 
A1a 
No 2    If No, go to A16 
Have you consumed any alcohol within the past 12 
months? 
Yes 1    If Yes, go to A4 
A1b 
No 2  If No, go to A16 
During the past 12 months, how frequently have you 




5-6 days per week 2 
3-4 days per week 3 
1-2 days per week 4 
1-3 days per month 5 
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(READ RESPONSES, USE SHOWCARD) Less than once a month 6 
Have you consumed any alcohol within the past 30 
days? 
Yes 1 A3 
No 2    If No, go to D1 
During the past 30 days, on how many occasions did 
you have at least one standard alcoholic drink? 
Number  
Don't know 77 └─┴─┘ 
A4 
During the past 30 days, when you drank alcohol, how 
many standard drinks on average did you have during 
one drinking occasion? 
(USE SHOWCARD) 
Number  
Don't know 77 
└─┴─┘ 
A5 
No. of standard drinks consumed in a month 




During the past 30 days, what was the largest number of 
standard drinks you had on a single occasion, counting 
all types of alcoholic drinks together? 
Largest number 
Don't Know 77 
└─┴─┘ 
A7 
During the past 30 days, how many times did you have  
four or more standard drinks in a single drinking 
occasion? 
Number of times 





The next questions ask about the fruits and vegetables that you usually eat. I have a nutrition card here that shows you some 
examples of local fruits and vegetables. Each picture represents the size of a serving. As you answer these questions please 
think of a typical week in the last year. 
Question Response Code 
In a typical week, on how many days do you eat fruit? 
(USE SHOWCARD) 
Number of days 
Don't Know 77 
└─┴─┘     If Zero days, go to  
D3 
D1 
How many servings of fruit do you eat on one of those 
days?  (USE SHOWCARD)  
Number of servings 
Don't Know 77 └─┴─┘ 
D2 
In a typical week, on how many days do you eat 
vegetables? (USE SHOWCARD) 
Number of days 
Don't Know 77 └─┴─┘     If Zero days, go to  
D5 
D3 
How many servings of vegetables do you eat on one of 
those days?  (USE SHOWCARD) 
Number of servings  
Don’t know 77 
└─┴─┘ 
D4 
Mean consumption of fruits and veg per day   D5 
Average fruits and vegetables servings per day  
≥5 servings per day 1 
<5 servings per day 2 
 






What type of oil or fat is most often used for meal 
preparation in your household?  
 
(USE SHOWCARD) 




Vegetable  oil 1  (Soybean or & Sunflower) 
Mustard 2 
Ghee 3 
 Veg or mustard oil 4      If Other, go to D5 other 
None in particular 5 
Other 6 





On average, how much oil does your family consume per 
month (in litre) ? 
Litre  
Don’t know 77 
└─┴─┘ 
D8 
Individual consumption of oil per month by a family 







Salt Questionnaire  
Question Response Code 
How often do you add salt during dining ? a. Mostly  1 
b. Occasionally (if salt level seems 
low)   2 
c. Rarely  3 
d. Never  4 
DS1 
How frequently do you eat  processed food (like noodles, crisps, fast 
foods) which usually contains high amount of salt ? 
a. Mostly  1 
b. Occasionally  2 
c. Never  3 
DS2 
In your opinion, how much amount of salt do you usually prefer ? a. Very high  1 
b. High  2 
c. Medium  3 
d. Low  4 
e. Very low 5 
DS3 
Do you think consuming high amount of salt would affect your health ? a. Yes  1 
b. No    2 
 
DS4 
What type of salt do you mostly use at your home ? a. Crystal salt  1 
c. Iodized packet salt  2 
d. Tibetan salt  3 
e. Other 4 
DS5 
How much amount of salt does your family usually consume ? (kg/month)  DS6 
Individual consumption of salt in your family member (gram/day) (DS6/no. 




 CORE:  Physical Activity 
Next I am going to ask you about the time you spend doing different types of physical activity in a typical week. Please 
answer these questions even if you do not consider yourself to be a physically active person.  
Think first about the time you spend doing work.  Think of work as the things that you have to do such as paid or unpaid 
work, study/training, household chores, harvesting food/crops, fishing or hunting for food, seeking employment. [Insert 
other examples if needed].  In answering the following questions 'vigorous-intensity activities' are activities that require 
hard physical effort and cause large increases in breathing or heart rate, 'moderate-intensity activities' are activities that 
require moderate physical effort and cause small increases in breathing or heart rate. 
Question Response Code 
Work 
Does your work involve vigorous-intensity activity that 
causes large increases in breathing or heart rate like 
[carrying or lifting heavy loads, digging or construction 
work]  for at least 10 minutes continuously?  
[INSERT EXAMPLES]  (USE SHOWCARD) 
Yes 1 
P1 
No 2     If No, go to P 4 
In a typical week, on how many days do you do 
vigorous-intensity activities as part of your work? 
Number of days 
└─┘ P2 
How much time do you spend doing vigorous-
intensity activities at work on a typical day? Hours : minutes 
└─┴─┘: └─┴─┘ 
    hrs                mins 
P3 
(a-b) 
Total time spent on vigorous physical activities in a 
typical week 




Does your work involve moderate-intensity activity, 
that causes small increases in breathing or heart rate 
such as brisk walking [or carrying light loads]  for at 
least 10 minutes continuously?   
 [INSERT EXAMPLES]   (USE SHOWCARD) 
Yes 1 
P5 
No 2      If No, go to P 7 
In a typical week, on how many days do you do 
moderate-intensity activities as part of your work?  
Number of days └─┘ P6 
How much time do you spend doing moderate-
intensity activities at work on a typical day? Hours : minutes 
└─┴─┘: └─┴─┘ 
    hrs                mins 
P7 
(a-b) 
Total time spent on moderate physical activities in a 
typical week (hours) (P6 X P7)   
P8 
Travel to and from places 
The next questions exclude the physical activities at work that you have already mentioned. 




CORE:  Physical Activity, Continued 
Question Response Code 
Recreational activities 
The next questions exclude the work and transport activities that you have already mentioned. 
Now I would like to ask you about sports, fitness and recreational activities (leisure), [Insert relevant terms]. 
Do you do any vigorous-intensity sports, fitness or 
recreational (leisure) activities that cause large 
increases in breathing or heart rate like [running or 
football]  for at least 10 minutes continuously?  
[INSERT EXAMPLES]   (USE SHOWCARD) 
Yes   1 
P13 
No 2      If No, go  to P 14 
In a typical week, on how many days do you do 
vigorous-intensity sports, fitness or recreational 
(leisure) activities? 
Number of days 
└─┘ 
P14 
How much time do you spend doing  vigorous-
intensity sports, fitness or recreational activities on a 
typical day? 
Hours : minutes 
└─┴─┘: └─┴─┘ 
    hrs                mins 
P15 
(a-b) 
Do you do any moderate-intensity sports, fitness or 
recreational (leisure) activities that cause a small 
increase in breathing or heart rate such as brisk 
walking, [cycling, swimming, volleyball] for at least 10 
minutes continuously? 
 [INSERT EXAMPLES]   (USE SHOWCARD) 
Yes   1 
P16 
No 2      If No, go to P17 
In a typical week, on how many days do you do 
moderate-intensity sports, fitness or recreational 
(leisure) activities?  




market, to place of worship. [Insert other examples if needed] 
Do you walk or use a bicycle (pedal cycle) for at least 
10 minutes continuously to get to and from places? 
Yes 1 
P9 
No 2      If No, go to P 10 
In a typical week, on how many days do you walk or 
bicycle for at least 10 minutes continuously to get to 
and from places? 
Number of days 
└─┘ 
P10 
How much time do you spend walking or bicycling for 
travel on a typical day?  
Hours : minutes 
└─┴─┘: └─┴─┘ 
     hrs               mins 
P11 
(a-b) 
Do you walk 30 minutes or more on a typical day ?  
Yes   1 




How much time do you spend doing moderate-
intensity sports, fitness or recreational (leisure) 
activities on a typical day? 
Hours : minutes 
└─┴─┘: └─┴─┘ 




EXPANDED:  Physical Activity 
Sedentary behaviour 
The following question is about sitting or reclining at work, at home, getting to and from places, or with friends including time spent 
sitting at a desk, sitting with friends, traveling in car, bus, train, reading, playing cards or watching television, but do not include 
time spent sleeping. 
[INSERT EXAMPLES]   (USE SHOWCARD) 
How much time do you usually spend sitting or reclining on 
a typical day?  
└─┴─┘: └─┴─┘ 





CORE: History of  Raised Blood Pressure 
Question Response Code 
Have you ever had your blood pressure measured by a 
doctor or other health worker? 
Yes 1 H1 
No 2       If No, go to H6 
Have you ever been told by a doctor or other health 




No 2       If No, go to H6 
Have you been told in the past 12 months? 
Yes 1 
H2b 
No 2  
In the past two weeks, have you taken any drugs 
(medication) for raised blood pressure prescribed by a 




Have you ever seen a traditional healer for raised blood 




Are you currently taking any herbal or traditional remedy 
for your raised blood pressure? 







CORE: History of  Diabetes 
Have you ever had your blood sugar measured by a 
doctor or other health worker? 
Yes 1 H6 
No 2       If No, go to H12 
Have you ever been told by a doctor or other health 
worker that you have raised blood sugar or diabetes? 
Yes 1 H7a 
No 2       If No, go to H12 
Have you been told so in the past 12 months? 
Yes 1 
H7b 
No 2  
In the past two weeks, have you taken any drugs 
(medication) for diabetes prescribed by a doctor or 




Are you currently taking insulin for diabetes prescribed 




Have you ever seen a traditional healer for diabetes or 




Are you currently taking any herbal or traditional 






CORE: History of Cardiovascular Diseases 
Have you ever had a heart attack or chest pain from 
heart disease (angina) ? 
Yes 1 H12 
No 2 
Do you have a family history of CVD ?  






CORE:  Lifestyle Advice 
1.1.1.1.1.1.1.1.1 During the past three years, has a doctor or other health worker advised you to do any of the following? 
(RECORD FOR EACH) 
Quit using tobacco or don’t start Yes 1 H14a 
No 2 

















Maintain a healthy body weight or lose weight 
Yes 1      If C1=1 go to M1 
H14f 




Step 2    Physical Measurements 
 
CORE: Blood Pressure  
Question Response Code 
Interviewer ID  
└─┴─┴─┘ 
M1 
Device ID for blood pressure                        
└─┴─┴─┘ 
M2 
Reading 1 Systolic (mmHg) M3a 
Dystolic (mmHg) M3b 
Heart rate (bpm) M3c 
Reading 2 Systolic (mmHg) M4a 
Dystolic (mmHg) M4b 
Heart rate (bpm) M4c 
Reading 3 Systolic (mmHg) M5a 
Dystolic (mmHg) M5b 
Heart rate (bpm) M5c 
Average systolic blood pressure  M6 
Average diastolic blood pressure  M7 
Average heart rate  M8 
Hypertension any Yes  1 
No   2 
M9 
Hypertension any or currently on hypertensive 
medication 
Yes  1 
No   2 
M10 
Hypertension known for the first time 
(H2a=No, M9=Yes) 
Yes  1 
No   2 
M11 
Pre-hypertension 
(SBP:120-139 mmHg or DBP: 80 to 89 Hg) 
Yes  1 
No   2 
M12 
Stage I hypertension  
(SBP:140-159 mmHg or DBP: 90-99 mmHg) 
Yes  1 
No   2 
M13 
Stage II hypertension 
(SBP: ≥160 mmHg or DBP:≥100 mmHg) 
Yes  1 
No   2 
M14 
Isolated systolic hypertension 
(SBP:≥140 mmHg and DBP: <90 mmHg) 
Yes  1 




CORE: Height and Weight   
For women : Are you pregnant ?                        Yes  1 If yes go to B1 
No   2 
M16 
Interviewer ID  
└─┴─┴─┘ 
M17 
Height in meter (m) M18 
Weight in Kilograms (kg) M19 
Body mass index in Kg/m2 M20 
Obesity  
1=<18.5 Kg/m2 (underwt.), 2=18.5-24.9  Kg/m2 (normal), 
3=25-29.9 Kg/m2 (preobese),  4=30-34.9 Kg/m2 (obesity I), 
5= 35-39.9 Kg/m2 (obesity II), 6= ≥40 Kg/m2 (obesity III) 
 
M21 
CORE: Waist and Hip Circumference   
Waist circumference in Centimeters (cm) M22 
Hip circumference in Centimeters (cm) M23 
Waist-hip ratio  M24 
High Waist circumference  
(IDF criteria for South Asian) 





(WHO recommendation of  metabolic 
complications) 
1 = Yes (if W-H ratio ≥0.90 for male and ≥0.85 for female) 
2= No  
M26 
 
Step 3    Biochemical Measurements 
 
CORE:  Blood Glucose 
Question Response Code 
Glycated hemoglobin (HbA1C) 
[CHOOSE ACCORDINGLY: MMOL/L OR 
MG/DL] 
 
mmol/mol  └─┴─┘. └─┴─┘ 
B1 
Estimated average glucose (eAG) mmol/mol  └─┴─┘. └─┴─┘ B2 
Diabetes  
(HbA1C= ≥ 48 mmol/mol) 
 
Yes  1      




Impaired glucose tolerance  
(HbA1c=  ≥ 39 to 47 mmol/mol ) 
Yes  1      
No   2 
B4 
Diabetes or currently on diabetes medication 
Yes  1      
No   2 
B5 
Diabetes known for the first time (H7a=No, B3 = Yes) 
Yes  1      
No   2 
B6 
CORE: Blood Lipids 
During the past two weeks, have you been treated for 
raised cholesterol with drugs (medication) prescribed 






[CHOOSE ACCORDINGLY: MMOL/L OR MG/DL] 
                                                mmol/L └─┴─┴─┘.└─┘ 
B8 
High levels of total cholesterol  (≥5.2 mmol/L) 
           Yes  1      
                                                   No   2 
B9 
Tryglyceride 
[CHOOSE ACCORDINGLY: MMOL/L OR MG/DL] 
                                                mmol/L └─┴─┴─┘.└─┘ 
B10 
High levels of tryglycerides (≥1.7 mmol/L) 
         Yes  1      
                                                   No   2 
B11 
HDL cholesterol 
[CHOOSE ACCORDINGLY: MMOL/L OR MG/DL] 
                                                mmol/L └─┴─┴─┘.└─┘ 
B12 
Low levels of HDL cholesterol 
 (<1.0 mmol/L for males and <1.3 mmol/L for females) 
         Yes  1      
                                                  No   2 
B13 
LDL cholesterol 
[CHOOSE ACCORDINGLY: MMOL/L OR MG/DL] 
                                                mmol/L └─┴─┴─┘.└─┘ 
B14 
High levels of LDL cholesterol  (≥3.4 mmol/L) 
          Yes  1      
                                                   No   2 
B15 
Non-HDL cholesterol 
[CHOOSE ACCORDINGLY: MMOL/L OR MG/DL] 
                                                mmol/L └─┴─┴─┘.└─┘ 
B16 
High levels of Non-HDL cholesterol  (≥4.1 mmol/L) 
         Yes  1      
                                                  No   2 
B17 




High total cholesterol to HDL ratio (≥ 5) 
        Yes  1      
                                                  No   2 
B19 
Dyslipidemia  
(Abnormal levels of at least one among TC, TG, HDL & 
LDL) 
        Yes  1      
                                                  No   2 
B20 
Clustering of lipids  
(More than one abnormal levels of TC, TG, HDL & 
LDL) 
        1= >1,  
                  2= 2 or more,  
                 3= 3 or more,  
             4= All four,  






WHO/ISH Risk Prediction  
Question Response Code 
10 year risk of fatal or non-fatal CVD event  (combined risk of MI and 
stroke) 
(According to WHO/ISH risk prediction chart for WHO region SEAR D, 
only among the participants aged 40 years or more) 
a. <10%  1 
b. 10% to <20%  2 
c. 20% to <30%   3 
d. 30% to <40%  4 
e.  ≥40%  5 








Appendix B: Questionnaire for Verifying Stroke Free Status 
Question Response Code 
Were you ever told by a physician that you had a 
stroke ?   
a. Yes  1  
b. No    2 
c. Unknown  3 
S1 
Were you ever told by a physician that you had a 
TIA, ministroke, or transient ischemic attack ? 
a. Yes  1  
b. No    2 
c. Unknown  3 
S2 
Have you ever had sudden painless weakness on 
one side of your body ? 
a. Yes  1  
b. No    2 
c. Unknown  3 
S3 
Have you ever had sudden numbness or a dead 
feeling on one side of your body ? 
a. Yes  1  
b. No    2 
c. Unknown  3 
S4 
Have you  ever had sudden painless loss of vision 
in one or both eyes ? 
a. Yes  1  
b. No    2 
c. Unknown  3 
S5 
Have you ever suddenly lost one half of your 
vision ? 
a. Yes  1  
b. No    2 
c. Unknown  3 
S6 
Have you ever suddenly lost the ability to 
understand what people are saying ? 
a. Yes  1  
b. No    2 
c. Unknown  3 
S7 
Have you ever suddenly lost the ability to express 
yourself verbally or in writing ? 
a. Yes  1  
b. No    2 
c. Unknown  3 
S8 
Jones W J et al. Validating the Questionnaire for Verifying Stroke-Free Status (QVSFS) by 




Appendix C: Participant Information Sheet 




Associate Prof. Stewart Mann 
Department of Medicine 
University of Otago, Wellington 
Contact phone 
number: 
+64 4 918 6793 
 
Thank you for showing an interest in this project.  Please read this information sheet 
carefully. Take time to consider and, if you wish, talk with relatives or friends, before 
deciding whether or not to participate.  
If you decide to participate we thank you. If you decide not to take part there will be no 
disadvantage to you and we thank you for considering our request.   
Our team is conducting a study on factors related to cardiovascular diseases in people 
living at high altitude in Nepal. Cardiovascular diseases are diseases of the heart and 
blood vessels. The most common risk factors of cardiovascular diseases are high levels of 
blood pressure, cholesterols, diabetes, obesity, smoking, dietary habit, physical inactivity 
etc. It is not clearly known whether people living at high altitude in Nepal are at risk of 
cardiovascular disease, and further research is needed. 
This study is sponsored by the University of Otago, New Zealand and has been supported 
by an independent cardiovascular research trust.  
We are seeking participants from people living permanently at high altitude (>2400 metre), 
aged 30 years or above, and who speak and understand the Nepalese language. We are 
sorry that we are unable to include those with impairments in hearing and speaking, 
pregnant women, and those unable or unwilling to provide written or verbal consent.  
If you agree, your participation in this study will involve you being asked some questions 
about your lifestyle, diet, medical conditions and history. Your height and weight, waist 
and hip measurements, and blood pressure will be measured. A very small sample of 
blood will be obtained from you once using a finger prick which may be briefly 
uncomfortable. A well-trained person will conduct this procedure.  The sample will be put 
into a machine immediately and will provide the results of cholesterol and diabetes test 
within a turnaround time of 15 minutes. After processing, blood sample will be disposed of 
straight away. We will also record an ECG (electrocardiogram) which involves making 
recordings of the electrical activity of your heart from stickers attached lightly to your skin. 
This whole study process will take approximately 45 minutes.  
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It would be greatly appreciated if you could take part in this study. Your participation in this 
study is entirely voluntary and your responses will be kept strictly confidential and 
anonymous. You will not be paid any money to be part of this study, nor be asked to pay 
any money to take part. Your decision on whether or not to participate in this study will 
have no consequences for your future healthcare. If you agree to participate, you have the 
right to withdraw from this study at any point without giving any reasons. You will be 
requested to provide consent by signing a form with signature or thumb print or by giving 
witnessed oral consent.  
Any questions? 
If you have any questions now or in the future, please feel free to contact either: 
Name Nirmal Aryal 
Position Student Investigator 
Department Medicine, University of Otago 
Contact phone number: 
       (To be confirmed) 
Name Stewart Mann 
Position Principal Investigator 
Department Medicine, University of Otago 
Contact phone number: 
+64 4 918 6793 
Name .................................... 
Position Research Assistant 
Department 
Contact phone number: 
……………………………… 
 
This study has been approved by the University of Otago Human Ethics Committee 
(Health). If you have any concerns about the ethical conduct of the research you may 
contact the Committee through the Human Ethics Committee Administrator (phone +64 3 
479 8256 or email gary.witte@otago.ac.nz). Any issues you raise will be treated in 





Appendix D: Participant Consent form 
 
Cardiovascular risk in high altitude people of Nepal 
Principal Investigator: Associate Prof. Stewart Mann, stewart.mann@otago.ac.nz 
CONSENT FORM FOR PARTICIPANTS 
Following signature and return to the research team this form will be stored in a secure place for 
ten years. 
Name of participant:…………………………………….. 
1. I have read the Information Sheet concerning this study and understand the 
aims of this research project. 
2. I have had sufficient time to talk with other people of my choice about 
participating in the study.   
3. I confirm that I meet the criteria for participation which are explained in the 
Information Sheet. 
4. All my questions about the project have been answered to my satisfaction, and I 
understand that I am free to request further information at any stage.  
5. I know that my participation in the project is entirely voluntary, and that I am free 
to withdraw from the project at any time without disadvantage. I also agree to 
inform my health practitioner that I am taking part in this study. 
6. I know that as a participant I will have to provide bio-physical measurements, 
bio-chemical tests from finger-pricked blood sample and an ECG recording. I will 
also be asked about my medical condition and medical history.  
7. I know that the questionnaire will mainly explore lifestyle and dietary information 
and that if the line of questioning  develops in such a way that I feel hesitant or 
uncomfortable I may decline to answer any particular question(s) , and /or may 
withdraw from the project without disadvantage of any kind. 
8. I understand the nature and size of the risks of discomfort or harm which are 
explained in the Information Sheet. 
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9. I know that when the project is completed all personal identifying information will 
be removed from the paper records and electronic files which represent the data 
from the project, and that these will be placed in secure storage and kept for at 
least ten years.  
10. I understand that the results of the project may be published and be available in 
the University of Otago Library. I agree that any personal identifying information 
will remain confidential between myself and the researchers during the study. It 
will not appear in any spoken or written report of the study. However, I may 
agree for my named results being provided to my preferred health care provider.  
11. I know that there is no remuneration offered for this study, and that no 
commercial use will be made of the data.  
12. I understand that the blood samples will be disposed by the study team 
immediately after testing using the standard procedure. 
Signature or thumb print of 
participant: 
 Date: 
   
   
Signature or thumb print and name 
of witness: 
 Date: 
   
   
 
  Or verbal agreement to participate but unable to provide signature or thumb print  
 I wish / do not wish (delete one) for my results to be provided to my usual health 
provider ………………………………..(name of provider) 
Signature / thumb print ………………………… 
For the study researcher or independent witness: The above statement has 
been read to and understood by the participants. He / She has verbally agreed to 
each of the above statements and has agreed to participate in this study. 
 Name: ………………………        
          
 Signature: ……………….....      
 Date:………………………… 
